>FW339228.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
CGTAATAT
>FW339226.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
CGGTAAAT
>FW339212.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
CATACGAA
>FW339193.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
ATTAACGC
>FW339190.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
ATGAAGCG
>FW339189.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
ATCCGTTA
>FW339188.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
ATCATACG
>FW339183.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
ATACGGAA
>FW339182.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
ATACGATG
>FW339173.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
AATCGCTA
>FW339132.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
GGTTTAAC
>FW339129.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
GGCATTAC
>FW339116.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
GCCTTTAC
>FW339115.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
GCAATAAC
>FW339075.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
CGATTGCG
>FW339049.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
ATTATCGG
>FW339047.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
ATTACCGC
>FW339009.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
ACGTTTAT
>FW339000.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
AATTAACG
>FW338999.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
AATGCGGT
>FW338977.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
AACGATTG
>FW338960.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
AAAACGCT
>FW338932.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
ATTTTTTT
>FW338931.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
AATTTTTT
>FW338930.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
AAATTTTT
>FW338929.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
AAAATTTT
>FW338928.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
AAAAATTT
>FW338927.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
AAAAAATT
>FW338926.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
AAAAAAAT
>FW338909.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
TTTTTTTT
>FW338842.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
TTTTTTTC
>FW338841.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
TTTTTTCC
>FW338840.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
TTTTTCCC
>FW338839.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
TTTTCCCC
>FW338838.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
TTTCCCCC
>FW338837.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
TTCCCCCC
>FW338836.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
TCCCCCCC
>FW338835.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
CGGGGGGG
>FW338834.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
CCGGGGGG
>FW338833.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
CCCGGGGG
>FW338832.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
CCCCGGGG
>FW338831.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
CCCCCGGG
>FW338830.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
CCCCCCGG
>FW338829.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
CCCCCCCG
>FW338803.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
GGGGGGGG
>FW338802.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
CCCCCCCC
>FW338772.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
AAAAAAAA
>FW338762.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
AATTCCGG
>FW337840.1 Oligonucleotide analogs having cationic intersubunit linkages
CATATTGA
>FW341631.1 Compositions of TLR Ligands and Antivirals
GATTGTGT
>FW341630.1 Compositions of TLR Ligands and Antivirals
NGTTGTGT
>HC874337.1 Sequence 37 from Patent WO2010052319
GCCCCGAA
>HC874336.1 Sequence 36 from Patent WO2010052319
TTCGGGGC
>HC872726.1 Sequence 112 from Patent WO2010054010
GCGGCCGC
>HC870746.1 Sequence 1902 from Patent WO2010054007
CCATGGCG
>HC870745.1 Sequence 1901 from Patent WO2010054007
CCATGGCA
>HC870734.1 Sequence 1890 from Patent WO2010054007
GCGGCCGC
>FW331718.1 DETECTING NUCLEIC ACIDS
CGAACGAT
>FW331682.1 DETECTING NUCLEIC ACIDS
TATCCTAC
>FW331627.1 DETECTING NUCLEIC ACIDS
GCAATGCT
>FW333597.1 METHODS FOR SELECTING MEDICATIONS
GGCTGCGC
>FW333578.1 METHODS FOR SELECTING MEDICATIONS
GGCGCGGC
>FW333577.1 METHODS FOR SELECTING MEDICATIONS
GGCGCGGG
>FW307551.1 Aptamer against interleukin-17 and use thereof
GGAGTCAG
>FW310658.1 High Throughput Genome Sequencing on DNA Arrays
AGCTANNN
>HC768543.1 Sequence 180 from Patent WO2010051502
GCGGCCGC
>HC767974.1 Sequence 108 from Patent WO2010049156
GCGTGGTG
>HC767934.1 Sequence 68 from Patent WO2010049156
GCACGTCC
>HC767884.1 Sequence 18 from Patent WO2010049156
GCACGTCC
>HC767412.1 Sequence 37 from Patent EP2186880
GCCCCGAA
>HC767411.1 Sequence 36 from Patent EP2186880
TTCGGGGC
>HC727829.1 Sequence 31 from Patent WO2010042543
CTATCTGT
>HC727827.1 Sequence 29 from Patent WO2010042543
CTATCTGA
>HC689114.1 Sequence 102 from Patent WO2010037539
TGGATCCA
>HC689113.1 Sequence 101 from Patent WO2010037539
ACCTAGGT
>HC689067.1 Sequence 55 from Patent WO2010037539
GGTTTTGG
>HC504643.1 Sequence 70 from Patent WO2010037593
ATGTAAAC
>HC503264.1 Sequence 16 from Patent EP2175391
GGAATCCC
>HC503251.1 Sequence 3 from Patent EP2175391
GGAATSCC
>HC503249.1 Sequence 1 from Patent EP2175391
GGAATGCC
>HC502192.1 Sequence 4 from Patent EP2175022
CTACCATG
>HC502190.1 Sequence 2 from Patent EP2175022
CCRCCATG
>FW301507.1 USE OF MULTIPLE TRANSFORMATION ENHANCER SEQUENCES TO IMPROVE PLANT TRANSFORMATION EFFICIENCY
TGTWTGTK
>FW300274.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CAGNNCGC
>FW300257.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGGNNCCA
>FW300250.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GCGNNGAC
>FW300213.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCGNNGAC
>FW300211.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GGCNNCGA
>FW300171.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GAGNNCGC
>FW300146.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
AGGNNCCG
>FW300145.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGGNNCAG
>FW300116.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGANNACG
>FW300110.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CAGNNGGC
>FW300103.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCGNNGTC
>FW300102.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GCGNNGCA
>FW300099.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GCANNGCC
>FW300096.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGGNNGCA
>FW300095.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNNGCC
>FW300084.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGTNNGCA
>FW300074.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGCNNACA
>FW300062.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCANNGGG
>FW300059.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGCNNGGA
>FW300044.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNNGAA
>FW300039.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
AGCNNCGC
>FW299989.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CAGNNGGG
>FW299985.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNNCCC
>FW299978.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GCCNNCGA
>FW299970.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GACNNCCC
>FW299924.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
ACGNNCCC
>FW299912.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNNTCC
>FW299909.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGCNNCCG
>FW299902.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCGNNGGC
>FW299893.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGGNNCCC
>FW299811.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GACNNCGC
>FW299806.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCGNNGCC
>FW299742.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNNGCG
>FW299724.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNNCGC
>FW299660.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GCGNNCCC
>FW299653.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
AGGNNGGG
>FW299647.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GCGNNGCC
>FW299624.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNNCGG
>HC488154.1 Sequence 173 from Patent WO2010033229
TTAATTAA
>FW301493.1 USE OF MULTIPLE TRANSFORMATION ENHANCER SEQUENCES TO IMPROVE PLANT TRANSFORMATION EFFICIENCY
CTGACGAA
>HC457412.1 Sequence 1080 from Patent WO2010017311
GAACAGGG
>HC456391.1 Sequence 59 from Patent WO2010017311
TCGGAGTT
>HC456384.1 Sequence 52 from Patent WO2010017311
TCGGAGTT
>HC456372.1 Sequence 40 from Patent WO2010017311
GGATCTTA
>HC456362.1 Sequence 30 from Patent WO2010017311
CGATTTTT
>HC456356.1 Sequence 24 from Patent WO2010017311
CTACACAA
>HC456344.1 Sequence 12 from Patent WO2010017311
GGATCTTA
>HC455198.1 Sequence 1080 from Patent WO2010017319
GAACAGGG
>HC454177.1 Sequence 59 from Patent WO2010017319
TCGGAGTT
>HC454170.1 Sequence 52 from Patent WO2010017319
TCGGAGTT
>HC454158.1 Sequence 40 from Patent WO2010017319
GGATCTTA
>HC454148.1 Sequence 30 from Patent WO2010017319
CGATTTTT
>HC454142.1 Sequence 24 from Patent WO2010017319
CTACACAA
>HC454130.1 Sequence 12 from Patent WO2010017319
GGATCTTA
>HC442435.1 Sequence 59 from Patent WO2008109370
TCGGAGTT
>HC442428.1 Sequence 52 from Patent WO2008109370
TCGGAGTT
>HC442416.1 Sequence 40 from Patent WO2008109370
GGATCTTA
>HC442406.1 Sequence 30 from Patent WO2008109370
CGATTTTT
>HC442400.1 Sequence 24 from Patent WO2008109370
CTACACAA
>HC442388.1 Sequence 12 from Patent WO2008109370
GGATCTTA
>HC446270.1 Sequence 1056 from Patent WO2008109368
GAACAGGG
>HC445273.1 Sequence 59 from Patent WO2008109368
TCGGAGTT
>HC445266.1 Sequence 52 from Patent WO2008109368
TCGGAGTT
>HC445254.1 Sequence 40 from Patent WO2008109368
GGATCTTA
>HC445244.1 Sequence 30 from Patent WO2008109368
CGATTTTT
>HC445238.1 Sequence 24 from Patent WO2008109368
CTACACAA
>HC445226.1 Sequence 12 from Patent WO2008109368
GGATCTTA
>HC444809.1 Sequence 1080 from Patent WO2008109369
GAACAGGG
>HC443788.1 Sequence 59 from Patent WO2008109369
TCGGAGTT
>HC443781.1 Sequence 52 from Patent WO2008109369
TCGGAGTT
>HC443769.1 Sequence 40 from Patent WO2008109369
GGATCTTA
>HC443759.1 Sequence 30 from Patent WO2008109369
CGATTTTT
>HC443753.1 Sequence 24 from Patent WO2008109369
CTACACAA
>HC443741.1 Sequence 12 from Patent WO2008109369
GGATCTTA
>HC443432.1 Sequence 1056 from Patent WO2008109370
GAACAGGG
>FU765976.1 COMPOUNDS AND METHODS FOR MODULATING GENE EXPRESSION
GCCACCAA
>FU770279.1 COMPOUNDS AND METHODS FOR MODULATING EXPRESSION OF SGLT2
GCCACCAA
>FU767552.1 COMPOUNDS AND METHODS FOR MODULATING EXPRESSION OF APOB
GCCACCAA
>HC440795.1 Sequence 24 from Patent WO2010012667
ATGTAGGA
>HC440792.1 Sequence 21 from Patent WO2010012667
TAGCATTA
>HC436274.1 Sequence 133 from Patent EP2151498
AACCCANT
>HC436273.1 Sequence 132 from Patent EP2151498
AACCCANC
>HC436237.1 Sequence 96 from Patent EP2151498
ATGAGTCG
>HC436236.1 Sequence 95 from Patent EP2151498
TTGAGTCA
>HC436235.1 Sequence 94 from Patent EP2151498
CTGAGTCA
>HC436234.1 Sequence 93 from Patent EP2151498
GTGAGTTA
>HC436233.1 Sequence 92 from Patent EP2151498
TNGAGTTG
>HC436232.1 Sequence 91 from Patent EP2151498
ANGAGTTG
>S94172.1 p53 [human, embryonal rhabdomyosarcoma cell line CTR, Genomic Mutant, 8 nt]
GTGCCGAG
>S83252.1 SRY=sex-determining region Y gene [human, Genomic Mutant, 8 nt]
GCTGCGAT
>S83254.1 SRY=sex-determining region Y gene [human, Genomic Mutant, 8 nt]
CGTGTAGT
>S75472.1 rhodopsin {exon 1 deletion of codons 68-71} [human, Genomic Mutant, 8 nt]
CTCAACTA
>S62718.1 CST3=cystatin C {promoter} [human, Genomic Mutant, 8 nt]
CCCCGGGG
>S62213.1 p53 {10 bp deletion at nt 215-224} [human, Genomic Mutant, 8 nt]
CCCCTGCA
>HC307398.1 Sequence 32 from Patent WO2009156030
TTATGTCA
>HC307397.1 Sequence 31 from Patent WO2009156030
TTACGTCA
>FU265543.1 MULTIVALENT PCV2 IMMUNOGENIC COMPOSITIONS AND METHODS OF PRODUCING SUCH COMPOSITIONS
CCGCCATG
>FU262289.1 STABILIZED IMMUNE MODULATORY RNA (SIMRA) COMPOUNDS FOR TLR7 AND TLR8
TGCTGCTT
>FU249783.1 PHARMACEUTICAL COMPOSITION COMPRISING ANTI-MIRNA ANTISENSE OLIGONUCLEOTIDES
AACGAACA
>FU249780.1 PHARMACEUTICAL COMPOSITION COMPRISING ANTI-MIRNA ANTISENSE OLIGONUCLEOTIDES
TTAGCATT
>FU249777.1 PHARMACEUTICAL COMPOSITION COMPRISING ANTI-MIRNA ANTISENSE OLIGONUCLEOTIDES
TCACACTC
>FU249774.1 PHARMACEUTICAL COMPOSITION COMPRISING ANTI-MIRNA ANTISENSE OLIGONUCLEOTIDES
GATTTGCA
>DM475805.1 Matrixmetalloproteinase 9 Gene Selective Expression Inhibitor
AGTCAGCA
>DM474156.1 THE POLYAMIDE RESIN COMPOSITION
GGATATCC
>DM465130.1 Method of Producing Cells Having Characteristics of Hematopoietic Stem/Progenitor Cell
GCAGGTGK
>DM463493.1 Soluble MHC complexes and methods of use thereof
CCACCATG
>DM463467.1 Soluble MHC complexes and methods of use thereof
CCACCATG
>HC090638.1 Sequence 13 from Patent EP2123762
TATATAGC
>HC090630.1 Sequence 5 from Patent EP2123762
AGACCACC
>DM461011.1 METHODS AND COMPOSITIONS RELATED TO THE MODULATION OF RIBOSWITCHES
GACGAGGA
>DM460241.1 TRANSGENIC BRINJAL (SOLANUM MELONGENA) COMPRISING EE-1 EVENT
ACCTGCCC
>DM381978.1 Method of gene amplification on chromosome using recombinase
GGCTATAG
>DM381977.1 Method of gene amplification on chromosome using recombinase
GTATAGTA
>BD193151.1 High-throughput screening method for identification of genetic mutations or disease-causing microorganisms using segmented primers
TGGTAGTT
>BD193150.1 High-throughput screening method for identification of genetic mutations or disease-causing microorganisms using segmented primers
ATAAACTT
>BD193149.1 High-throughput screening method for identification of genetic mutations or disease-causing microorganisms using segmented primers
GGAGCTGG
>BD193147.1 High-throughput screening method for identification of genetic mutations or disease-causing microorganisms using segmented primers
TGGAGCTG
>BD193146.1 High-throughput screening method for identification of genetic mutations or disease-causing microorganisms using segmented primers
TTGGAGCT
>BD106879.1 Isolated nucleic acid molecule coding for tumor rejection antigen precursors MAGE-C1 and MAGE-C2 and uses thereof
CTGGAAAG
>BD057721.1 Fusion proteins comprising bacteriophage coat protein and a single-chain T cell receptor
CCACCATG
>HC050664.1 Sequence 119 from Patent WO2009126271
TGGTGGAG
>HC050663.1 Sequence 118 from Patent WO2009126271
GGAGGCTG
>HC050662.1 Sequence 117 from Patent WO2009126271
CTCCTCCT
>HC050661.1 Sequence 116 from Patent WO2009126271
CTGGGGCT
>HC050660.1 Sequence 115 from Patent WO2009126271
CAGGAGAA
>HC050659.1 Sequence 114 from Patent WO2009126271
TCTGGAGC
>HC050658.1 Sequence 113 from Patent WO2009126271
CTGGGCAA
>HC050657.1 Sequence 112 from Patent WO2009126271
GAAGGCAG
>HC050656.1 Sequence 111 from Patent WO2009126271
GGCAGCAG
>HC050655.1 Sequence 110 from Patent WO2009126271
CTTCCTCC
>HC050654.1 Sequence 109 from Patent WO2009126271
CCAGGCTG
>DM377932.1 Vaccine prepared from glycoprotein of virus causative of AIDS
GATCTGCA
>DM377626.1 Promoter of hyaluronate synthetase gene
ACCAGCCC
>DM380158.1 Process for producing protein by Aspergillus oryza
CAAAGCAG
>E11548.1 Oligonucleotide primer to detect trace DNA or RNA by PCR or Southern blotting
SWSWSWSV
>HC010759.1 Sequence 72 from Patent WO2009112022
CCTTCTCG
>HC010742.1 Sequence 55 from Patent WO2009112022
CGGATGCA
>HC010727.1 Sequence 40 from Patent WO2009112022
CCCCCTTC
>HC010724.1 Sequence 37 from Patent WO2009112022
CTCGAGAA
>HC010723.1 Sequence 36 from Patent WO2009112022
TTGAGTGG
>HC010714.1 Sequence 27 from Patent WO2009112022
CTCCCTCA
>HC010713.1 Sequence 26 from Patent WO2009112022
AAGTCGAA
>HC010691.1 Sequence 4 from Patent WO2009112022
CGCAACAC
>DM376406.1 Polynucleotide and its derivatives
TGAATAAA
>DM376405.1 Polynucleotide and its derivatives
ATGAATAA
>DM376404.1 Polynucleotide and its derivatives
AGATGAAT
>DM374408.1 Natural ligand of G protein coupled receptor CHEMR23 and uses thereof
TGACGTCA
>HC004610.1 Sequence 182 from Patent WO2009109665
ACTACCTC
>HC004605.1 Sequence 177 from Patent WO2009109665
ATTTGCAC
>HC004604.1 Sequence 176 from Patent WO2009109665
AGCACTTT
>HC004603.1 Sequence 175 from Patent WO2009109665
TCAACATC
>HC004602.1 Sequence 174 from Patent WO2009109665
ATCAGTCT
>HC004601.1 Sequence 173 from Patent WO2009109665
TCTGATAA
>HC004595.1 Sequence 167 from Patent WO2009109665
CACACTCC
>HC004593.1 Sequence 165 from Patent WO2009109665
TAGCATTA
>HC004591.1 Sequence 163 from Patent WO2009109665
GATAAGCT
>HC004539.1 Sequence 111 from Patent WO2009109665
AGCACTTT
>HC004538.1 Sequence 110 from Patent WO2009109665
TCCCCACC
>HC004537.1 Sequence 109 from Patent WO2009109665
TCCCAACC
>HC004536.1 Sequence 108 from Patent WO2009109665
AGTGCAAT
>HC004535.1 Sequence 107 from Patent WO2009109665
ACGAACAA
>HC004534.1 Sequence 106 from Patent WO2009109665
ATTTTGAG
>HC004533.1 Sequence 105 from Patent WO2009109665
AAGCACTT
>HC004532.1 Sequence 104 from Patent WO2009109665
CAGCACTT
>HC004531.1 Sequence 103 from Patent WO2009109665
CGTGCAAT
>HC004530.1 Sequence 102 from Patent WO2009109665
TTACTTGA
>HC004529.1 Sequence 101 from Patent WO2009109665
AGTGCAAT
>HC004528.1 Sequence 100 from Patent WO2009109665
GCTACTGA
>HC004527.1 Sequence 99 from Patent WO2009109665
GATGTAGC
>HC004526.1 Sequence 98 from Patent WO2009109665
ATGCCAGG
>HC004525.1 Sequence 97 from Patent WO2009109665
AATGTAGC
>HC004524.1 Sequence 96 from Patent WO2009109665
GATAAGCT
>HC004523.1 Sequence 95 from Patent WO2009109665
TACTACAG
>HC004522.1 Sequence 94 from Patent WO2009109665
AGCACTTT
>HC004521.1 Sequence 93 from Patent WO2009109665
TAATGCAG
>HC004520.1 Sequence 92 from Patent WO2009109665
AGCACTTT
>HC004519.1 Sequence 91 from Patent WO2009109665
ACATTTCA
>HC004518.1 Sequence 90 from Patent WO2009109665
GCAGTATT
>HC004517.1 Sequence 89 from Patent WO2009109665
ATTTGCAC
>HC004516.1 Sequence 88 from Patent WO2009109665
TGCAAAAC
>HC004515.1 Sequence 87 from Patent WO2009109665
ATTTGCAC
>HC004514.1 Sequence 86 from Patent WO2009109665
TTTAGGGC
>HC004513.1 Sequence 85 from Patent WO2009109665
TGCACCTT
>HC004512.1 Sequence 84 from Patent WO2009109665
TAGGGCAG
>HC004511.1 Sequence 83 from Patent WO2009109665
TGCACCTT
>HC004510.1 Sequence 82 from Patent WO2009109665
TCGATGGT
>HC004509.1 Sequence 81 from Patent WO2009109665
TTGAATGT
>HC004508.1 Sequence 80 from Patent WO2009109665
ATGAATGT
>HC004507.1 Sequence 79 from Patent WO2009109665
GTCAGTGG
>HC004506.1 Sequence 78 from Patent WO2009109665
GTCGATGG
>HC004505.1 Sequence 77 from Patent WO2009109665
TTGAATGT
>HC004504.1 Sequence 76 from Patent WO2009109665
CACTGCAG
>HC004503.1 Sequence 75 from Patent WO2009109665
AGCACTTT
>HC004502.1 Sequence 74 from Patent WO2009109665
TAGCATTA
>HC004501.1 Sequence 73 from Patent WO2009109665
TACTTTAT
>HC004500.1 Sequence 72 from Patent WO2009109665
AACACTAC
>HC004499.1 Sequence 71 from Patent WO2009109665
TGGAAGAT
>HC004498.1 Sequence 70 from Patent WO2009109665
ACAGTGTT
>HC004497.1 Sequence 69 from Patent WO2009109665
TCTCAGGG
>HC004496.1 Sequence 68 from Patent WO2009109665
CACACTCC
>HC004495.1 Sequence 67 from Patent WO2009109665
TACAGGGT
>HC004494.1 Sequence 66 from Patent WO2009109665
ACAGTGCG
>HC004493.1 Sequence 65 from Patent WO2009109665
AGCACTTT
>HC004492.1 Sequence 64 from Patent WO2009109665
ACATTGCA
>HC004491.1 Sequence 63 from Patent WO2009109665
AGCACTTT
>HC004490.1 Sequence 62 from Patent WO2009109665
TACATTCC
>HC003913.1 Sequence 6 from Patent EP2105146
TTGAACTC
>HC003912.1 Sequence 5 from Patent EP2105146
AAGTGCTT
>DM208824.1 Adjuvant for vaccine against influenza and vaccine against influenza
CGTCGACG
>DM208823.1 Adjuvant for vaccine against influenza and vaccine against influenza
CGACGTCG
>DM208822.1 Adjuvant for vaccine against influenza and vaccine against influenza
ACGGCCGT
>DM208821.1 Adjuvant for vaccine against influenza and vaccine against influenza
TAGCGCTA
>DM208820.1 Adjuvant for vaccine against influenza and vaccine against influenza
ACGTACGT
>DM208819.1 Adjuvant for vaccine against influenza and vaccine against influenza
AGCGCGCT
>DM208818.1 Adjuvant for vaccine against influenza and vaccine against influenza
CAACGTTG
>DM208817.1 Adjuvant for vaccine against influenza and vaccine against influenza
GAACGTTC
>DM208816.1 Adjuvant for vaccine against influenza and vaccine against influenza
ATCGCGAT
>DM208815.1 Adjuvant for vaccine against influenza and vaccine against influenza
GATCGATC
>DM208814.1 Adjuvant for vaccine against influenza and vaccine against influenza
CATCGATG
>DM208813.1 Adjuvant for vaccine against influenza and vaccine against influenza
ACGATCGT
>DM208812.1 Adjuvant for vaccine against influenza and vaccine against influenza
GCGATCGC
>DM208811.1 Adjuvant for vaccine against influenza and vaccine against influenza
CCGATCGG
>DM367362.1 IMMUNOSTIMULATORY NUCLEIC ACID PACKAGED PARTICLES FOR THE TREATMENT OF HYPERSENSITIVITY
CAACGTTG
>DM367357.1 IMMUNOSTIMULATORY NUCLEIC ACID PACKAGED PARTICLES FOR THE TREATMENT OF HYPERSENSITIVITY
ACGATCGT
>DM204111.1 E-CADHERIN GENE EXPRESSION INHIBITOR
TGCCACCT
>DM204110.1 E-CADHERIN GENE EXPRESSION INHIBITOR
AGGTGCGT
>DM204030.1 Method for detecting micro RNA
ACTATACA
>DM204029.1 Method for detecting micro RNA
ACTATGCA
>DM209064.1 Agent for preventing or treating hepatitis
CGTCGACG
>DM209063.1 Agent for preventing or treating hepatitis
CGACGTCG
>DM209062.1 Agent for preventing or treating hepatitis
ACGGCCGT
>DM209061.1 Agent for preventing or treating hepatitis
TAGCGCTA
>DM209060.1 Agent for preventing or treating hepatitis
ACGTACGT
>DM209059.1 Agent for preventing or treating hepatitis
AGCGCGCT
>DM209058.1 Agent for preventing or treating hepatitis
CAACGTTG
>DM209057.1 Agent for preventing or treating hepatitis
GAACGTTC
>DM209056.1 Agent for preventing or treating hepatitis
ATCGCGAT
>DM209055.1 Agent for preventing or treating hepatitis
GATCGATC
>DM209054.1 Agent for preventing or treating hepatitis
CATCGATG
>DM209053.1 Agent for preventing or treating hepatitis
ACGATCGT
>DM209052.1 Agent for preventing or treating hepatitis
GCGATCGC
>DM209051.1 Agent for preventing or treating hepatitis
CCGATCGG
>DM208932.1 Adjuvant for vaccine against Japanese encephalitis and vaccine against Japanese encephalitis
CGTCGACG
>DM208931.1 Adjuvant for vaccine against Japanese encephalitis and vaccine against Japanese encephalitis
CGACGTCG
>DM208930.1 Adjuvant for vaccine against Japanese encephalitis and vaccine against Japanese encephalitis
ACGGCCGT
>DM208929.1 Adjuvant for vaccine against Japanese encephalitis and vaccine against Japanese encephalitis
TAGCGCTA
>DM208928.1 Adjuvant for vaccine against Japanese encephalitis and vaccine against Japanese encephalitis
ACGTACGT
>DM208927.1 Adjuvant for vaccine against Japanese encephalitis and vaccine against Japanese encephalitis
AGCGCGCT
>DM208926.1 Adjuvant for vaccine against Japanese encephalitis and vaccine against Japanese encephalitis
CAACGTTG
>DM208925.1 Adjuvant for vaccine against Japanese encephalitis and vaccine against Japanese encephalitis
GAACGTTC
>DM208924.1 Adjuvant for vaccine against Japanese encephalitis and vaccine against Japanese encephalitis
ATCGCGAT
>DM208923.1 Adjuvant for vaccine against Japanese encephalitis and vaccine against Japanese encephalitis
GATCGATC
>DM208922.1 Adjuvant for vaccine against Japanese encephalitis and vaccine against Japanese encephalitis
CATCGATG
>DM208921.1 Adjuvant for vaccine against Japanese encephalitis and vaccine against Japanese encephalitis
ACGATCGT
>DM208920.1 Adjuvant for vaccine against Japanese encephalitis and vaccine against Japanese encephalitis
GCGATCGC
>DM208919.1 Adjuvant for vaccine against Japanese encephalitis and vaccine against Japanese encephalitis
CCGATCGG
>HB975565.1 Sequence 47 from Patent EP2096172
GGTCGACC
>HB975564.1 Sequence 46 from Patent EP2096172
GGCGCGCC
>HB975563.1 Sequence 45 from Patent EP2096172
GGGATCCC
>DM188807.1 Compositions comprising compounds facilitating nucleic acid synthesis and use thereof, and method for producing the compounds
ATGCGCAT
>DM188806.1 Compositions comprising compounds facilitating nucleic acid synthesis and use thereof, and method for producing the compounds
ATGCGCAT
>DM188805.1 Compositions comprising compounds facilitating nucleic acid synthesis and use thereof, and method for producing the compounds
CGGCGCCG
>DM188804.1 Compositions comprising compounds facilitating nucleic acid synthesis and use thereof, and method for producing the compounds
CGGCGCCG
>DM193573.1 PEPTIDE-DICER SUBSTRATE RNA CONJUGATES AS DELIVERY VEHICLES FOR SIRNA
GGATCTTA
>DM193559.1 PEPTIDE-DICER SUBSTRATE RNA CONJUGATES AS DELIVERY VEHICLES FOR SIRNA
GGATCTTA
>DM193545.1 PEPTIDE-DICER SUBSTRATE RNA CONJUGATES AS DELIVERY VEHICLES FOR SIRNA
GGATCTTA
>DM193540.1 PEPTIDE-DICER SUBSTRATE RNA CONJUGATES AS DELIVERY VEHICLES FOR SIRNA
AGACAATG
>DM193531.1 PEPTIDE-DICER SUBSTRATE RNA CONJUGATES AS DELIVERY VEHICLES FOR SIRNA
GGATCTTA
>DM192972.1 DISEASE RESISTANT PLANTS
CAGCCTTT
>DM196044.1 Improvements in sequencing
TCGAGCTA
>DM191495.1 Aurora Kinese A and Aurora Kinese B Gene Selective Expression Inhibitor
AGATTTGA
>DM189833.1 NOVEL COSMETIC DESIGNS AND PRODUCTS USING INTRONIC RNA
GTAAGAGK
>DM202902.1 Multitargeting interfering RNAs and Methods of their Use and Design
CTATTCTG
>DM202899.1 Multitargeting interfering RNAs and Methods of their Use and Design
CAGAATAG
>DM202883.1 Multitargeting interfering RNAs and Methods of their Use and Design
CCCACTGA
>DM202882.1 Multitargeting interfering RNAs and Methods of their Use and Design
TCAGTGGG
>HB650681.1 Sequence 25 from Patent WO2009091815
TGACGTGR
>HB649990.1 Sequence 39 from Patent WO2009091659
GTAAGAGT
>HB649955.1 Sequence 4 from Patent WO2009091659
GTAAGAGK
>HB855128.1 Sequence 47 from Patent WO2009093253
GGAGGGGG
>HB855127.1 Sequence 46 from Patent WO2009093253
GAAGGGGA
>HB855045.1 Sequence 102 from Patent WO2009095226
TGGATCCA
>HB855044.1 Sequence 101 from Patent WO2009095226
ACCTAGGT
>HB854998.1 Sequence 55 from Patent WO2009095226
GGTTTTGG
>DM179886.1 A MORTIERELLA ALPINA C16/18 FATTY ACID ELONGASE
ACCAGCCC
>DM186277.1 Cyclitol Linker Polymer Conjugate
GTGAATGC
>DM186276.1 Cyclitol Linker Polymer Conjugate
TTGGACGC
>DM179376.1 MULTICOMPONENT NUCLEIC ACID ENZYMES AND METHODS FOR THEIR USE
GGCTAGCT
>DM179373.1 MULTICOMPONENT NUCLEIC ACID ENZYMES AND METHODS FOR THEIR USE
TACTACGA
>DM179372.1 MULTICOMPONENT NUCLEIC ACID ENZYMES AND METHODS FOR THEIR USE
TACATCGA
>DM179371.1 MULTICOMPONENT NUCLEIC ACID ENZYMES AND METHODS FOR THEIR USE
TTCAACGA
>DM179370.1 MULTICOMPONENT NUCLEIC ACID ENZYMES AND METHODS FOR THEIR USE
TACAACAA
>DM179369.1 MULTICOMPONENT NUCLEIC ACID ENZYMES AND METHODS FOR THEIR USE
TACAACGA
>DM179368.1 MULTICOMPONENT NUCLEIC ACID ENZYMES AND METHODS FOR THEIR USE
TACAACGA
>DM179366.1 MULTICOMPONENT NUCLEIC ACID ENZYMES AND METHODS FOR THEIR USE
CGGTCGAA
>DM179365.1 MULTICOMPONENT NUCLEIC ACID ENZYMES AND METHODS FOR THEIR USE
TACAACGA
>DM170741.1 NUCLEIC ACID BINDING POLYPEPTIDE LIBRARY
NNNNGGCG
>DM170582.1 HYPOXIA INDUCIBLE FACTOR-1 AND METHOD OF USE
CACGTGCT
>DM170581.1 HYPOXIA INDUCIBLE FACTOR-1 AND METHOD OF USE
BACGTGCK
>DM170580.1 HYPOXIA INDUCIBLE FACTOR-1 AND METHOD OF USE
CACGTGCG
>DM170579.1 HYPOXIA INDUCIBLE FACTOR-1 AND METHOD OF USE
GACGTGCG
>DM170578.1 HYPOXIA INDUCIBLE FACTOR-1 AND METHOD OF USE
TACGTGCT
>DM187672.1 APTAMERS COMPRISING ARABINOSE MODIFIED NUCLEOTIDES
TTNGGNTT
>DM187671.1 APTAMERS COMPRISING ARABINOSE MODIFIED NUCLEOTIDES
TTGNGNTT
>DM187670.1 APTAMERS COMPRISING ARABINOSE MODIFIED NUCLEOTIDES
TTNGNGTT
>DM187669.1 APTAMERS COMPRISING ARABINOSE MODIFIED NUCLEOTIDES
NNGGGGNN
>DM187668.1 APTAMERS COMPRISING ARABINOSE MODIFIED NUCLEOTIDES
TTNNNNTT
>DM187666.1 APTAMERS COMPRISING ARABINOSE MODIFIED NUCLEOTIDES
TTGGGGTT
>DM187665.1 APTAMERS COMPRISING ARABINOSE MODIFIED NUCLEOTIDES
TTGGGGTT
>DM177503.1 snRNA GENE-LIKE TRANSCRIPTIONAL UNITS AND USES THEREOF
ATGCAAAT
>DM177502.1 snRNA GENE-LIKE TRANSCRIPTIONAL UNITS AND USES THEREOF
ATTTGCAT
>DM187588.1 OLIGONUCLEOTIDE ANALOGUES INCORPORATING 5-AZA-CYTOSINE THEREIN
TTCGCGAA
>DM187587.1 OLIGONUCLEOTIDE ANALOGUES INCORPORATING 5-AZA-CYTOSINE THEREIN
TTNGNGAA
>DM187579.1 OLIGONUCLEOTIDE ANALOGUES INCORPORATING 5-AZA-CYTOSINE THEREIN
AGGCTTTA
>DM187578.1 OLIGONUCLEOTIDE ANALOGUES INCORPORATING 5-AZA-CYTOSINE THEREIN
TAGCAGTG
>DM187577.1 OLIGONUCLEOTIDE ANALOGUES INCORPORATING 5-AZA-CYTOSINE THEREIN
CAGCGATA
>DM187576.1 OLIGONUCLEOTIDE ANALOGUES INCORPORATING 5-AZA-CYTOSINE THEREIN
GTGCAGCA
>DM187573.1 OLIGONUCLEOTIDE ANALOGUES INCORPORATING 5-AZA-CYTOSINE THEREIN
GCGCCGAC
>DM187572.1 OLIGONUCLEOTIDE ANALOGUES INCORPORATING 5-AZA-CYTOSINE THEREIN
AGCAGCAT
>DM187571.1 OLIGONUCLEOTIDE ANALOGUES INCORPORATING 5-AZA-CYTOSINE THEREIN
CGGGCGGC
>DM187567.1 OLIGONUCLEOTIDE ANALOGUES INCORPORATING 5-AZA-CYTOSINE THEREIN
GCTCGGCT
>DM187566.1 OLIGONUCLEOTIDE ANALOGUES INCORPORATING 5-AZA-CYTOSINE THEREIN
CGGCCCGG
>DM187565.1 OLIGONUCLEOTIDE ANALOGUES INCORPORATING 5-AZA-CYTOSINE THEREIN
TGCCGGCT
>DM187564.1 OLIGONUCLEOTIDE ANALOGUES INCORPORATING 5-AZA-CYTOSINE THEREIN
TGCCTCGT
>DM187563.1 OLIGONUCLEOTIDE ANALOGUES INCORPORATING 5-AZA-CYTOSINE THEREIN
TTCGCGAA
>DM187559.1 OLIGONUCLEOTIDE ANALOGUES INCORPORATING 5-AZA-CYTOSINE THEREIN
GTGNAGNA
>DM187557.1 OLIGONUCLEOTIDE ANALOGUES INCORPORATING 5-AZA-CYTOSINE THEREIN
TGCCTNGT
>DM187556.1 OLIGONUCLEOTIDE ANALOGUES INCORPORATING 5-AZA-CYTOSINE THEREIN
TTNGNGAA
>HB559469.1 Sequence 84 from Patent EP2088200
GTAGGTAG
>DM168778.1 RNA ANTAGONIST COMPOUNDS FOR THE INHIBITION OF APO-B100 EXPRESSION
GCATTGGT
>DM168777.1 RNA ANTAGONIST COMPOUNDS FOR THE INHIBITION OF APO-B100 EXPRESSION
TCAGCATT
>DM168776.1 RNA ANTAGONIST COMPOUNDS FOR THE INHIBITION OF APO-B100 EXPRESSION
GGTATTCA
>DM168775.1 RNA ANTAGONIST COMPOUNDS FOR THE INHIBITION OF APO-B100 EXPRESSION
GTATTCAG
>DM159446.1 Methods for Preparing Recombinant Apolipoprotein C-I
TAGCATGC
>DM162542.1 B7-2: CTL A4/CD28 COUNTER RECEPTOR
CTCTAAAG
>HB464056.1 Sequence 11 from Patent WO2009085215
CTANNTTA
>HB464055.1 Sequence 10 from Patent WO2009085215
CTNAGNTA
>HB464054.1 Sequence 9 from Patent WO2009085215
CTAAGTTA
>HB464043.1 Sequence 11 from Patent WO2009085172
GAATATTC
>HB464042.1 Sequence 10 from Patent WO2009085172
GAAATTTC
>HB464041.1 Sequence 9 from Patent WO2009085172
GAAGCTTC
>HB464040.1 Sequence 8 from Patent WO2009085172
GAACGTTC
>HB464039.1 Sequence 7 from Patent WO2009085172
GAANNTTC
>HB472002.1 Sequence 14 from Patent EP2083015
GNTGAATG
>HB471991.1 Sequence 3 from Patent EP2083015
TGACAGAT
>HB471990.1 Sequence 2 from Patent EP2083015
GGTGAATG
>HB471989.1 Sequence 1 from Patent EP2083015
CATTCACC
>DM148771.1 Compositions and Methods Relating to Orthogonal Ribosome mRNA Pairs
CCGNNGGC
>DM148768.1 Compositions and Methods Relating to Orthogonal Ribosome mRNA Pairs
CCGGTGGC
>DM148766.1 Compositions and Methods Relating to Orthogonal Ribosome mRNA Pairs
CCGGTGGC
>DM148762.1 Compositions and Methods Relating to Orthogonal Ribosome mRNA Pairs
CCGCAGGC
>DM148760.1 Compositions and Methods Relating to Orthogonal Ribosome mRNA Pairs
CCGCGGGC
>DM148757.1 Compositions and Methods Relating to Orthogonal Ribosome mRNA Pairs
CCGACGGC
>DM148755.1 Compositions and Methods Relating to Orthogonal Ribosome mRNA Pairs
CCGGTGGC
>DM148753.1 Compositions and Methods Relating to Orthogonal Ribosome mRNA Pairs
CCGCAGGC
>DM148751.1 Compositions and Methods Relating to Orthogonal Ribosome mRNA Pairs
CCGCGGGC
>DM148749.1 Compositions and Methods Relating to Orthogonal Ribosome mRNA Pairs
CCGAGGGC
>DM147515.1 Hybridization method and apparatus
CGTACGTA
>DM156375.1 PRODUCTION OF MULTIVALENT VIRUS LIKE PARTICLES
AACGTTCG
>DM150170.1 TARGETED INTEGRATION AND EXPRESSION OF EXOGENOUS NUCLEIC ACID SEQUENCES
GACCACAT
>HB445863.1 Sequence 1 from Patent WO2009078939
ATGCAAAT
>DM134846.1 Immunogenic and Therapeutic Compositions for Streptococcus pyogenes
AAAAAAAA
>DM139885.1 NOVEL TARGETS FOR THE IDENTIFICATION OF ANTIBIOTICS THAT ARE NOT SUSCEPTIBLE TO ANTIBIOTIC RESISTANCE
GGAGTCTG
>DM139877.1 NOVEL TARGETS FOR THE IDENTIFICATION OF ANTIBIOTICS THAT ARE NOT SUSCEPTIBLE TO ANTIBIOTIC RESISTANCE
GCCAGCGG
>DM139875.1 NOVEL TARGETS FOR THE IDENTIFICATION OF ANTIBIOTICS THAT ARE NOT SUSCEPTIBLE TO ANTIBIOTIC RESISTANCE
CAGCTCGT
>DM139866.1 NOVEL TARGETS FOR THE IDENTIFICATION OF ANTIBIOTICS THAT ARE NOT SUSCEPTIBLE TO ANTIBIOTIC RESISTANCE
CGCCTGGG
>DM139849.1 NOVEL TARGETS FOR THE IDENTIFICATION OF ANTIBIOTICS THAT ARE NOT SUSCEPTIBLE TO ANTIBIOTIC RESISTANCE
GCCTGATG
>DM139842.1 NOVEL TARGETS FOR THE IDENTIFICATION OF ANTIBIOTICS THAT ARE NOT SUSCEPTIBLE TO ANTIBIOTIC RESISTANCE
CCTAGCTG
>DM139840.1 NOVEL TARGETS FOR THE IDENTIFICATION OF ANTIBIOTICS THAT ARE NOT SUSCEPTIBLE TO ANTIBIOTIC RESISTANCE
CAGATGGG
>DM121673.1 Production mrthod of light-up fluorophore used for gene diagnosis
CGGGCCCG
>DM121672.1 Production mrthod of light-up fluorophore used for gene diagnosis
CGAATTCG
>DM130708.1 ENZYMATIC DNA MOLECULES
TCACTATN
>HB436700.1 Sequence 15 from Patent WO2009075886
AGCGAGCG
>HB433239.1 Sequence 15 from Patent EP2075582
ACCTCGGC
>DM113280.1 GENOMIC PROFILING OF REGULATORY FACTOR BINDING SITES
CTTGGCGG
>DM113279.1 GENOMIC PROFILING OF REGULATORY FACTOR BINDING SITES
AGGGAGGG
>DM113272.1 GENOMIC PROFILING OF REGULATORY FACTOR BINDING SITES
CTTGGCGG
>DM113271.1 GENOMIC PROFILING OF REGULATORY FACTOR BINDING SITES
CTTGGCGG
>DM113270.1 GENOMIC PROFILING OF REGULATORY FACTOR BINDING SITES
CTTGGCGG
>DM113269.1 GENOMIC PROFILING OF REGULATORY FACTOR BINDING SITES
AGGGAGGG
>DM113268.1 GENOMIC PROFILING OF REGULATORY FACTOR BINDING SITES
TGACGTAG
>DM113257.1 GENOMIC PROFILING OF REGULATORY FACTOR BINDING SITES
GCGACAAA
>DM113224.1 GENOMIC PROFILING OF REGULATORY FACTOR BINDING SITES
TTTGGCGG
>DM119082.1 VEGF VARIANTS
GTGAATGC
>DM119081.1 VEGF VARIANTS
TTGGACGC
>DM117960.1 ANTIBODIES TO MYOSTATIN
GTCTAGAC
>DM114126.1 VECTOR AND VIRAL VECTORS, AND PACKAGING CELL LINES FOR PROPAGATING SAME
TATATAAA
>DM114116.1 VECTOR AND VIRAL VECTORS, AND PACKAGING CELL LINES FOR PROPAGATING SAME
AGACGTCT
>HA115877.1 Sequence 1 from Patent WO2004094636
TTGCTATA
>GM604696.1 Sequence 117 from Patent WO2007050794
GCCCTCTG
>GM604695.1 Sequence 116 from Patent WO2007050794
GCCTCCTG
>GM604694.1 Sequence 115 from Patent WO2007050794
GCTCCCTG
>GM604693.1 Sequence 114 from Patent WO2007050794
GTCCCCTG
>GM604692.1 Sequence 113 from Patent WO2007050794
ACCCCCTG
>GM604691.1 Sequence 112 from Patent WO2007050794
GCCCCCTG
>HB389720.1 Sequence 112 from Patent WO2008156661
GAGACAGG
>HB384525.1 Sequence 11425 from Patent WO2006110688
TTTGTTAT
>HB384524.1 Sequence 11424 from Patent WO2006110688
AAAAAAAA
>HA643027.1 Sequence 20 from Patent WO2009058679
TTGWHCGT
>HA642983.1 Sequence 2 from Patent WO2009058304
GAAGGAGA
>HA641974.1 Sequence 4 from Patent WO2009058413
GTAAGAGK
>HA639731.1 Sequence 1 from Patent WO2009053988
GCGGCCGC
>DM100733.1 DNA-Based Transposon System for the Introduction of Nucleic Acid into DNA of a Cell
ACATACAC
>GN366613.1 Sequence 97 from Patent EP2055781
TTCCAGAG
>GN366605.1 Sequence 89 from Patent EP2055781
TTCACCAG
>GN363745.1 Sequence 145 from Patent WO2009046231
ACCAGCCC
>GN363319.1 Sequence 68 from Patent WO2009046248
ACCAGCCC
>GN345261.1 Sequence 25 from Patent WO2009043353
ACTACCTC
>GN345256.1 Sequence 20 from Patent WO2009043353
ATTTGCAC
>GN345255.1 Sequence 19 from Patent WO2009043353
AGCACTTT
>GN345253.1 Sequence 17 from Patent WO2009043353
CGTAATGA
>GN345252.1 Sequence 16 from Patent WO2009043353
GGTAAACT
>GN345251.1 Sequence 15 from Patent WO2009043353
TCAACATC
>GN345250.1 Sequence 14 from Patent WO2009043353
ATCAGTCT
>GN345249.1 Sequence 13 from Patent WO2009043353
TCTGATAA
>GN345242.1 Sequence 6 from Patent WO2009043353
CACACTCC
>GN345240.1 Sequence 4 from Patent WO2009043353
TAGCATTA
>GN345238.1 Sequence 2 from Patent WO2009043353
GATAAGCT
>GN343375.1 Sequence 1080 from Patent EP2053058
GAACAGGG
>GN342354.1 Sequence 59 from Patent EP2053058
TCGGAGTT
>GN342347.1 Sequence 52 from Patent EP2053058
TCGGAGTT
>GN342335.1 Sequence 40 from Patent EP2053058
GGATCTTA
>GN342325.1 Sequence 30 from Patent EP2053058
CGATTTTT
>GN342319.1 Sequence 24 from Patent EP2053058
CTACACAA
>GN342307.1 Sequence 12 from Patent EP2053058
GGATCTTA
>GN338000.1 Sequence 182 from Patent WO2009040113
NNNKVGNM
>GN337999.1 Sequence 181 from Patent WO2009040113
NNGCCNNN
>GN337998.1 Sequence 180 from Patent WO2009040113
NNNAGCNN
>GN337997.1 Sequence 179 from Patent WO2009040113
NNGCYNNN
>GN115362.1 Sequence 67 from Patent WO2009037183
GGGGGGGG
>GN115302.1 Sequence 7 from Patent WO2009037183
TGACGTTC
>DM065730.1 A method of detecting a nucleic acid
TTGCATTG
>DM065729.1 A method of detecting a nucleic acid
TTGCCTTG
>DM077456.1 ATTENUATED HUMAN PARAINFLUENZA VIRUS, METHODS AND USES THEREOF
GCGGCCGC
>DM091202.1 RNAI THERAPEUTIC FOR RESPIRATORY VIRUS INFECTION
TTTGTTAT
>DM091201.1 RNAI THERAPEUTIC FOR RESPIRATORY VIRUS INFECTION
AAAAAAAA
>GN085232.1 Sequence 59 from Patent WO2009029293
TCGGAGTT
>GN085225.1 Sequence 52 from Patent WO2009029293
TCGGAGTT
>GN085213.1 Sequence 40 from Patent WO2009029293
GGATCTTA
>GN085203.1 Sequence 30 from Patent WO2009029293
CGATTTTT
>GN085197.1 Sequence 24 from Patent WO2009029293
CTACACAA
>GN085185.1 Sequence 12 from Patent WO2009029293
GGATCTTA
>GN089227.1 Sequence 1 from Patent WO2009030684
CCGCCATG
>GN086229.1 Sequence 1056 from Patent WO2009029293
GAACAGGG
>GN093059.1 Sequence 83 from Patent EP2042510
TCGAAGTA
>GN079364.1 Sequence 3 from Patent EP2039781
GAAACTTG
>GN079363.1 Sequence 2 from Patent EP2039781
GTTCAAAG
>GN079362.1 Sequence 1 from Patent EP2039781
GTTCAAAG
>DM059531.1 COMPOSITIONS COMPRISING STRUCTURALLY STABLE CONJUGATE MOLECULES
GGCGCCCG
>DM059530.1 COMPOSITIONS COMPRISING STRUCTURALLY STABLE CONJUGATE MOLECULES
GGCGTCCG
>DM059529.1 COMPOSITIONS COMPRISING STRUCTURALLY STABLE CONJUGATE MOLECULES
GGCGCTCG
>DM059528.1 COMPOSITIONS COMPRISING STRUCTURALLY STABLE CONJUGATE MOLECULES
GGCGTTCG
>DM059527.1 COMPOSITIONS COMPRISING STRUCTURALLY STABLE CONJUGATE MOLECULES
AACGCTCG
>DM059526.1 COMPOSITIONS COMPRISING STRUCTURALLY STABLE CONJUGATE MOLECULES
AACGTTCG
>DM059525.1 COMPOSITIONS COMPRISING STRUCTURALLY STABLE CONJUGATE MOLECULES
AACGCCCG
>DM059524.1 COMPOSITIONS COMPRISING STRUCTURALLY STABLE CONJUGATE MOLECULES
AACGTCCG
>DM059523.1 COMPOSITIONS COMPRISING STRUCTURALLY STABLE CONJUGATE MOLECULES
AGCGCCCG
>DM059522.1 COMPOSITIONS COMPRISING STRUCTURALLY STABLE CONJUGATE MOLECULES
AGCGTCCG
>DM059521.1 COMPOSITIONS COMPRISING STRUCTURALLY STABLE CONJUGATE MOLECULES
AGCGTTCG
>DM059520.1 COMPOSITIONS COMPRISING STRUCTURALLY STABLE CONJUGATE MOLECULES
AGCGCTCG
>DM059519.1 COMPOSITIONS COMPRISING STRUCTURALLY STABLE CONJUGATE MOLECULES
GACGTTCG
>DM059518.1 COMPOSITIONS COMPRISING STRUCTURALLY STABLE CONJUGATE MOLECULES
GACGCCCG
>DM059517.1 COMPOSITIONS COMPRISING STRUCTURALLY STABLE CONJUGATE MOLECULES
GACGTCCG
>DM059516.1 COMPOSITIONS COMPRISING STRUCTURALLY STABLE CONJUGATE MOLECULES
GACGCTCG
>DM059515.1 COMPOSITIONS COMPRISING STRUCTURALLY STABLE CONJUGATE MOLECULES
GGCGCCCC
>DM059514.1 COMPOSITIONS COMPRISING STRUCTURALLY STABLE CONJUGATE MOLECULES
GGCGTCCC
>DM059513.1 COMPOSITIONS COMPRISING STRUCTURALLY STABLE CONJUGATE MOLECULES
GGCGCTCC
>DM059512.1 COMPOSITIONS COMPRISING STRUCTURALLY STABLE CONJUGATE MOLECULES
GGCGTTCC
>DM059511.1 COMPOSITIONS COMPRISING STRUCTURALLY STABLE CONJUGATE MOLECULES
AACGCTCC
>DM059510.1 COMPOSITIONS COMPRISING STRUCTURALLY STABLE CONJUGATE MOLECULES
AACGTTCC
>DM059509.1 COMPOSITIONS COMPRISING STRUCTURALLY STABLE CONJUGATE MOLECULES
AACGCCCC
>DM059508.1 COMPOSITIONS COMPRISING STRUCTURALLY STABLE CONJUGATE MOLECULES
AACGTCCC
>DM059507.1 COMPOSITIONS COMPRISING STRUCTURALLY STABLE CONJUGATE MOLECULES
AGCGCCCC
>DM059506.1 COMPOSITIONS COMPRISING STRUCTURALLY STABLE CONJUGATE MOLECULES
AGCGTCCC
>DM059505.1 COMPOSITIONS COMPRISING STRUCTURALLY STABLE CONJUGATE MOLECULES
AGCGCTCC
>DM059504.1 COMPOSITIONS COMPRISING STRUCTURALLY STABLE CONJUGATE MOLECULES
AGCGTTCC
>DM059503.1 COMPOSITIONS COMPRISING STRUCTURALLY STABLE CONJUGATE MOLECULES
GACGCCCC
>DM059502.1 COMPOSITIONS COMPRISING STRUCTURALLY STABLE CONJUGATE MOLECULES
GACGTTCC
>DM059501.1 COMPOSITIONS COMPRISING STRUCTURALLY STABLE CONJUGATE MOLECULES
GACGTCCC
>DM059500.1 COMPOSITIONS COMPRISING STRUCTURALLY STABLE CONJUGATE MOLECULES
GACGCTCC
>DM059433.1 METHOD OF GENOTYPING AND PHENOTYPING HEPATITIS B VIRUSES RESISTANT TO ANTIVIRAL MOLECULES
GCGGCCGC
>DM059428.1 METHOD OF GENOTYPING AND PHENOTYPING HEPATITIS B VIRUSES RESISTANT TO ANTIVIRAL MOLECULES
TGCGCAGA
>DM059416.1 METHOD OF GENOTYPING AND PHENOTYPING HEPATITIS B VIRUSES RESISTANT TO ANTIVIRAL MOLECULES
CTGGTGCG
>DM042545.1 Circadian rhythm gene and clock motif
GACGAGCC
>DM042544.1 Circadian rhythm gene and clock motif
GCGCACGA
>DM042537.1 Circadian rhythm gene and clock motif
GGGTTAAT
>DM042536.1 Circadian rhythm gene and clock motif
CGTGCGCC
>DM042534.1 Circadian rhythm gene and clock motif
GCGAGCGC
>DM042532.1 Circadian rhythm gene and clock motif
CGCCATTA
>DM039758.1 Novel HLA-B allele
GCATGTAT
>GN054781.1 Sequence 1080 from Patent WO2008109465
GAACAGGG
>GN053760.1 Sequence 59 from Patent WO2008109465
TCGGAGTT
>GN053753.1 Sequence 52 from Patent WO2008109465
TCGGAGTT
>GN053741.1 Sequence 40 from Patent WO2008109465
GGATCTTA
>GN053731.1 Sequence 30 from Patent WO2008109465
CGATTTTT
>GN053725.1 Sequence 24 from Patent WO2008109465
CTACACAA
>GN053713.1 Sequence 12 from Patent WO2008109465
GGATCTTA
>DM014175.1 Evolving New Molecular Function
ACCCGTCA
>DM014174.1 Evolving New Molecular Function
TGACGGGT
>DM036286.1 IMMUNOMODULATORY COMPOSITIONS, COMBINATIONS AND METHODS
TTTTTTTT
>DM019550.1 DIACYLGLYCEROL ACYLTRANSFERASES FOR ALTERATION OF POLYUNSATURATED FATTY ACIDS AND OIL CONTENT IN OLEAGINOUS ORGANISMS
ACCAGCCC
>DM024285.1 PCV2 IMMUNOGENIC COMPOSITIONS AND METHODS OF PRODUCING SUCH COMPOSITIONS
CCGCCATG
>DM023423.1 COMPOSITIONS AND METHODS FOR INDUCING AN IMMUNE RESPONSE IN A MAMMAL AND METHODS OF AVOIDING AN IMMUNE RESPONSE TO OLIGONUCLEOTIDE AGENTS SUCH AS SHORT INTERFERING RNAs
GTCCTTCA
>DM017680.1 Detection of human papilloma virus
YCAYAAYA
>DM038930.1 Immunostimulatory Combinations and Methods
TTTTTTTT
>DM038864.1 METHOD FOR MAKING TARGETED THERAPEUTIC AGENTS
NCTAAANC
>DM038858.1 METHOD FOR MAKING TARGETED THERAPEUTIC AGENTS
NCTAACNC
>DM017513.1 Detection of human papilloma virus
TTATAATA
>DM017512.1 Detection of human papilloma virus
CCATAATA
>DM017511.1 Detection of human papilloma virus
TTATAATA
>DM017510.1 Detection of human papilloma virus
CCATAACA
>DM017509.1 Detection of human papilloma virus
TTATAATA
>DM017508.1 Detection of human papilloma virus
TCATAACA
>DM017507.1 Detection of human papilloma virus
TTATAATA
>DM017506.1 Detection of human papilloma virus
CCACAATA
>DM017505.1 Detection of human papilloma virus
TTATAATA
>DM017504.1 Detection of human papilloma virus
TCATAACA
>DM017503.1 Detection of human papilloma virus
TTATAATA
>DM017502.1 Detection of human papilloma virus
CCACAATA
>DM017501.1 Detection of human papilloma virus
TTATAATA
>DM017500.1 Detection of human papilloma virus
CCACAACA
>DM017499.1 Detection of human papilloma virus
TTATAATA
>DM017498.1 Detection of human papilloma virus
CCATAATA
>DM017497.1 Detection of human papilloma virus
TTATAATA
>DM017496.1 Detection of human papilloma virus
TCATAATA
>DM021868.1 Methods of screening biodiverse gene fragment libraries and uses of biological modulators isolated therefrom
GCTTATCA
>DM021812.1 Methods of screening biodiverse gene fragment libraries and uses of biological modulators isolated therefrom
CTACCATG
>DM021810.1 Methods of screening biodiverse gene fragment libraries and uses of biological modulators isolated therefrom
CCRCCATG
>GN013879.1 Sequence 22 from Patent WO2009007982
AATAAAGC
>GN013876.1 Sequence 19 from Patent WO2009007982
GCCTCAAT
>GN013859.1 Sequence 2 from Patent WO2009007982
CACTGCTT
>DM001574.1 POPULATIONS OF REPORTER SEQUENCES AND METHODS OF THEIR USE
TTTCCCGC
>DM001564.1 POPULATIONS OF REPORTER SEQUENCES AND METHODS OF THEIR USE
CTCCCCAA
>DM001543.1 POPULATIONS OF REPORTER SEQUENCES AND METHODS OF THEIR USE
TGACGTMA
>DM003642.1 DOCOSAHEXAENOIC ACID PRODUCING STRAINS OF YARROWIA LIPOLYTICA
ACCAGCCC
>DM003220.1 HIGH EICOSAPENTAENOIC ACID PRODUCING STRAINS OF YARROWIA LIPOLYTICA
ACCAGCCC
>DM008811.1 HIGH ARACHIDONIC ACID PRODUCING STRAINS OF YARROWIA LIPOLYTICA
ACCAGCCC
>GM993094.1 Sequence 131 from Patent WO2008144754
GCGGCCGC
>GM976349.1 Sequence 20 from Patent WO2008148575
AAAGGAGG
>GN000252.1 Sequence 563 from Patent WO2008156702
GAGACAGG
>DL479196.1 Plant promoters and uses thereof
ACCTCCCC
>DL465911.1 Glycine Riboswitches, Methods for Their Use, and Compositions for Use with Glycine Riboswitches
RRRACYRY
>DL479157.1 Molecular Targets And Compounds, And Methods To Identify The Same, Useful In The Treatment Of Joint Degenerative And Inflammatory Diseases
TTGCTATA
>DL478371.1 USE OF RNA TRANS-SPLICING FOR ANTIBODY GENE TRANSFER AND ANTIBODY POLYPEPTIDE PRODUCTION
AGGTRAGT
>DL464302.1 A composition for promoting a recovery of cytopenia
AGTCGACA
>DL477531.1 KALLIKREIN INHIBITORS AND USES THEREOF
TTCGCGAA
>DL463772.1 Transposase of Tol1 element and DNA introduction system using the same
GTTGCAGC
>DL463771.1 Transposase of Tol1 element and DNA introduction system using the same
GTCCCATC
>DL463770.1 Transposase of Tol1 element and DNA introduction system using the same
CCTTTAGC
>DL477247.1 DELIVERY OF POLYNUCLEOTIDES
TGTCGCGG
>DL477246.1 DELIVERY OF POLYNUCLEOTIDES
TGTGGCGC
>DL477245.1 DELIVERY OF POLYNUCLEOTIDES
TTTCGGGC
>DL477244.1 DELIVERY OF POLYNUCLEOTIDES
GGTCGCGC
>DL477243.1 DELIVERY OF POLYNUCLEOTIDES
CGTCGCGC
>DL477242.1 DELIVERY OF POLYNUCLEOTIDES
CTTCCCGG
>DL477241.1 DELIVERY OF POLYNUCLEOTIDES
TGTCGCGC
>DL477240.1 DELIVERY OF POLYNUCLEOTIDES
GTTGCCGG
>DL477239.1 DELIVERY OF POLYNUCLEOTIDES
CTTGCCGG
>DL477238.1 DELIVERY OF POLYNUCLEOTIDES
TTTCCCGG
>DL477237.1 DELIVERY OF POLYNUCLEOTIDES
GTTCGCGG
>DL477236.1 DELIVERY OF POLYNUCLEOTIDES
GTTCGCGG
>DL477235.1 DELIVERY OF POLYNUCLEOTIDES
GTTGGCGG
>DL477233.1 DELIVERY OF POLYNUCLEOTIDES
GGTGCGCG
>DL477232.1 DELIVERY OF POLYNUCLEOTIDES
GTAGCGCG
>DL477231.1 DELIVERY OF POLYNUCLEOTIDES
GTTGCGCG
>DL477230.1 DELIVERY OF POLYNUCLEOTIDES
TGAGCGCG
>DL477229.1 DELIVERY OF POLYNUCLEOTIDES
TGTGCGCG
>DL477228.1 DELIVERY OF POLYNUCLEOTIDES
TTAGCGCG
>DL477227.1 DELIVERY OF POLYNUCLEOTIDES
TTTGCGCG
>DL477226.1 DELIVERY OF POLYNUCLEOTIDES
CTTCGCGG
>DL477225.1 DELIVERY OF POLYNUCLEOTIDES
GTTCCCGG
>DL477224.1 DELIVERY OF POLYNUCLEOTIDES
TTTGCCGG
>DL477223.1 DELIVERY OF POLYNUCLEOTIDES
CTTCCCGG
>DL477222.1 DELIVERY OF POLYNUCLEOTIDES
CGTCCGCC
>DL477221.1 DELIVERY OF POLYNUCLEOTIDES
CTTCCGCC
>DL477220.1 DELIVERY OF POLYNUCLEOTIDES
GGTCCGCC
>DL477219.1 DELIVERY OF POLYNUCLEOTIDES
GTTCCGCC
>DL477218.1 DELIVERY OF POLYNUCLEOTIDES
TGTCCGCC
>DL477217.1 DELIVERY OF POLYNUCLEOTIDES
TTTCCGCC
>DL477216.1 DELIVERY OF POLYNUCLEOTIDES
CGACCGCC
>DL477215.1 DELIVERY OF POLYNUCLEOTIDES
CTACCGCC
>DL477214.1 DELIVERY OF POLYNUCLEOTIDES
GGACCGCC
>DL477213.1 DELIVERY OF POLYNUCLEOTIDES
GTACCGCC
>DL477212.1 DELIVERY OF POLYNUCLEOTIDES
TGACCGCC
>DL477211.1 DELIVERY OF POLYNUCLEOTIDES
TTACCGCC
>DL477210.1 DELIVERY OF POLYNUCLEOTIDES
TTTGGCGG
>DL477209.1 DELIVERY OF POLYNUCLEOTIDES
GTTGCCGC
>DL477208.1 DELIVERY OF POLYNUCLEOTIDES
CTTGCCGC
>DL477207.1 DELIVERY OF POLYNUCLEOTIDES
CTTGGCGC
>DL477206.1 DELIVERY OF POLYNUCLEOTIDES
GTTGGCGC
>DL477205.1 DELIVERY OF POLYNUCLEOTIDES
TTTCGCGG
>DL477203.1 DELIVERY OF POLYNUCLEOTIDES
CGTGCGCC
>DL477202.1 DELIVERY OF POLYNUCLEOTIDES
CTTGCGCC
>DL477201.1 DELIVERY OF POLYNUCLEOTIDES
GGTGCGCC
>DL477200.1 DELIVERY OF POLYNUCLEOTIDES
GTTGCGCC
>DL477199.1 DELIVERY OF POLYNUCLEOTIDES
TGTGCGCC
>DL477198.1 DELIVERY OF POLYNUCLEOTIDES
TTTGCGCC
>DL477197.1 DELIVERY OF POLYNUCLEOTIDES
GTTCGCGC
>DL477196.1 DELIVERY OF POLYNUCLEOTIDES
CGAGCGCC
>DL477195.1 DELIVERY OF POLYNUCLEOTIDES
CTAGCGCC
>DL477194.1 DELIVERY OF POLYNUCLEOTIDES
GGAGCGCC
>DL477193.1 DELIVERY OF POLYNUCLEOTIDES
GTAGCGCC
>DL477192.1 DELIVERY OF POLYNUCLEOTIDES
TGAGCGCC
>DL477191.1 DELIVERY OF POLYNUCLEOTIDES
TTAGCGCC
>DL477190.1 DELIVERY OF POLYNUCLEOTIDES
CTTCGCGC
>DL477189.1 DELIVERY OF POLYNUCLEOTIDES
GTTCCCGC
>DL477188.1 DELIVERY OF POLYNUCLEOTIDES
CTTCCCGC
>DL477187.1 DELIVERY OF POLYNUCLEOTIDES
TTTGCCGC
>DL477186.1 DELIVERY OF POLYNUCLEOTIDES
TTTCCCGC
>DL477185.1 DELIVERY OF POLYNUCLEOTIDES
TTTCGCGC
>DL477184.1 DELIVERY OF POLYNUCLEOTIDES
TTTGGCGC
>DL477183.1 DELIVERY OF POLYNUCLEOTIDES
TTTSGCGS
>DL477107.1 DELIVERY OF POLYNUCLEOTIDES
GATTTCCC
>DL477105.1 DELIVERY OF POLYNUCLEOTIDES
TTGAAGGC
>DL477102.1 DELIVERY OF POLYNUCLEOTIDES
GGATTTCC
>DL477098.1 DELIVERY OF POLYNUCLEOTIDES
GACTTTCC
>DL482927.1 TARGETED TRANS-SPLICING OF HIGHLY ABUNDANT TRANSCRIPTS FOR IN VIVO PRODUCTION OF RECOMBINANT PROTEINS
AGGTRAGT
>DL461096.1 Novel CTLA4/CD28 Ligands and Uses Therefor
CTCTAAAG
>GM773220.1 Sequence 17261 from Patent WO2008115851
TTTGTTAT
>GM773219.1 Sequence 17260 from Patent WO2008115851
AAAAAAAA
>GM836087.1 Sequence 17 from Patent EP1982998
GCGGCCGC
>GM834982.1 Sequence 24 from Patent WO2008120016
CGCNNGCG
>GM828031.1 Sequence 2 from Patent WO2008114282
ACCTGCCC
>FB507876.1 Sequence 1 from Patent WO2008097926
TTTTTTTT
>GM704013.1 Sequence 24 from Patent WO2008084087
GCTGTGCA
>GM703996.1 Sequence 7 from Patent WO2008084087
ACGCACGG
>FB505803.1 Sequence 1 from Patent WO2008098909
CCGCCATG
>GM670216.1 Sequence 1 from Patent WO2008081015
CCGCCATG
>GM620774.1 Sequence 24 from Patent EP1941867
TTCGCGAA
>GM737258.1 Sequence 32 from Patent WO2008104184
AGTCAGTC
>GM669364.1 Sequence 24 from Patent EP1944369
GCTGTGCA
>GM669347.1 Sequence 7 from Patent EP1944369
ACGCACGG
>GM884179.1 Sequence 7 from Patent EP1994824
AGTCGACA
>GM037457.1 Sequence 2 from Patent WO2008052774
GCGCCATC
>FB744609.1 Sequence 55 from Patent WO2008014979
GGTTTTGG
>FB708715.1 Sequence 78 from Patent WO2007124751
GGTGGTGG
>GM015077.1 Sequence 35 from Patent WO2008054565
ACCAGCCC
>GM952235.1 Sequence 22 from Patent WO2008139262
NGTTGTGT
>GM952233.1 Sequence 20 from Patent WO2008139262
GTTGTGTN
>GM952231.1 Sequence 18 from Patent WO2008139262
GTTGTGTN
>GM952230.1 Sequence 17 from Patent WO2008139262
GTTGTGTN
>GM952229.1 Sequence 16 from Patent WO2008139262
GTTGTGTN
>GM952228.1 Sequence 15 from Patent WO2008139262
TTTTGGGG
>GM952227.1 Sequence 14 from Patent WO2008139262
GTTGTGTN
>GM952224.1 Sequence 11 from Patent WO2008139262
GTTGTGTN
>GM832122.1 Sequence 4 from Patent WO2008119562
NTTACCTN
>GM832121.1 Sequence 3 from Patent WO2008119562
NGAAAGGN
>GM889537.1 Sequence 10 from Patent WO2008137466
CAAAGGCT
>GM006698.1 Sequence 8 from Patent WO2008039538
GATTGTGT
>GM006697.1 Sequence 7 from Patent WO2008039538
NGTTGTGT
>GM005909.1 Sequence 42 from Patent EP1921088
GGGCGGGG
>GM005908.1 Sequence 41 from Patent EP1921088
GGGNGSGG
>GM005907.1 Sequence 40 from Patent EP1921088
GGGKGGGG
>GM751698.1 Sequence 4 from Patent EP1978103
NTTACCTN
>GM751697.1 Sequence 3 from Patent EP1978103
NGAAAGGN
>FB727207.1 Sequence 35 from Patent WO2008002672
GTTCTCTC
>FB727206.1 Sequence 34 from Patent WO2008002672
ATGCTCTC
>FB727205.1 Sequence 33 from Patent WO2008002672
ATGCTCCC
>FB727204.1 Sequence 32 from Patent WO2008002672
ATGTTTCT
>FB727203.1 Sequence 31 from Patent WO2008002672
ATTCTCTC
>FB727202.1 Sequence 30 from Patent WO2008002672
ACTCCCTC
>FB727201.1 Sequence 29 from Patent WO2008002672
ATTCCCTC
>FB726252.1 Sequence 269 from Patent WO2007146959
GCGGCCGC
>GM876851.1 Sequence 5 from Patent WO2008132458
TAAATTTA
>FB665094.1 Sequence 11 from Patent WO2007120120
GCGGCCGC
>GM010369.1 Sequence 5 from Patent WO2008043366
AGACGCCA
>GM006636.1 Sequence 59 from Patent WO2008049078
TCGGAGTT
>GM006629.1 Sequence 52 from Patent WO2008049078
TCGGAGTT
>GM006617.1 Sequence 40 from Patent WO2008049078
GGATCTTA
>GM006607.1 Sequence 30 from Patent WO2008049078
CGATTTTT
>GM006601.1 Sequence 24 from Patent WO2008049078
CTACACAA
>GM006589.1 Sequence 12 from Patent WO2008049078
GGATCTTA
>GM060271.1 Sequence 111 from Patent WO2008063340
ACCAGCCC
>GM839297.1 Sequence 24 from Patent EP1985712
ATAGATAG
>GM839295.1 Sequence 22 from Patent EP1985712
GTACGTCG
>GM839293.1 Sequence 20 from Patent EP1985712
CGTCGAAA
>GM839292.1 Sequence 19 from Patent EP1985712
GTAGAGAG
>GM839291.1 Sequence 18 from Patent EP1985712
ATAGATAG
>GM839290.1 Sequence 17 from Patent EP1985712
ACATCGAC
>GM839289.1 Sequence 16 from Patent EP1985712
TACGCGGA
>GM839288.1 Sequence 15 from Patent EP1985712
GTACAAGG
>GM839287.1 Sequence 14 from Patent EP1985712
AGTCATAT
>GM010031.1 Sequence 5 from Patent WO2006123929
ATTTGCAT
>GM010030.1 Sequence 4 from Patent WO2006123929
ATGCAAAT
>FB677543.1 Sequence 66 from Patent WO2007121489
ACTCGTGG
>FB677542.1 Sequence 65 from Patent WO2007121489
ACTCGTGT
>FB677541.1 Sequence 64 from Patent WO2007121489
ACTCGTGC
>FB677527.1 Sequence 50 from Patent WO2007121489
TAAGAGCT
>FB677526.1 Sequence 49 from Patent WO2007121489
CCACATAT
>FB677525.1 Sequence 48 from Patent WO2007121489
GCCACGAA
>FB677523.1 Sequence 46 from Patent WO2007121489
TGTGCTCA
>FB677522.1 Sequence 45 from Patent WO2007121489
CGTGCTCA
>FB677521.1 Sequence 44 from Patent WO2007121489
GGTGCTCA
>FB677520.1 Sequence 43 from Patent WO2007121489
AGTGCTCA
>FB677500.1 Sequence 23 from Patent WO2007121489
CTGTTCGT
>GM668904.1 Sequence 28 from Patent WO2008073661
NNCGNNCG
>DL256336.1 SYSTEMS AND METHODS FOR PROTEIN PRODUCTION
TGACGTGA
>DL256335.1 SYSTEMS AND METHODS FOR PROTEIN PRODUCTION
TGACGTGG
>DL241643.1 GENOMIC DNA FRAGMENTS CONTAINING REGULATORY AND CODING SEQUENCES FOR THE B2-SUBUNIT OF THE NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR AND TRANSGENIC ANIMALS MADE USING THESE FRAGMENTS OR MUTATED FRAGMENTS
TCCACTTG
>DL241642.1 GENOMIC DNA FRAGMENTS CONTAINING REGULATORY AND CODING SEQUENCES FOR THE B2-SUBUNIT OF THE NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR AND TRANSGENIC ANIMALS MADE USING THESE FRAGMENTS OR MUTATED FRAGMENTS
TCCTCAGG
>DL241020.1 HIF Oligonucleotide Decoy Molecules
YACGTGCN
>FB749199.1 Sequence 39 from Patent WO2008015447
AAGGAGGT
>FB752081.1 Sequence 53 from Patent EP1906184
CTCTAGAG
>DL213320.1 PREVENTION AND REDUCTION OF BLOOD LOSS
TTCGCGAA
>DL230190.1 Novel full length cDNA
TCATTGTT
>DL230172.1 Novel full length cDNA
ATGCAAAT
>DL230167.1 Novel full length cDNA
GGACCTGC
>DL230166.1 Novel full length cDNA
TTGGGAGG
>FB673934.1 Sequence 1558 from Patent WO2007146511
GCCACCAA
>FB675517.1 Sequence 52 from Patent WO2006138666
TTTCTACG
>FB675511.1 Sequence 46 from Patent WO2006138666
TTTCTACG
>FB675505.1 Sequence 40 from Patent WO2006138666
TTTGATGG
>FB675499.1 Sequence 34 from Patent WO2006138666
TTTGATGG
>FB675493.1 Sequence 28 from Patent WO2006138666
TTTAGGGA
>FB292003.1 Sequence 2 from Patent WO2007109441
GAAAGGTC
>FB659994.1 Sequence 13 from Patent WO2006133312
TGTGATGG
>FB580718.1 Sequence 25 from Patent EP1852186
TTNCNNNA
>FB580707.1 Sequence 14 from Patent EP1852186
ATGCAAAT
>FB580703.1 Sequence 10 from Patent EP1852186
TTNCNNNA
>FB580699.1 Sequence 6 from Patent EP1852186
TTTSSCGC
>FB580695.1 Sequence 2 from Patent EP1852186
TGACCTCA
>FB583316.1 Sequence 7 from Patent EP1867994
TGACGTCA
>FB579898.1 Sequence 46 from Patent WO2006103211
TACCCANC
>FB579884.1 Sequence 32 from Patent WO2006103211
GNAAGTTG
>DL192766.1 NOVEL NUCLEOTIDE AND AMINO ACID SEQUENCES, AND ASSAYS AND METHODS OF USE THEREOF FOR DIAGNOSIS OF LUNG CANCER
TATACCAG
>DL192682.1 NOVEL NUCLEOTIDE AND AMINO ACID SEQUENCES, AND ASSAYS AND METHODS OF USE THEREOF FOR DIAGNOSIS OF LUNG CANCER
TCCCGCCG
>DL192596.1 NOVEL NUCLEOTIDE AND AMINO ACID SEQUENCES, AND ASSAYS AND METHODS OF USE THEREOF FOR DIAGNOSIS OF LUNG CANCER
ACCCTTCC
>DL189567.1 Linkers
CCATGGGC
>DL189534.1 Linkers
GCGGCCGC
>DL192153.1 NOVEL NUCLEOTIDE AND AMINO ACID SEQUENCES, AND ASSAYS AND METHODS OF USE THEREOF FOR DIAGNOSIS OF LUNG CANCER
TGAAGCAG
>DL192116.1 NOVEL NUCLEOTIDE AND AMINO ACID SEQUENCES, AND ASSAYS AND METHODS OF USE THEREOF FOR DIAGNOSIS OF LUNG CANCER
CATCCGAG
>DL191975.1 NOVEL NUCLEOTIDE AND AMINO ACID SEQUENCES, AND ASSAYS AND METHODS OF USE THEREOF FOR DIAGNOSIS OF LUNG CANCER
TATACCAG
>DL191952.1 NOVEL NUCLEOTIDE AND AMINO ACID SEQUENCES, AND ASSAYS AND METHODS OF USE THEREOF FOR DIAGNOSIS OF LUNG CANCER
ACACGCAC
>DL199092.1 Compositions and methods for detection of hepatitis A virus nucleic acid
GAAGAAAG
>DL191846.1 NOVEL NUCLEOTIDE AND AMINO ACID SEQUENCES, AND ASSAYS AND METHODS OF USE THEREOF FOR DIAGNOSIS OF LUNG CANCER
TCCCGCCG
>DL193939.1 METHODS AND COMPOSITIONS FOR INDUCING ANTIGEN-SPECIFIC IMMUNE RESPONSES
CCGCGCGG
>DL193697.1 METHODS FOR MONITORING GENOMIC DNA OF ORGANISMS
GGCACTGC
>DL193696.1 METHODS FOR MONITORING GENOMIC DNA OF ORGANISMS
GCGAGGAT
>DL183663.1 Ligands for Induction of Antigen Specific Apoptosis in T Cells
CTCTAAAG
>DL193490.1 Methods and Agents for Screening for Compounds Capable of Modulating Gene Expression
TATTTATT
>FB513067.1 Sequence 80 from Patent WO2007112753
AACGAACA
>FB513064.1 Sequence 77 from Patent WO2007112753
TTAGCATT
>FB513061.1 Sequence 74 from Patent WO2007112753
TCACACTC
>FB513058.1 Sequence 71 from Patent WO2007112753
GATTTGCA
>CS804661.1 Sequence 16 from Patent WO2006096441
CCTGTCTC
>CS803533.1 Sequence 2 from Patent WO2007091277
ACCTGCCC
>CQ787958.1 Sequence 264 from Patent WO2004020664
AGTGACTG
>CQ787926.1 Sequence 232 from Patent WO2004020664
TCCCTCCC
>CQ787903.1 Sequence 209 from Patent WO2004020664
TGTCCTCT
>CQ787902.1 Sequence 208 from Patent WO2004020664
TGTCTCCT
>CS298383.1 Sequence 182 from Patent EP1659185
TCCACGCA
>CS298344.1 Sequence 143 from Patent EP1659185
ATTTGTTT
>DL157657.1 OLIGONUCLEOTIDE MEDIATED INHIBITION OF HEPATITIS B VIRUS AND HEPATITIS C VIRUS REPLICATION
AAGTTCGN
>DL157656.1 OLIGONUCLEOTIDE MEDIATED INHIBITION OF HEPATITIS B VIRUS AND HEPATITIS C VIRUS REPLICATION
GCTTGAAN
>DL157648.1 OLIGONUCLEOTIDE MEDIATED INHIBITION OF HEPATITIS B VIRUS AND HEPATITIS C VIRUS REPLICATION
AAGTTCGN
>DL157647.1 OLIGONUCLEOTIDE MEDIATED INHIBITION OF HEPATITIS B VIRUS AND HEPATITIS C VIRUS REPLICATION
GCTTGAAN
>DL157576.1 OLIGONUCLEOTIDE MEDIATED INHIBITION OF HEPATITIS B VIRUS AND HEPATITIS C VIRUS REPLICATION
TTCATTCA
>DL157575.1 OLIGONUCLEOTIDE MEDIATED INHIBITION OF HEPATITIS B VIRUS AND HEPATITIS C VIRUS REPLICATION
TCATTCAT
>DL157574.1 OLIGONUCLEOTIDE MEDIATED INHIBITION OF HEPATITIS B VIRUS AND HEPATITIS C VIRUS REPLICATION
CATTCATT
>DL157573.1 OLIGONUCLEOTIDE MEDIATED INHIBITION OF HEPATITIS B VIRUS AND HEPATITIS C VIRUS REPLICATION
ATTCATTC
>DL181613.1 IMMUNOSTIMULATORY NUCLEIC ACID MOLECULES
TCAACGTC
>DL181612.1 IMMUNOSTIMULATORY NUCLEIC ACID MOLECULES
CCAACGTT
>DL181611.1 IMMUNOSTIMULATORY NUCLEIC ACID MOLECULES
TCTTCGAA
>DL181610.1 IMMUNOSTIMULATORY NUCLEIC ACID MOLECULES
TCATCGAT
>DL181609.1 IMMUNOSTIMULATORY NUCLEIC ACID MOLECULES
TCAGCGCT
>DL181608.1 IMMUNOSTIMULATORY NUCLEIC ACID MOLECULES
TCAAGCTT
>DL181607.1 IMMUNOSTIMULATORY NUCLEIC ACID MOLECULES
TCAACGTT
>DL181321.1 TRANSGENIC NON-HUMAN ANIMALS CAPABLE OF PRODUCING HETEROLOGOUS ANTIBODIES
TAACTGGG
>DL174601.1 PEPTIDES AND RELATED MOLECULES THAT BIND TO TALL-1
GGGCGGGG
>DL174600.1 PEPTIDES AND RELATED MOLECULES THAT BIND TO TALL-1
GGGNGSGG
>DL174599.1 PEPTIDES AND RELATED MOLECULES THAT BIND TO TALL-1
GGGKGGGG
>DL180142.1 Novel full length cDNA
TCATTGTT
>DL180124.1 Novel full length cDNA
ATGCAAAT
>DL180119.1 Novel full length cDNA
GGACCTGC
>DL180118.1 Novel full length cDNA
TTGGGAGG
>DL163562.1 MOBILITY-MODIFIED NUCLEOBASE POLYMERS AND METHODS OF USING SAME
ATGCATGC
>DL163561.1 MOBILITY-MODIFIED NUCLEOBASE POLYMERS AND METHODS OF USING SAME
ATGCATGC
>DL176750.1 GENETICALLY ENGINEERED VACCINE STRAIN
TCGAGTTT
>DL176749.1 GENETICALLY ENGINEERED VACCINE STRAIN
GGCCAAAC
>CU951754.1 Brassica napus GSS, clone JBnB141L14, end read, primer SACL2(forward), genomic survey sequence
GATCTTCC
>CU958556.1 Brassica napus GSS, clone JBnB047P18, end read, primer SACR2(reverse), genomic survey sequence
CACCTCTG
>CU958468.1 Brassica napus GSS, clone JBnB047N07, end read, primer SACR2(reverse), genomic survey sequence
CCTTGTGA
>CU961975.1 Brassica napus GSS, clone JBnB060M06, end read, primer SACR2(reverse), genomic survey sequence
CCCTTCTG
>CU961857.1 Brassica napus GSS, clone JBnB060C08, end read, primer SACR2(reverse), genomic survey sequence
CCCTTCTG
>CU954428.1 Brassica napus GSS, clone JBnB144J23, end read, primer SACR2(reverse), genomic survey sequence
CACTTTTG
>CU954354.1 Brassica napus GSS, clone JBnB141K13, end read, primer SACL2(forward), genomic survey sequence
GATCTTCC
>CU957416.1 Brassica napus GSS, clone JBnB007K09, end read, primer SACR2(reverse), genomic survey sequence
CCCCCTTG
>CU957330.1 Brassica napus GSS, clone JBnB007A23, end read, primer SACR2(reverse), genomic survey sequence
CCCCTTTG
>CU967884.1 Brassica napus GSS, clone JBnB172J10, end read, primer SACR2(reverse), genomic survey sequence
CCGTTATC
>CU970903.1 Brassica napus GSS, clone JBnB051M08, end read, primer SACR2(reverse), genomic survey sequence
GCGGCCGC
>CU960133.1 Brassica napus GSS, clone JBnB150O16, end read, primer SACR2(reverse), genomic survey sequence
CCCATCTG
>CU956127.1 Brassica napus GSS, clone JBnB181F07, end read, primer SACR2(reverse), genomic survey sequence
CCTTAGCT
>CU969615.1 Brassica napus GSS, clone JBnB188H07, end read, primer SACL2(forward), genomic survey sequence
CAATACTT
>CU933566.1 Brassica napus GSS, clone JBnB051J16, end read, primer SACR2(reverse), genomic survey sequence
CGTTATAA
>CU933551.1 Brassica napus GSS, clone JBnB051J14, end read, primer SACR2(reverse), genomic survey sequence
CGTTTAAG
>CU937870.1 Brassica napus GSS, clone JBnB068D24, end read, primer SACR2(reverse), genomic survey sequence
GCGGCCGC
>FB300249.1 Sequence 15 from Patent WO2007114986
CCGCCACC
>FB300248.1 Sequence 14 from Patent WO2007114986
GGTGGCGG
>DL127081.1 MICROPARTICLES FOR DELIVERY OF THE HETEROLOGOUS NUCLEIC ACIDS
TCTTCGAA
>DL127080.1 MICROPARTICLES FOR DELIVERY OF THE HETEROLOGOUS NUCLEIC ACIDS
TCATCGAT
>DL127079.1 MICROPARTICLES FOR DELIVERY OF THE HETEROLOGOUS NUCLEIC ACIDS
TCAACGCT
>DL127078.1 MICROPARTICLES FOR DELIVERY OF THE HETEROLOGOUS NUCLEIC ACIDS
TCAGCGCT
>DL127077.1 MICROPARTICLES FOR DELIVERY OF THE HETEROLOGOUS NUCLEIC ACIDS
TCGACGTC
>DL127076.1 MICROPARTICLES FOR DELIVERY OF THE HETEROLOGOUS NUCLEIC ACIDS
GCAACGTT
>DL127075.1 MICROPARTICLES FOR DELIVERY OF THE HETEROLOGOUS NUCLEIC ACIDS
TCAACGTT
>DL141814.1 METHODS AND MEANS FOR TREATMENT OF OSTEOARTHRITIS
TTGCTATA
>DL080266.1 Methods For Identification, And Compounds Useful For The Treatment Of Degenerative & Inflammatory Diseases
TTGCTATA
>DL069466.1 METHODS AND COMPOSITIONS FOR SIMULTANEOUS SACCHARIFICATION AND FERMENTATION
GGCGCGCC
>DL070414.1 Method for Isolating and Characterizing Nucleic Acid Sequences
GAAAGGTC
>DL069597.1 NOVEL TUMOR ANTIGEN USEFUL IN DIAGNOSIS AND THERAPY OF BLADDER, OVARY, LUNG, AND KIDNEY CANCERS
ACCTCGGC
>DL005002.1 METHODS FOR DIRECT VISUALIZATION OF ACTIVE SYNAPSES
GCTAGCGC
>DJ493612.1 Human Artificial Chromosome (HAC) Vector and Human Cell Medicine Comprising Same
CGGGGTAC
>DJ493611.1 Human Artificial Chromosome (HAC) Vector and Human Cell Medicine Comprising Same
CCCGCATG
>DJ437605.1 NUCLEIC ACID APTAMERS CONJUGATED TO HIGH MOLECULAR WEIGHT STERIC GROUPS
GTGAATGC
>DJ437604.1 NUCLEIC ACID APTAMERS CONJUGATED TO HIGH MOLECULAR WEIGHT STERIC GROUPS
TTGGACGC
>DJ436644.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BY SMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
TTCTCATC
>DJ436632.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BY SMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
TCGTCGTT
>DJ436630.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BY SMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
TCNTCNTT
>DJ436628.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BY SMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
TCGTCGTT
>DJ436467.1 Compositions and Methods Comprising a Ligand of ChemerinR
TGACGTCA
>DJ435253.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
TCNTCNTT
>DJ435248.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
TCNTCNTT
>DJ435241.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
TCGTCGTT
>DJ435194.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
TCGTCGTT
>DJ435184.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
GACNTTCT
>DJ435183.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
GANGTTCT
>DJ435176.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
GTCNTTCT
>DJ435175.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
GTNGTTCT
>DJ435172.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
TTCNTTCT
>DJ435171.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
TTNGTTCT
>DJ435168.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
TCGTCGTT
>DJ435164.1 SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
TTGTGCTT
>DJ444143.1 Methods, Compositions and Compound Assays for Inhibiting Amyloid-Beta Protein Production
TTGCTATA
>DJ434770.1 Cosmid vector for transforming plant and use thereof
AGGGCCCA
>DJ434140.1 Immune stimulating oligonucleotide and use thereof in pharmaceutical
CGTCGACG
>DJ434139.1 Immune stimulating oligonucleotide and use thereof in pharmaceutical
CGACGTCG
>DJ434138.1 Immune stimulating oligonucleotide and use thereof in pharmaceutical
ACGGCCGT
>DJ434137.1 Immune stimulating oligonucleotide and use thereof in pharmaceutical
TAGCGCTA
>DJ434136.1 Immune stimulating oligonucleotide and use thereof in pharmaceutical
ACGTACGT
>DJ434135.1 Immune stimulating oligonucleotide and use thereof in pharmaceutical
AGCGCGCT
>DJ434134.1 Immune stimulating oligonucleotide and use thereof in pharmaceutical
CAACGTTG
>DJ434133.1 Immune stimulating oligonucleotide and use thereof in pharmaceutical
GAACGTTC
>DJ434132.1 Immune stimulating oligonucleotide and use thereof in pharmaceutical
ATCGCGAT
>DJ434131.1 Immune stimulating oligonucleotide and use thereof in pharmaceutical
GATCGATC
>DJ434130.1 Immune stimulating oligonucleotide and use thereof in pharmaceutical
CATCGATG
>DJ434129.1 Immune stimulating oligonucleotide and use thereof in pharmaceutical
ACGATCGT
>DJ434128.1 Immune stimulating oligonucleotide and use thereof in pharmaceutical
GCGATCGC
>DJ434127.1 Immune stimulating oligonucleotide and use thereof in pharmaceutical
CCGATCGG
>DJ418928.1 APTAMERS SELECTED FROM LIVE TUMOR CELLS AND THE USE THEREOF
TGGAAGGA
>DJ390570.1 Aptamer
CACTGGCC
>DJ387638.1 Polyamide nucleic acid derivatives with a negative charge, agents and methods for preparing them
CCCCTTCC
>DJ381591.1 Mitochondrial Dosimeter
TAACCATA
>DJ379376.1 Method for Treating Inflammation
CGCGTCTC
>DJ379375.1 Method for Treating Inflammation
AATTGAGA
>CS723912.1 Sequence 170 from Patent WO2007100584
GGGAATTT
>CS723911.1 Sequence 169 from Patent WO2007100584
GGGACTTT
>CS723909.1 Sequence 167 from Patent WO2007100584
GGGGATTT
>DJ359506.1 OLIGONUCLEOTIDE ANALOG AND METHOD FOR TREATING FLAVIVIRUS INFECTIONS
CATATTGA
>DJ359504.1 OLIGONUCLEOTIDE ANALOG AND METHOD FOR TREATING FLAVIVIRUS INFECTIONS
TCAATATG
>DJ357279.1 GASTROINTESTINAL PROLIFERATIVE FACTOR AND USES THEREOF
AGTCGACA
>DJ351296.1 RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA)
TCGAAGTA
>DJ351290.1 RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA)
TCGAAGTA
>DJ351255.1 RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA)
TCGAAGTA
>DJ351253.1 RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA)
TCGAAGTA
>DJ351043.1 RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA)
TCGAAGTA
>DJ350947.1 Stabilized Aptamers to Platelet Derived Growth Factor and Their Use as Oncology Therapeutics
TGATCCTG
>DJ350942.1 Stabilized Aptamers to Platelet Derived Growth Factor and Their Use as Oncology Therapeutics
TGATCCTG
>DJ350941.1 Stabilized Aptamers to Platelet Derived Growth Factor and Their Use as Oncology Therapeutics
TGATCCTG
>DJ350931.1 Stabilized Aptamers to Platelet Derived Growth Factor and Their Use as Oncology Therapeutics
TGATCCTG
>DJ350926.1 Stabilized Aptamers to Platelet Derived Growth Factor and Their Use as Oncology Therapeutics
TGATCCTG
>DJ350923.1 Stabilized Aptamers to Platelet Derived Growth Factor and Their Use as Oncology Therapeutics
TGATCCTG
>DJ350920.1 Stabilized Aptamers to Platelet Derived Growth Factor and Their Use as Oncology Therapeutics
TGATCCTG
>DJ350917.1 Stabilized Aptamers to Platelet Derived Growth Factor and Their Use as Oncology Therapeutics
TGATCCTG
>DJ349868.1 Methods for Selecting Medications
GGCTGCGC
>DJ349849.1 Methods for Selecting Medications
GGCGCGGC
>DJ349848.1 Methods for Selecting Medications
GGCGCGGG
>DJ334177.1 AAV VIRIONS WITH DECREASED IMMUNOREACTIVITY AND USES THEREFOR
CCTGCAGG
>DI006421.1 PEPTIDES AND RELATED MOLECULES THAT BIND TO TALL-1
GGGKGGGG
>DI020922.1 Immunostimulatory Nucleic Acids
TCACCGGT
>DI033204.1 DNA sequences comprising gene transcription regulatory qualities and
CCGNNGGC
>DI019878.1 Immunostimulatory Nucleic Acids
TAGACGTC
>DJ090012.1 EXPRESSION OF APOA-1 AND VARIANTS THEREOF USING SPLICEOSOME MEDIATED RNA TRANS-SPLICING
AGGTRAGT
>DJ090004.1 NUCLEIC ACID SEQUENCING BY RAMAN MONITORING OF UPTAKE OF NUCLEOTIDES DURING MOLECULAR REPLICATION
AGACATAT
>DI166628.1 Linkers
GCGGCCGC
>DI166323.1 Linkers
CCATGGGC
>DI156556.1 Gastrointestinal Proliferative Factor and uses thereof
AGTCGACA
>DI155550.1 Sequence Accelerating Expression of Gene at Mild Low Temperature
TCAACGCC
>DI155531.1 Sequence Accelerating Expression of Gene at Mild Low Temperature
TCCCCGTC
>DI155499.1 Sequence Accelerating Expression of Gene at Mild Low Temperature
GGCGGGGA
>DI155124.1 NUCLEIC ACID SEQUENCING BY RAMAN MONITORING OF UPTAKEOF NUCLEOTIDES DURING MOLECULAR REPLICATION
AGACATAT
>DI155098.1 Sequence Accelerating Expression of Gene at Mild Low Temperature
TCCCATCC
>DI154928.1 Sequence Accelerating Expression of Gene at Mild Low Temperature
TCCCCACC
>DI154630.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BYSMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
TCGTCGTT
>DI154072.1 Sequence Accelerating Expression of Gene at Mild Low Temperature
GACCCGCC
>DI153717.1 Sequence Accelerating Expression of Gene at Mild Low Temperature
GGGGGGGA
>DI152673.1 Sequence Accelerating Expression of Gene at Mild Low Temperature
TCCAAGCC
>DI152390.1 Sequence Accelerating Expression of Gene at Mild Low Temperature
TCCCCGCT
>DI152293.1 Sequence Accelerating Expression of Gene at Mild Low Temperature
TCCCCGAA
>DI152042.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BYSMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
TTCTCATC
>DI151789.1 Sequence Accelerating Expression of Gene at Mild Low Temperature
TCCCCTAC
>DI151631.1 Sequence Accelerating Expression of Gene at Mild Low Temperature
TCCCCCCC
>DI150896.1 Sequence Accelerating Expression of Gene at Mild Low Temperature
TAACCGCC
>DI149783.1 Novel Rubisco Promoters and Uses Thereof
ACCAGCCC
>DI139673.1 CPG FORMULATIONS AND RELATED METHODS
AACGTTCT
>DI135764.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
TTCGTTCT
>DI135062.1 CPG FORMULATIONS AND RELATED METHODS
TCATCGAT
>DI134504.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
GANGTTCT
>DI134375.1 CPG FORMULATIONS AND RELATED METHODS
TCAGCGCT
>DI133266.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
GACNTTCT
>DI132304.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
GTCNTTCT
>DI131446.1 GENETIC VACCINE AGAINST HUMAN IMMUNODEFICIENCY VIRUS
AAGAAGAA
>DI130823.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
GTCGTTCT
>DI130385.1 Peptide nucleic acid derivatives with a negative charge,agents and methods for producing them
CCCCTTCC
>DI129623.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
GACGTTCT
>DI129554.1 CPG FORMULATIONS AND RELATED METHODS
TCAACGTC
>DI128539.1 CPG FORMULATIONS AND RELATED METHODS
TCAACGTT
>DI127086.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
TTCNTTCT
>DI126096.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
GTNGTTCT
>DI125036.1 CPG FORMULATIONS AND RELATED METHODS
TCTTCGAA
>DI121386.1 GENOMIC PROFILING OF REGULATORY FACTORBINDING SITES
CTTGGCGG
>DI121256.1 GENOMIC PROFILING OF REGULATORY FACTORBINDING SITES
CTTGGCGG
>DI121072.1 GENOMIC PROFILING OF REGULATORY FACTORBINDING SITES
CTTGGCGG
>DI120977.1 GENOMIC PROFILING OF REGULATORY FACTORBINDING SITES
CTTGGCGG
>DI120762.1 A METHOD OF ANALYSING A MARKER NUCLEIC ACID MOLECULE
CTAACTGG
>DI120445.1 GENOMIC PROFILING OF REGULATORY FACTORBINDING SITES
AGGGAGGG
>DI120390.1 GENOMIC PROFILING OF REGULATORY FACTORBINDING SITES
GCGACAAA
>DI120049.1 GENOMIC PROFILING OF REGULATORY FACTORBINDING SITES
TGACGTAG
>DI119583.1 STABILIZED IMMUNOMODULATORY OLIGONUCLEOTIDES
TTGTGCTT
>DI119409.1 STABILIZED IMMUNOMODULATORY OLIGONUCLEOTIDES
TCGTCGTT
>DI119272.1 STABILIZED IMMUNOMODULATORY OLIGONUCLEOTIDES
TCGTCGTT
>DI119087.1 STABILIZED IMMUNOMODULATORY OLIGONUCLEOTIDES
TCGTCGTT
>DI118538.1 Statistical Analysis Of RegulatoryFactor Binding Sites Of Differentially Expressed Genes
TTTGGCGG
>DI118388.1 STABILIZED IMMUNOMODULATORY OLIGONUCLEOTIDES
TCNTCNTT
>DI117733.1 Sterol regulatory element in liver-type glucokinase promoter
CCAGCCAC
>DI093270.1 Phosphorothioate oligonucleotides containing modified nucleotideswith six-membered azasugars and use for AIDS therapy thereof
ATGGGGAT
>DI090944.1 DNA sequences comprising gene transcription regulatory qualities and
CCGNNGTC
>DI089519.1 Immunostimulatory Nucleic Acids
TTAACGTT
>DI089096.1 Immunostimulatory Nucleic Acids
TCATCGAT
>DI088791.1 Immunostimulatory Nucleic Acids
CCTTCGAT
>DI087298.1 DNA sequences comprising gene transcription regulatory qualities and
AGGNNGGG
>DI087029.1 DNA sequences comprising gene transcription regulatory qualities and
CGTNNGCA
>DI086536.1 DNA sequences comprising gene transcription regulatory qualities and
CCCNNCGC
>DI086377.1 Immunostimulatory Nucleic Acids
AAAACGTT
>DI086249.1 DNA sequences comprising gene transcription regulatory qualities and
CAGNNGGG
>DI085342.1 DNA sequences comprising gene transcription regulatory qualities and
CGGNNCCC
>DI084872.1 METHODS AND COMPOSITIONS FOR SIMULTANEOUSSACCHARIFICATION AND FERMENTATION
GGCGCGCC
>DI082908.1 Immunostimulatory Nucleic Acids
TAAGCGCT
>DI081766.1 Immunostimulatory Nucleic Acids
TGCGCTCT
>DI080045.1 Immunostimulatory Nucleic Acids
CGAACGTT
>DI079498.1 Immunostimulatory Nucleic Acids
CCATGCAT
>DI078313.1 Immunostimulatory Nucleic Acids
CCCCCCCC
>DI078023.1 ALVAC CANARYPOX VIRUS RECOMBINANTS AND USES THEREOF
TCGAGTTT
>DI076572.1 NOVEL MINIATURE INVERTED-REPEAT TRANSPOSABLE ELEMENTS (MITEs)-LIKEELEMENT AND TRANSCRIPTIONAL ACTIVATION ELEMENT
TTTGCAAC
>DI076068.1 Immunostimulatory Nucleic Acids
TCTTCGAA
>DI075936.1 Immunostimulatory Nucleic Acids
TCCGTACG
>DI073827.1 Immunostimulatory Nucleic Acids
CTAGCGCT
>DI073215.1 Immunostimulatory Nucleic Acids
GCAACGTT
>DI072955.1 ALVAC CANARYPOX VIRUS RECOMBINANTS AND USES THEREOF
GGCCAAAC
>DI072000.1 DNA sequences comprising gene transcription regulatory qualities and
CCCNNGCC
>DI071596.1 Immunostimulatory Nucleic Acids
CAAACGTT
>DI071545.1 Immunostimulatory Nucleic Acids
TCAACGTT
>DI070064.1 DNA sequences comprising gene transcription regulatory qualities and
CGANNACG
>DI069112.1 DNA sequences comprising gene transcription regulatory qualities and
CGCNNACA
>DI068250.1 Immunostimulatory Nucleic Acids
CTAACGTT
>DI065756.1 PEPTIDES AND RELATED MOLECULES THAT BIND TO TALL-1
GGGNGSGG
>DI062522.1 Immunostimulatory Nucleic Acids
CCAACGTT
>DI062182.1 Immunostimulatory Nucleic Acids
TCAGCGCT
>DI061709.1 DNA sequences comprising gene transcription regulatory qualities and
CAGNNCGC
>DI061397.1 Immunostimulatory Nucleic Acids
TCAACGTT
>DI059368.1 Immunostimulatory Nucleic Acids
ATGCATGT
>DI058912.1 DNA sequences comprising gene transcription regulatory qualities and
GCANNGCC
>DI057256.1 Immunostimulatory Nucleic Acids
TCAACGTT
>DI056622.1 Replicons derived from positive strand RNA virusgenomes useful for the production of heterologousproteins
CGAGCATG
>DI056278.1 DNA sequences comprising gene transcription regulatory qualities and
CCGNNGCC
>DI055669.1 DNA sequences comprising gene transcription regulatory qualities and
CCCNNGCG
>DI055197.1 Nucleotide Sequences for Gene Regulation and Methods ofUse Thereof
GGAGGAAA
>DI054758.1 Surface Transfection and Expression Procedure
TGACGTCA
>DI052826.1 Immunostimulatory Nucleic Acids
ATGATCGT
>DI050800.1 Immunostimulatory Nucleic Acids
TGAACGTT
>DI049076.1 Immunostimulatory Nucleic Acids
TCAGNGCT
>DI048657.1 Polynucleotide
GACTAGTC
>DI047646.1 Immunostimulatory Nucleic Acids
AGAACGTT
>DI047530.1 PROTEINASE INHIBITORS METHOD FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
ACCATGGT
>DI046844.1 DNA sequences comprising gene transcription regulatory qualities and
CCGNNGAC
>DI046731.1 Immunostimulatory Nucleic Acids
TCAACGTT
>DI046073.1 DNA sequences comprising gene transcription regulatory qualities and
CAGNNGGC
>DI045757.1 DNA sequences comprising gene transcription regulatory qualities and
CCCNNGAA
>DI044746.1 NOVEL MINIATURE INVERTED-REPEAT TRANSPOSABLE ELEMENTS (MITEs)-LIKEELEMENT AND TRANSCRIPTIONAL ACTIVATION ELEMENT
TTTGCAAA
>DI041558.1 Isometric primer extension method and kit for detectionand quantification of specific nucleic acid
TTAAAGGA
>DI041383.1 Immunostimulatory Nucleic Acids
TCGTCGTT
>DI040250.1 DNA sequences comprising gene transcription regulatory qualities and
GCGNNGCC
>DI039177.1 Immunostimulatory Nucleic Acids
TCCGATCG
>DI036556.1 EINSETZUNG DES BACILLUS THURINGIENSIS KRISTALLPROTEINGENS INPFLANZEN KOLONISIERENDE MIKROORGANISMEN UND DEREN VERWE
CCTGCAGG
>DI036383.1 Immunostimulatory Nucleic Acids
ACAACGTT
>DI035748.1 Immunostimulatory Nucleic Acids
TCAACGTT
>DI034320.1 DNA sequences comprising gene transcription regulatory qualities and
GACNNCGC
>DI034221.1 Immunostimulatory Nucleic Acids
CTGACGTG
>DI031847.1 DNA sequences comprising gene transcription regulatory qualities and
CCANNGGG
>DI030517.1 DNA sequences comprising gene transcription regulatory qualities and
GACNNCCC
>DI029781.1 DNA sequences comprising gene transcription regulatory qualities and
CGGNNGCA
>DI028799.1 DNA sequences comprising gene transcription regulatory qualities and
CCCNNCCC
>DI028565.1 DNA sequences comprising gene transcription regulatory qualities and
GCGNNGAC
>DI027429.1 Immunostimulatory Nucleic Acids
ATCGATGT
>DI027323.1 Immunostimulatory Nucleic Acids
TCAANGTT
>DI027255.1 Immunostimulatory Nucleic Acids
ATAACGTT
>DI027202.1 DNA sequences comprising gene transcription regulatory qualities and
GAGNNCGC
>DI026109.1 COMPOSITIONS AND METHODS FOR HIGH-LEVEL, LARGE-SCALEPRODUCTION OF RECOMBINANT PROTEINS
GACTAGTC
>DI025333.1 DNA sequences comprising gene transcription regulatory qualities and
GCGNNCCC
>DI024827.1 Immunostimulatory Nucleic Acids
CCATCGAT
>DI024096.1 Immunostimulatory Nucleic Acids
AACGTTCT
>DI022211.1 TROVAC FOWLPOX VIRUS RECOMBINANTS AND USES THEREOF
TCGAGTTT
>DI021914.1 Immunostimulatory Nucleic Acids
AACGTTGA
>DI018688.1 Immunostimulatory Nucleic Acids
GAAACGTT
>DI017400.1 Soluble single-chain T-cell receptor proteins
CCACCATG
>DI015536.1 Surface Transfection and Expression Procedure
CCAGGAAG
>DI015333.1 Immunostimulatory Nucleic Acids
TAAACGTT
>DI014893.1 DNA sequences comprising gene transcription regulatory qualities and
GCGNNGCA
>DI014344.1 NOVEL MINIATURE INVERTED-REPEAT TRANSPOSABLE ELEMENTS (MITEs)-LIKEELEMENT AND TRANSCRIPTIONAL ACTIVATION ELEMENT
GTTGCAAC
>DI013163.1 Immunostimulatory Nucleic Acids
CCTTCGAT
>DI012588.1 DNA sequences comprising gene transcription regulatory qualities and
ACGNNCCC
>DI006193.1 Immunostimulatory Nucleic Acids
TCAACGTT
>DI006142.1 Immunostimulatory Nucleic Acids
TCAAGCTT
>DI009141.1 Immunostimulatory Nucleic Acids
GGAACGTT
>DI005880.1 DNA sequences comprising gene transcription regulatory qualities and
CCCNNCGG
>DI033567.1 Immunostimulatory Nucleic Acids
AGGATATC
>DI033520.1 DNA sequences comprising gene transcription regulatory qualities and
CGGNNCAG
>DJ084359.1 A method for hybridizing nucleic acids and hybridization apparatus
CGTACGTA
>DJ086390.1 A Rubisco Promoter and the Use Thereof
ACCAGCCC
>DI009026.1 DNA sequences comprising gene transcription regulatory qualities and
AGGNNCCG
>DI155880.1 Sequence Accelerating Expression of Gene at Mild Low Temperature
TCCCCGCC
>DI155586.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BYSMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
TCNTCNTT
>DI155351.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BYSMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
TCGTCGTT
>DI153340.1 Sequence Accelerating Expression of Gene at Mild Low Temperature
ACCCCGCC
>DI153281.1 Sequence Accelerating Expression of Gene at Mild Low Temperature
GCCCCGCC
>DI133489.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
TTNGTTCT
>DI129466.1 CPG FORMULATIONS AND RELATED METHODS
CCAACGTT
>DI127163.1 CPG FORMULATIONS AND RELATED METHODS
TCTTCGAT
>DI121493.1 GENOMIC PROFILING OF REGULATORY FACTORBINDING SITES
AGGGAGGG
>DI119943.1 GENOMIC PROFILING OF REGULATORY FACTORBINDING SITES
TTTGGCGG
>DI119163.1 STABILIZED IMMUNOMODULATORY OLIGONUCLEOTIDES
TCNTCNTT
>DI101324.1 A NOVEL NUCLEIC ACID BASED STEGANOGRAPHY SYSTEM AND APPLICATIONTHEREOF
CCGATGCA
>DI084805.1 DNA sequences comprising gene transcription regulatory qualities and
CGGNNCCA
>DI076949.1 Immunostimulatory Nucleic Acids
GACGTCAT
>DI071476.1 Immunostimulatory Nucleic Acids
TCAAGCTT
>DI068704.1 PEPTIDES AND RELATED MOLECULES THAT BIND TO TALL-1
GGGCGGGG
>DI066390.1 DNA sequences comprising gene transcription regulatory qualities and
AGCNNCGC
>DI065125.1 Immunostimulatory Nucleic Acids
TCGACGTC
>DI064881.1 Immunostimulatory Nucleic Acids
TCAACGTT
>DI064795.1 TROVAC FOWLPOX VIRUS RECOMBINANTS AND USES THEREOF
GGCCAAAC
>DI063963.1 DNA sequences comprising gene transcription regulatory qualities and
CCCNNTCC
>DI063333.1 DNA sequences comprising gene transcription regulatory qualities and
CGCNNGGA
>DI061871.1 Immunostimulatory Nucleic Acids
TCAACGTC
>DI055556.1 DNA sequences comprising gene transcription regulatory qualities and
CGCNNCCG
>DI053847.1 DNA sequences comprising gene transcription regulatory qualities and
GCCNNCGA
>DI053495.1 DNA sequences comprising gene transcription regulatory qualities and
GGCNNCGA
>DI049936.1 NOVEL MINIATURE INVERTED-REPEAT TRANSPOSABLE ELEMENTS (MITEs)-LIKEELEMENT AND TRANSCRIPTIONAL ACTIVATION ELEMENT
GTTGCAAA
>DI045246.1 Immunostimulatory Nucleic Acids
AACGTTGA
>DI041750.1 Immunostimulatory Nucleic Acids
CCATCGAT
>DI041458.1 Immunostimulatory Nucleic Acids
TNAACGTT
>DI039851.1 CHIMERIC GLYCOPROTEINS CONTAINING IMMUNOGENIC SEGMENTS OF HUMAN PARAINFLUENZA VIRUS TYPE 3
GTCTAGAG
>DI034008.1 Immunostimulatory Nucleic Acids
TCGTATGA
>DI032761.1 Immunostimulatory Nucleic Acids
TCAACGTT
>DI032093.1 Nucleotide Sequences for Gene Regulation and Methods ofUse Thereof
CCCGGAAG
>DI031429.1 RECOMBINANT HOSTS SUITABLE FOR SIMULTANEOUSSACCHARIFICATION AND FERMENTATION
GGCGCGCC
>DI031016.1 Immunostimulatory Nucleic Acids
AGCGCTGA
>DI024557.1 Isometric primer extension method and kit for detectionand quantification of specific nucleic acid
GCCTGCTG
>DI018243.1 METHOD FOR CONFERRING HERBICIDE, PEST, OR DISEASE RESISTANCE INPLANT HOSTS
GCGGCCGC
>DI011764.1 OLIGONUCLEOTIDES HAVING PHOSPHOROTHIOATE LINKAGES OF HIGH CHIRAL PURITY
TTGGGGTT
>DI004332.1 Immunostimulatory Nucleic Acids
GTAACGTT
>DJ066944.1 COMBINATORIAL NUCLEOBASE OLIGOMERS COMPRISING UNIVERSAL BASE ANALOGUES AND METHODS FOR MAKING AND USING SAME
GATCCGTA
>DJ069087.1 Identification of Clonal Cells by Repeats in (Eg.) T-Cell Receptor V/D/J Genes
CTAACTGG
>DJ068442.1 METADHERIN POLYPEPTIDES, ENCODING NUCLEIC ACIDS AND METHODS OF USE
TTNNNNNN
>DJ062050.1 Statistical Analysis Of Regulatory Factor Binding Sites Of Differentially Expressed Genes
TTTGGCGG
>DJ058408.1 HIF Oligonucleotide Decoy Molecules
YACGTGCN
>DJ058338.1 NF-kB Oligonucleotide Decoy Molecules
GATTTCCC
>DJ058336.1 NF-kB Oligonucleotide Decoy Molecules
TTGAAGGC
>DJ058333.1 NF-kB Oligonucleotide Decoy Molecules
GGATTTCC
>DJ058329.1 NF-kB Oligonucleotide Decoy Molecules
GACTTTCC
>DJ058665.1 SYSTEM AND METHODS FOR NUCLEIC ACID AND POLYPEPTIDE SELECTION
NCTAAANC
>DJ058659.1 SYSTEM AND METHODS FOR NUCLEIC ACID AND POLYPEPTIDE SELECTION
NCTAACNC
>FB296089.1 Sequence 12 from Patent WO2007100412
GACGAGGA
>DJ020614.1 Double-Stranded RNA Structures and Constructs, and Methods For Generating and Using the Same
CCCTCTNN
>DJ020611.1 Double-Stranded RNA Structures and Constructs, and Methods For Generating and Using the Same
CCCTCTAA
>DJ020598.1 Double-Stranded RNA Structures and Constructs, and Methods For Generating and Using the Same
AAAAAAAA
>DJ052597.1 Nucleic acids useful for triggering tumor cell lethality
ACGCACGG
>DJ045406.1 METHODS AND COMPOSITIONS FOR SYNTHESIS OF LABELLED OLIGONUCLEOTIDES AND ANALOGS ON SOLID-SUPPORTS
TCCTCCTT
>DJ045405.1 METHODS AND COMPOSITIONS FOR SYNTHESIS OF LABELLED OLIGONUCLEOTIDES AND ANALOGS ON SOLID-SUPPORTS
TCCTCCTT
>DJ045398.1 METHODS AND COMPOSITIONS FOR SYNTHESIS OF LABELLED OLIGONUCLEOTIDES AND ANALOGS ON SOLID-SUPPORTS
TCCTCCTT
>DJ045397.1 METHODS AND COMPOSITIONS FOR SYNTHESIS OF LABELLED OLIGONUCLEOTIDES AND ANALOGS ON SOLID-SUPPORTS
TCCTCCTT
>DJ050703.1 Compositions a,d methods to inhibit the production of Abeta peptide
CCAGGATC
>DJ049895.1 DUAL PHASE-PNA CONJUGATES FOR THE DELIVERY OF PNA THROUGH THE BLOOD BRAIN BARRIER
CCGCTCCG
>CU225142.1 Populus EST from leave
GATTCAGT
>CU224749.1 Populus EST from leave
GGCGTCAG
>CS793361.1 Sequence 2 from Patent EP1832567
ACCCGTCA
>CS793360.1 Sequence 1 from Patent EP1832567
TGACGGGT
>CS721575.1 Sequence 17 from Patent WO2007098042
NAGATCTG
>CS720968.1 Sequence 26 from Patent WO2007093819
TAACATAA
>CS720931.1 Sequence 23 from Patent WO2007096275
CAATTATT
>CS805255.1 Sequence 34 from Patent WO2007095976
GGCGCCCG
>CS805254.1 Sequence 33 from Patent WO2007095976
GGCGTCCG
>CS805253.1 Sequence 32 from Patent WO2007095976
GGCGCTCG
>CS805252.1 Sequence 31 from Patent WO2007095976
GGCGTTCG
>CS805251.1 Sequence 30 from Patent WO2007095976
AACGCCCG
>CS805250.1 Sequence 29 from Patent WO2007095976
AACGTCCG
>CS805249.1 Sequence 28 from Patent WO2007095976
AACGCTCG
>CS805248.1 Sequence 27 from Patent WO2007095976
AACGTTCG
>CS805247.1 Sequence 26 from Patent WO2007095976
AGCGCCCG
>CS805246.1 Sequence 25 from Patent WO2007095976
AGCGTCCG
>CS805245.1 Sequence 24 from Patent WO2007095976
AGCGCTCG
>CS805244.1 Sequence 23 from Patent WO2007095976
AGCGTTCG
>CS805243.1 Sequence 22 from Patent WO2007095976
GACGCCCG
>CS805242.1 Sequence 21 from Patent WO2007095976
GACGTCCG
>CS805241.1 Sequence 20 from Patent WO2007095976
GACGCTCG
>CS805240.1 Sequence 19 from Patent WO2007095976
GACGTTCG
>CS805239.1 Sequence 18 from Patent WO2007095976
GGCGCCCC
>CS805238.1 Sequence 17 from Patent WO2007095976
GGCGTCCC
>CS805237.1 Sequence 16 from Patent WO2007095976
GGCGCTCC
>CS805236.1 Sequence 15 from Patent WO2007095976
GGCGTTCC
>CS805235.1 Sequence 14 from Patent WO2007095976
AACGCCCC
>CS805234.1 Sequence 13 from Patent WO2007095976
AACGTCCC
>CS805233.1 Sequence 12 from Patent WO2007095976
AACGCTCC
>CS805232.1 Sequence 11 from Patent WO2007095976
AACGTTCC
>CS805231.1 Sequence 10 from Patent WO2007095976
AGCGCCCC
>CS805230.1 Sequence 9 from Patent WO2007095976
AGCGTCCC
>CS805229.1 Sequence 8 from Patent WO2007095976
AGCGCTCC
>CS805228.1 Sequence 7 from Patent WO2007095976
AGCGTTCC
>CS805227.1 Sequence 6 from Patent WO2007095976
GACGCCCC
>CS805226.1 Sequence 5 from Patent WO2007095976
GACGTCCC
>CS805225.1 Sequence 4 from Patent WO2007095976
GACGCTCC
>CS805224.1 Sequence 3 from Patent WO2007095976
GACGTTCC
>CS805223.1 Sequence 2 from Patent WO2007095976
NNNCGNNN
>DJ042907.1 NUCLEIC ACID-LIPOPHILIC CONJUGATES
TCGTACGA
>DJ042902.1 NUCLEIC ACID-LIPOPHILIC CONJUGATES
TCGCGCGA
>DJ042883.1 NUCLEIC ACID-LIPOPHILIC CONJUGATES
TGACGTTT
>DJ042882.1 NUCLEIC ACID-LIPOPHILIC CONJUGATES
TAACGTTT
>DJ042881.1 NUCLEIC ACID-LIPOPHILIC CONJUGATES
CGACGTCG
>DJ028001.1 PROGRAM AND METHOD FOR WAVEFORM SEPARATION
ATGCATTC
>DJ028000.1 PROGRAM AND METHOD FOR WAVEFORM SEPARATION
ATGCATGC
>DJ027999.1 PROGRAM AND METHOD FOR WAVEFORM SEPARATION
AGCGAGCT
>DJ027998.1 PROGRAM AND METHOD FOR WAVEFORM SEPARATION
AGCTAGCT
>DJ029369.1 Catalytic DNA molecules
TCACTATN
>CS685399.1 Sequence 131 from Patent WO2007064437
GCGGCCGC
>CS692853.1 Sequence 847 from Patent WO2007073737
ACATTCCA
>CS692846.1 Sequence 840 from Patent WO2007073737
TGCCTTAA
>DJ009228.1 Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics
AATTATGG
>DJ012138.1 METHODS AND COMPOSITIONS FOR TARGETED CLEAVAGE AND RECOMBINATION
GACCACAT
>DJ011684.1 COMBINATION THERAPY FOR THE TREATMENT OF OCULAR NEOVASCULAR DISORDERS
GTGAATGC
>DJ011683.1 COMBINATION THERAPY FOR THE TREATMENT OF OCULAR NEOVASCULAR DISORDERS
TTGGACGC
>DJ004005.1 5'- AND 3'- CAPPED APTAMERS AND USES THEREFOR
GTGAATGC
>DJ004004.1 5'- AND 3'- CAPPED APTAMERS AND USES THEREFOR
TTGGACGC
>CS671311.1 Sequence 21 from Patent WO2007059920
TGGCTGTG
>CS673320.1 Sequence 8 from Patent EP1811043
ACGGAAGT
>CS672880.1 Sequence 4 from Patent WO2007062107
ATAGGCAC
>CS672879.1 Sequence 3 from Patent WO2007062107
CTAGGCAC
>CS672878.1 Sequence 2 from Patent WO2007062107
TTAGGCAC
>CS672877.1 Sequence 1 from Patent WO2007062107
GTAGGCAC
>DD467806.1 Immunogenic Compositions for Streptococcus pyogenes
AGTTGGTA
>DD463369.1 Polynucleotide Detection h Chips and Polynucleotide Detection Apparatus
TGGCCGTC
>DD463368.1 Polynucleotide Detection h Chips and Polynucleotide Detection Apparatus
GGCCGTCG
>DD463367.1 Polynucleotide Detection h Chips and Polynucleotide Detection Apparatus
CCGTCGTT
>DD463366.1 Polynucleotide Detection h Chips and Polynucleotide Detection Apparatus
CCGTCGTT
>CS644972.1 Sequence 61 from Patent WO2006083800
GAAGCTTG
>CS644969.1 Sequence 58 from Patent WO2006083800
GAAGCTTG
>DD454928.1 Exciplexes
CGATTCTG
>DD454927.1 Exciplexes
TGCTTGGC
>DD454926.1 Exciplexes
CGATTGGC
>DD454925.1 Exciplexes
TGTTTGGC
>DD454907.1 Exciplexes
GACTTAGC
>DD454905.1 Exciplexes
GTCTTAGC
>DD454904.1 Exciplexes
CGGTTTGT
>CS641555.1 Sequence 34 from Patent EP1806357
CACGTGCT
>CS641554.1 Sequence 33 from Patent EP1806357
BACGTGCK
>CS641553.1 Sequence 32 from Patent EP1806357
CACGTGCG
>CS641552.1 Sequence 31 from Patent EP1806357
GACGTGCG
>CS641551.1 Sequence 30 from Patent EP1806357
TACGTGCT
>CS641468.1 Sequence 121 from Patent WO2007056153
GGATCTTA
>CS641454.1 Sequence 107 from Patent WO2007056153
GGATCTTA
>CS641440.1 Sequence 93 from Patent WO2007056153
GGATCTTA
>CS641435.1 Sequence 88 from Patent WO2007056153
AGACAATG
>CS641426.1 Sequence 79 from Patent WO2007056153
GGATCTTA
>CS644036.1 Sequence 16 from Patent EP1806402
CTCTAAAG
>CS626780.1 Sequence 27 from Patent WO2007051626
CAGCCTTT
>CS623222.1 Sequence 16 from Patent WO2007051483
CAGCCTTT
>CS624676.1 Sequence 28 from Patent EP1803733
CGCGTCTC
>CS624675.1 Sequence 27 from Patent EP1803733
AATTGAGA
>DD450562.1 METHODS FOR MODULATING ANGIOGENESIS WITH APELIN COMPOSITIONS
TACGTGGG
>DD449111.1 RNA INTERFERENCE COMPOSITIONS AND METHODS
TTCTAGAA
>CS607063.1 Sequence 299 from Patent WO2007039903
CTCCTCGG
>CS606931.1 Sequence 167 from Patent WO2007039903
CTCTGCAT
>CS592986.1 Sequence 214 from Patent WO2007039454
GCAGTGGA
>CS592980.1 Sequence 208 from Patent WO2007039454
CATCCTCC
>CS592979.1 Sequence 207 from Patent WO2007039454
AGGAGCAG
>CS599316.1 Sequence 3 from Patent WO2007016380
GTGAATGC
>CS599315.1 Sequence 2 from Patent WO2007016380
TTGGACGC
>CS588633.1 Sequence 6 from Patent WO2007034527
ATGCAAAT
>CS588632.1 Sequence 5 from Patent WO2007034527
ATTTGCAT
>CS575962.1 Sequence 36 from Patent WO2007031091
CKCATGTA
>CS575961.1 Sequence 35 from Patent WO2007031091
GCRCTGTA
>CS575958.1 Sequence 32 from Patent WO2007031091
CTGTACTC
>CS575957.1 Sequence 31 from Patent WO2007031091
TGTACTCY
>CS575946.1 Sequence 20 from Patent WO2007031091
TATTCRTC
>CS575945.1 Sequence 19 from Patent WO2007031091
TCRTATTC
>CS575944.1 Sequence 18 from Patent WO2007031091
TCYACAAA
>CS575943.1 Sequence 17 from Patent WO2007031091
ATYAGCTG
>CS575942.1 Sequence 16 from Patent WO2007031091
TTCTGRAT
>CS575941.1 Sequence 15 from Patent WO2007031091
AGCTGKAT
>CS575744.1 Sequence 62 from Patent WO2007031081
GCATTGGT
>CS575743.1 Sequence 61 from Patent WO2007031081
TCAGCATT
>CS575742.1 Sequence 60 from Patent WO2007031081
GGTATTCA
>CS575741.1 Sequence 59 from Patent WO2007031081
GTATTCAG
>CS570672.1 Sequence 1 from Patent WO2006042232
AGGTRAGT
>CS543365.1 Sequence 110 from Patent EP1775349
ATACTCAC
>CS503980.1 Sequence 64 from Patent WO2007011733
TGTCTATA
>CS503979.1 Sequence 63 from Patent WO2007011733
TATCTTGA
>CS503978.1 Sequence 62 from Patent WO2007011733
TATCTACA
>CS503977.1 Sequence 61 from Patent WO2007011733
TCTCCAGA
>CS503976.1 Sequence 60 from Patent WO2007011733
TCTCTGGA
>CS503975.1 Sequence 59 from Patent WO2007011733
TATTTGAA
>CS503974.1 Sequence 58 from Patent WO2007011733
TTTCTACA
>CS503973.1 Sequence 57 from Patent WO2007011733
TATCTAGA
>CS503972.1 Sequence 56 from Patent WO2007011733
TTATTGAA
>CS503971.1 Sequence 55 from Patent WO2007011733
TTTTTGAA
>CS503960.1 Sequence 44 from Patent WO2007011733
CTTTTGAA
>CS503959.1 Sequence 43 from Patent WO2007011733
TTTCTAGA
>CS503934.1 Sequence 18 from Patent WO2007011733
TTTCTCGA
>CS503933.1 Sequence 17 from Patent WO2007011733
TGAGAGAA
>CS503932.1 Sequence 16 from Patent WO2007011733
TTTTGTGA
>CS503931.1 Sequence 15 from Patent WO2007011733
TGATTGGA
>CS503930.1 Sequence 14 from Patent WO2007011733
TCCACAGA
>CS503929.1 Sequence 13 from Patent WO2007011733
TCTCTTGA
>CS503928.1 Sequence 12 from Patent WO2007011733
TTCCGAGA
>CS503927.1 Sequence 11 from Patent WO2007011733
TCTCTAGA
>CS503926.1 Sequence 10 from Patent WO2007011733
TTCCATAA
>CS503925.1 Sequence 9 from Patent WO2007011733
TATACAAA
>CS503924.1 Sequence 8 from Patent WO2007011733
TGTAATGA
>CS503923.1 Sequence 7 from Patent WO2007011733
TGAAAAGA
>CS503922.1 Sequence 6 from Patent WO2007011733
TTTAGGTA
>CS503921.1 Sequence 5 from Patent WO2007011733
TGTAAAAA
>CS503920.1 Sequence 4 from Patent WO2007011733
TTTCTGGA
>CS503919.1 Sequence 3 from Patent WO2007011733
TTTCTTGA
>CS503918.1 Sequence 2 from Patent WO2007011733
TTTTCTAA
>CS503917.1 Sequence 1 from Patent WO2007011733
TCTATGTA
>CS502987.1 Sequence 109 from Patent WO2007010221
CCGCAGGC
>CS502985.1 Sequence 107 from Patent WO2007010221
CCGCGGGC
>CS502982.1 Sequence 104 from Patent WO2007010221
CCGACGGC
>CS502980.1 Sequence 102 from Patent WO2007010221
CCGGTGGC
>CS502978.1 Sequence 100 from Patent WO2007010221
CCGCAGGC
>CS502976.1 Sequence 98 from Patent WO2007010221
CCGCGGGC
>CS502974.1 Sequence 96 from Patent WO2007010221
CCGAGGGC
>CS502996.1 Sequence 118 from Patent WO2007010221
CCGNNGGC
>CS502993.1 Sequence 115 from Patent WO2007010221
CCGGTGGC
>CS502991.1 Sequence 113 from Patent WO2007010221
CCGGTGGC
>CS500299.1 Sequence 52 from Patent WO2006107317
GGCACTGC
>CS500298.1 Sequence 51 from Patent WO2006107317
GCGAGGAT
>DD412037.1 A pharmaceutical composition and a food composition for the enhancement of the immune response having AT oligonucleotide as the active ingredient
ATTTTTAC
>DD411663.1 Protocol and kit for Gene detection by photo-sensitized reduction
TCCTGTCA
>DD410792.1 Protocol and kit for Gene detection by photo-sensitized reduction
TCCTGTCA
>DD414225.1 PROSTATE CANCER-RELATED COMPOSITIONS, METHODS, AND KITS BASED ON DNA MACROARRAY PROTEOMICS PLATFORMS
CACAATGA
>DD414224.1 PROSTATE CANCER-RELATED COMPOSITIONS, METHODS, AND KITS BASED ON DNA MACROARRAY PROTEOMICS PLATFORMS
CACGGATG
>CS490845.1 Sequence 15 from Patent WO2007005766
ACCTCGGC
>CS485309.1 Sequence 3 from Patent WO2006019954
GTCTAGAC
>CS466015.1 Sequence 45 from Patent EP1743648
CGCGTCTC
>CS466014.1 Sequence 44 from Patent EP1743648
AATTGAGA
>DD385312.1 Chimeric non-human animals and uses thereof
AGTCGACA
>CS461968.1 Sequence 77 from Patent WO2006120197
TAAATGNA
>CS461967.1 Sequence 76 from Patent WO2006120197
TAAATANA
>CS461961.1 Sequence 70 from Patent WO2006120197
TCAATGNA
>CS461960.1 Sequence 69 from Patent WO2006120197
TAGATGNA
>CS459439.1 Sequence 94 from Patent EP1733735
TCTTCGAT
>CS459373.1 Sequence 28 from Patent EP1733735
TCAACGTC
>CS459372.1 Sequence 27 from Patent EP1733735
AACGTTCT
>CS459371.1 Sequence 26 from Patent EP1733735
CCAACGTT
>CS459369.1 Sequence 24 from Patent EP1733735
TCTTCGAA
>CS459368.1 Sequence 23 from Patent EP1733735
TCATCGAT
>CS459367.1 Sequence 22 from Patent EP1733735
TCAGCGCT
>CS459366.1 Sequence 21 from Patent EP1733735
TCAACGTT
>DD367935.1 Pharmaceutical Agent Comprising Decoy and Its Use For Bone Metabolism
GTCTAGAC
>DD367933.1 Pharmaceutical Agent Comprising Decoy and Its Use For Bone Metabolism
TTTCCCGC
>DD367932.1 Pharmaceutical Agent Comprising Decoy and Its Use For Bone Metabolism
TTTSSCGS
>DD366754.1 DNA catalytic molecules
TCACTATN
>DD362086.1 Method for identifying a structural motif
GGAATTCG
>DD362075.1 Primer Set for Distinguishing Paraserianthes falcataria Individuals and Individuals Distinguishing Method using the same
ACCAGCCC
>CS454160.1 Sequence 15 from Patent WO2006040479
ACCTCCCC
>CS454094.1 Sequence 59 from Patent WO2006119035
GTGAATGC
>CS454093.1 Sequence 58 from Patent WO2006119035
TTGGACGC
>DD360716.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
GACNTTCT
>DD360715.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
GANGTTCT
>DD360708.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
GTCNTTCT
>DD360707.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
GTNGTTCT
>DD360704.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TTCNTTCT
>DD360703.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TTNGTTCT
>DD360699.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TTCGTTCT
>DD360691.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
GTCGTTCT
>DD360686.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
GACGTTCT
>CS448659.1 Sequence 133 from Patent WO2006111541
AACCCANT
>CS448658.1 Sequence 132 from Patent WO2006111541
AACCCANC
>CS448622.1 Sequence 96 from Patent WO2006111541
ATGAGTCG
>CS448621.1 Sequence 95 from Patent WO2006111541
TTGAGTCA
>CS448620.1 Sequence 94 from Patent WO2006111541
CTGAGTCA
>CS448619.1 Sequence 93 from Patent WO2006111541
GTGAGTTA
>CS448618.1 Sequence 92 from Patent WO2006111541
TNGAGTTG
>CS448617.1 Sequence 91 from Patent WO2006111541
ANGAGTTG
>AJ246165.1 Homo sapiens lalp70 gene for lysosomal apyrase-like protein, exon 1 and joined CDS
ATGGGGAG
>X92434.1 H.sapiens COL6A1 gene intron 2 (donor site)
GTAGGAGG
>X92432.1 H.sapiens COL6A1 gene intron 1 (donor site)
GTGAGTGG
>X68900.1 Chloroplast Chlamydomonas pallidostigmatica rrnL gene, exon 2
CCTAAGGT
>CS444581.1 Sequence 19 from Patent WO2006110680
GTAATCCC
>CS444579.1 Sequence 17 from Patent WO2006110680
AATGTAGC
>CS444578.1 Sequence 16 from Patent WO2006110680
GACACCTC
>CS444577.1 Sequence 15 from Patent WO2006110680
CCAGAATT
>CS444573.1 Sequence 11 from Patent WO2006110680
AATGAGTT
>CS444568.1 Sequence 6 from Patent WO2006110680
GGCCTCAA
>CS444567.1 Sequence 5 from Patent WO2006110680
TCTGAGAA
>CS444566.1 Sequence 4 from Patent WO2006110680
AGAGTGTT
>CS444565.1 Sequence 3 from Patent WO2006110680
ACAGAGTT
>CS444564.1 Sequence 2 from Patent WO2006110680
ACTAGACA
>CS444563.1 Sequence 1 from Patent WO2006110680
AATCTGCA
>CS446326.1 Sequence 30 from Patent WO2006110506
GNATATNC
>CS435968.1 Sequence 112 from Patent WO2006085973
TCGATAGT
>CS435938.1 Sequence 82 from Patent WO2006085973
ATCGTCGC
>CS435916.1 Sequence 60 from Patent WO2006085973
ACGTTGAG
>DD350550.1 ENDOGENOUS RETROVIRUS UP-REGULATED IN PROSTATE CANCER
GCCAAGAA
>DD350545.1 ENDOGENOUS RETROVIRUS UP-REGULATED IN PROSTATE CANCER
AAAATTAA
>DD350519.1 ENDOGENOUS RETROVIRUS UP-REGULATED IN PROSTATE CANCER
TGGCTGTT
>DD350518.1 ENDOGENOUS RETROVIRUS UP-REGULATED IN PROSTATE CANCER
TAGGGGTG
>DD350517.1 ENDOGENOUS RETROVIRUS UP-REGULATED IN PROSTATE CANCER
TAGGTCTC
>DD349551.1 SCREENING METHODS FOR IDENTIFICATION OF EFFICIENT PRE-TRANS-SPLICING MOLECULES
GGCGCGCC
>DD334896.1 Chimera (double) decoy
TTTCCCGC
>DD334890.1 Chimera (double) decoy
TTCNNNGA
>DD334888.1 Chimera (double) decoy
TTTSSCGS
>DD345276.1 Oligonucleotide Conjugates
AGGGTTAG
>CS430753.1 Sequence 4 from Patent WO2006028889
TGACGTGA
>CS430752.1 Sequence 3 from Patent WO2006028889
TGACGTGG
>CS414259.1 Sequence 1145 from Patent EP1700603
TCGTCGTT
>CS414252.1 Sequence 1138 from Patent EP1700603
TCGTATGA
>CS414249.1 Sequence 1135 from Patent EP1700603
ATGATCGT
>CS414106.1 Sequence 992 from Patent EP1700603
TCAACGTT
>CS413937.1 Sequence 823 from Patent EP1700603
CTGACGTG
>CS413927.1 Sequence 813 from Patent EP1700603
CCCCCCCC
>CS413924.1 Sequence 810 from Patent EP1700603
TGCGCTCT
>CS413905.1 Sequence 791 from Patent EP1700603
TCAACGTC
>CS413904.1 Sequence 790 from Patent EP1700603
TCTTCGAA
>CS413823.1 Sequence 709 from Patent EP1700603
TNAACGTT
>CS413821.1 Sequence 707 from Patent EP1700603
TCAGNGCT
>CS413813.1 Sequence 699 from Patent EP1700603
CCTTCGAT
>CS413812.1 Sequence 698 from Patent EP1700603
TCAANGTT
>CS413795.1 Sequence 681 from Patent EP1700603
TCCGTACG
>CS413794.1 Sequence 680 from Patent EP1700603
TCCGATCG
>CS413793.1 Sequence 679 from Patent EP1700603
AACGTTCT
>CS413792.1 Sequence 678 from Patent EP1700603
ATAACGTT
>CS413791.1 Sequence 677 from Patent EP1700603
AAAACGTT
>CS413790.1 Sequence 676 from Patent EP1700603
TTAACGTT
>CS413789.1 Sequence 675 from Patent EP1700603
ACAACGTT
>CS413788.1 Sequence 674 from Patent EP1700603
TGAACGTT
>CS413787.1 Sequence 673 from Patent EP1700603
GGAACGTT
>CS413786.1 Sequence 672 from Patent EP1700603
CTAACGTT
>CS413785.1 Sequence 671 from Patent EP1700603
CAAACGTT
>CS413784.1 Sequence 670 from Patent EP1700603
GAAACGTT
>CS413783.1 Sequence 669 from Patent EP1700603
CGAACGTT
>CS413782.1 Sequence 668 from Patent EP1700603
GTAACGTT
>CS413781.1 Sequence 667 from Patent EP1700603
GCAACGTT
>CS413770.1 Sequence 656 from Patent EP1700603
TAAGCGCT
>CS413769.1 Sequence 655 from Patent EP1700603
CTAGCGCT
>CS413768.1 Sequence 654 from Patent EP1700603
TCGACGTC
>CS413767.1 Sequence 653 from Patent EP1700603
CCATCGAT
>CS413764.1 Sequence 650 from Patent EP1700603
TCACCGGT
>CS413755.1 Sequence 641 from Patent EP1700603
CCAACGTT
>CS413754.1 Sequence 640 from Patent EP1700603
TAAACGTT
>CS413753.1 Sequence 639 from Patent EP1700603
TCATCGAT
>CS413752.1 Sequence 638 from Patent EP1700603
AGAACGTT
>CS413750.1 Sequence 636 from Patent EP1700603
TCAACGTT
>CS413746.1 Sequence 632 from Patent EP1700603
AACGTTGA
>CS413745.1 Sequence 631 from Patent EP1700603
TCAACGTT
>CS413744.1 Sequence 630 from Patent EP1700603
TCAACGTT
>CS413741.1 Sequence 627 from Patent EP1700603
CCTTCGAT
>CS413740.1 Sequence 626 from Patent EP1700603
TCAGCGCT
>CS413739.1 Sequence 625 from Patent EP1700603
AGCGCTGA
>CS413738.1 Sequence 624 from Patent EP1700603
CCATGCAT
>CS413737.1 Sequence 623 from Patent EP1700603
ATGCATGT
>CS413736.1 Sequence 622 from Patent EP1700603
ATCGATGT
>CS413735.1 Sequence 621 from Patent EP1700603
CCATCGAT
>CS413734.1 Sequence 620 from Patent EP1700603
GACGTCAT
>CS413733.1 Sequence 619 from Patent EP1700603
TAGACGTC
>CS413732.1 Sequence 618 from Patent EP1700603
AGGATATC
>CS413730.1 Sequence 616 from Patent EP1700603
TCAAGCTT
>CS413717.1 Sequence 603 from Patent EP1700603
AACGTTGA
>CS413715.1 Sequence 601 from Patent EP1700603
TCAACGTT
>CS413479.1 Sequence 365 from Patent EP1700603
TCAACGTT
>CS413421.1 Sequence 307 from Patent EP1700603
TCAACGTT
>CS413316.1 Sequence 202 from Patent EP1700603
TCAAGCTT
>CS413315.1 Sequence 201 from Patent EP1700603
TCAACGTT
>CS417120.1 Sequence 80 from Patent WO2006094976
AGGTAAGT
>CS413114.1 Sequence 251 from Patent WO2006092209
TTGCTATA
>CS412564.1 Sequence 61 from Patent WO2006031267
GAAGCTTG
>CS412561.1 Sequence 58 from Patent WO2006031267
GAAGCTTG
>CS411335.1 Sequence 236 from Patent WO2006042027
AAAAAAAA
>CS410931.1 Sequence 129 from Patent WO2006043271
AGCCAGAG
>CS410847.1 Sequence 45 from Patent WO2006043271
CTGTGCAC
>CS410819.1 Sequence 17 from Patent WO2006043271
CTAAGAAG
>CS410600.1 Sequence 44 from Patent WO2006029196
CGGTTGAG
>CS410599.1 Sequence 43 from Patent WO2006029196
CGGTGTGA
>CS414772.1 Sequence 8 from Patent EP1700915
TCACTATN
>DD329689.1 Methods and Compositions for use in Spliceosome Mediated RNA Trans-splicing
CGGTAAGT
>DD329679.1 Methods and Compositions for use in Spliceosome Mediated RNA Trans-splicing
AGGTRAGT
>DD321890.1 TEMPLATE-DEPENDENT LIGATION WITH PNA-DNA CHIMERIC PROBES
TAGTTCTA
>CS400111.1 Sequence 2 from Patent EP1696038
GGAATTCC
>CS400031.1 Sequence 2 from Patent EP1696037
GGAATTCC
>CS389276.1 Sequence 184 from Patent WO2005069724
GAAGCTAC
>CS389004.1 Sequence 33 from Patent EP1696040
GCGGCCGC
>CS388999.1 Sequence 28 from Patent EP1696040
TGCGCAGA
>CS388987.1 Sequence 16 from Patent EP1696040
CTGGTGCG
>CS409774.1 Sequence 33 from Patent WO2006090262
GCGGCCGC
>CS409769.1 Sequence 28 from Patent WO2006090262
TGCGCAGA
>CS409757.1 Sequence 16 from Patent WO2006090262
CTGGTGCG
>CS409712.1 Sequence 98 from Patent WO2006089950
CACCCANC
>CS407599.1 Sequence 871 from Patent WO2006040357
TTGCTATA
>DD292526.1 Adenoviral VA1 POL III Promoter System for RNAi Expression
GAAGCTTG
>DD312994.1 USE OF CHIMERIC NUCLEASES TO STIMULATE GENE TARGETING
GCGTGGCG
>DD290364.1 TGF-beta gene expression repression agent
TGTGTCTC
>DD289965.1 GENOMIC PROFILING OF REGULATORY FACTOR BINDING SITES
CTTGGCGG
>DD289964.1 GENOMIC PROFILING OF REGULATORY FACTOR BINDING SITES
AGGGAGGG
>DD289957.1 GENOMIC PROFILING OF REGULATORY FACTOR BINDING SITES
CTTGGCGG
>DD289956.1 GENOMIC PROFILING OF REGULATORY FACTOR BINDING SITES
CTTGGCGG
>DD289955.1 GENOMIC PROFILING OF REGULATORY FACTOR BINDING SITES
CTTGGCGG
>DD289954.1 GENOMIC PROFILING OF REGULATORY FACTOR BINDING SITES
AGGGAGGG
>DD289953.1 GENOMIC PROFILING OF REGULATORY FACTOR BINDING SITES
TGACGTAG
>DD289942.1 GENOMIC PROFILING OF REGULATORY FACTOR BINDING SITES
GCGACAAA
>DD289909.1 GENOMIC PROFILING OF REGULATORY FACTOR BINDING SITES
TTTGGCGG
>A31112.1 linker 3 from patent WO9202553
GCGGCCGC
>A31111.1 linker 3 from patent WO9202553
GCGGCCGC
>A25262.1 Synthetic Ser A 1507 linker
CTCTAGAG
>A23693.1 Detection method oligonucleotide
AGCATTTT
>A23685.1 Primer hybridisation location
AAAATGCT
>A14891.1 Synthetic linker from patent WO8706611
GACATAAG
>A10385.1 oligonucleotide
CATCTTTA
>CS377421.1 Sequence 112 from Patent EP1688147
TCTTCGAT
>CS377420.1 Sequence 111 from Patent EP1688147
TCTTCGAA
>CS377384.1 Sequence 75 from Patent EP1688147
TCATCGAT
>CS377382.1 Sequence 73 from Patent EP1688147
TCAGCGCT
>CS377381.1 Sequence 72 from Patent EP1688147
TCAACGTT
>CS377380.1 Sequence 71 from Patent EP1688147
TCAACGTC
>CS377366.1 Sequence 57 from Patent EP1688147
CCAACGTT
>CS377347.1 Sequence 38 from Patent EP1688147
AACGTTCT
>CS360984.1 Sequence 187 from Patent WO2006076288
AGCGCACC
>CS360982.1 Sequence 185 from Patent WO2006076288
TGGTACAG
>CS360927.1 Sequence 130 from Patent WO2006076288
TGGTACAG
>BD268086.1 Cell specific promoters of uncoupling protein 3
CCACGTGC
>BD267855.1 Methods for the prevention and treatment of parasitic infections and related diseases using CPG oligonucleotides
TCAACGTC
>BD267853.1 Methods for the prevention and treatment of parasitic infections and related diseases using CPG oligonucleotides
CCAACGTT
>BD267851.1 Methods for the prevention and treatment of parasitic infections and related diseases using CPG oligonucleotides
TCTTCGAA
>BD267850.1 Methods for the prevention and treatment of parasitic infections and related diseases using CPG oligonucleotides
TCTTCGAT
>BD267849.1 Methods for the prevention and treatment of parasitic infections and related diseases using CPG oligonucleotides
TCAGCGCT
>BD267848.1 Methods for the prevention and treatment of parasitic infections and related diseases using CPG oligonucleotides
TCAACGTT
>BD266014.1 Universal arrays
GCATGCAT
>BD261315.1 Methods and products for inducing mucosal immunity
TCTTCGAT
>BD261249.1 Methods and products for inducing mucosal immunity
TCAACGTC
>BD261248.1 Methods and products for inducing mucosal immunity
AACGTTCT
>BD261247.1 Methods and products for inducing mucosal immunity
CCAACGTT
>BD261245.1 Methods and products for inducing mucosal immunity
TCTTCGAA
>BD261244.1 Methods and products for inducing mucosal immunity
TCATCGAT
>BD261243.1 Methods and products for inducing mucosal immunity
TCAGCGCT
>BD261242.1 Methods and products for inducing mucosal immunity
TCAACGTT
>BD261086.1 Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
TCAACGTC
>BD261084.1 Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
CCAACGTT
>BD261082.1 Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
TCTTCGAA
>BD261081.1 Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
TCTTCGAT
>BD261080.1 Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
TCAGCGCT
>BD261079.1 Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
TCAAGCTT
>BD261078.1 Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
TCAACGTT
>BD260031.1 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
CGGCTCTA
>BD260028.1 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
CGGGCAAA
>BD251952.1 Artificial matrix attachment region for increasing expression of genes introduced in plant cells
TATAAAAA
>BD251282.1 Enhancement of Neisseria antigen bactericidal activity using CG motif-containing oligonucleotide
TCTTCGAA
>BD251281.1 Enhancement of Neisseria antigen bactericidal activity using CG motif-containing oligonucleotide
TCATCGAT
>BD251280.1 Enhancement of Neisseria antigen bactericidal activity using CG motif-containing oligonucleotide
TCAACGCT
>BD251279.1 Enhancement of Neisseria antigen bactericidal activity using CG motif-containing oligonucleotide
TCAGCGCT
>BD251278.1 Enhancement of Neisseria antigen bactericidal activity using CG motif-containing oligonucleotide
TCGACGTC
>BD251277.1 Enhancement of Neisseria antigen bactericidal activity using CG motif-containing oligonucleotide
GCAACGTT
>BD251276.1 Enhancement of Neisseria antigen bactericidal activity using CG motif-containing oligonucleotide
TCAACGTT
>BD249175.1 Method for generating transcriptionally active DNA fragments
GAGAGAGA
>BD245251.1 Method of electrochemically detecting nucleic acid
GAACCGAG
>BD245250.1 Method of electrochemically detecting nucleic acid
GGAACCGA
>BD245249.1 Method of electrochemically detecting nucleic acid
GGGAACCG
>BD245248.1 Method of electrochemically detecting nucleic acid
AGGGAACC
>BD245247.1 Method of electrochemically detecting nucleic acid
CAGGGAAC
>BD245246.1 Method of electrochemically detecting nucleic acid
TCAGGGAA
>BD244968.1 Targeted gene modification by parvoviral vectors
AGGCCCGT
>BD244960.1 Targeted gene modification by parvoviral vectors
CCCCGGCT
>BD244959.1 Targeted gene modification by parvoviral vectors
CCAGTTGG
>BD240826.1 Substantially complete ribozyme libraries
GGGGGGTG
>BD234357.1 Improved method for inserting nucleic acid into cyclic vector
TAGTGATC
>BD234351.1 Improved method for inserting nucleic acid into cyclic vector
ATAGGGAA
>BD231733.1 Primer extension methods utilizing donor and acceptor molecules for detecting nucleic acids
TGGTAGTT
>BD231732.1 Primer extension methods utilizing donor and acceptor molecules for detecting nucleic acids
ATAAACTT
>BD231731.1 Primer extension methods utilizing donor and acceptor molecules for detecting nucleic acids
GGAGCTGG
>BD231729.1 Primer extension methods utilizing donor and acceptor molecules for detecting nucleic acids
TGGAGCTG
>BD231728.1 Primer extension methods utilizing donor and acceptor molecules for detecting nucleic acids
TTGGAGCT
>BD230086.1 Method for making complementary oligonucleotide tag sets
CCTTAGGG
>BD226184.1 Glaucoma therapeutics and diagnostics based on a novel human transcription factor
CCATGCCG
>BD217897.1 Sequence determination by hybridization
GGTCATAG
>BD217896.1 Sequence determination by hybridization
TGGTCATA
>BD217895.1 Sequence determination by hybridization
ATGGTCAT
>BD217894.1 Sequence determination by hybridization
CCAGTCAC
>BD217893.1 Sequence determination by hybridization
CAGTCACG
>BD217892.1 Sequence determination by hybridization
AGTCACGA
>BD217891.1 Sequence determination by hybridization
GTCACGAC
>BD217890.1 Sequence determination by hybridization
TCACGACG
>BD217889.1 Sequence determination by hybridization
TGGAGAAG
>BD217888.1 Sequence determination by hybridization
GTGGAGAA
>BD217887.1 Sequence determination by hybridization
TGTGGAGA
>BD217886.1 Sequence determination by hybridization
CTGTGGAG
>BD217885.1 Sequence determination by hybridization
CCTGTGGA
>BD217884.1 Sequence determination by hybridization
TCCTGTGG
>BD217883.1 Sequence determination by hybridization
CTCCTGTG
>BD217882.1 Sequence determination by hybridization
ACTCCTGT
>BD217879.1 Sequence determination by hybridization
GGTCATAG
>BD217878.1 Sequence determination by hybridization
TGGTCATA
>BD217877.1 Sequence determination by hybridization
ATGGTCAT
>BD217876.1 Sequence determination by hybridization
CCAGTCAC
>BD217875.1 Sequence determination by hybridization
CAGTCACG
>BD217874.1 Sequence determination by hybridization
AGTCACGA
>BD217873.1 Sequence determination by hybridization
GTCACGAC
>BD217872.1 Sequence determination by hybridization
TCACGACG
>BD217871.1 Sequence determination by hybridization
AGGAGAAG
>BD217870.1 Sequence determination by hybridization
GAGGAGAA
>BD217869.1 Sequence determination by hybridization
TGAGGAGA
>BD217868.1 Sequence determination by hybridization
CTGAGGAG
>BD217867.1 Sequence determination by hybridization
CCTGAGGA
>BD217866.1 Sequence determination by hybridization
TCCTGAGG
>BD217865.1 Sequence determination by hybridization
CTCCTGAG
>BD217864.1 Sequence determination by hybridization
ACTCCTGA
>BD217863.1 Sequence determination by hybridization
CTAGGACC
>BD217862.1 Sequence determination by hybridization
CTACGACC
>BD217861.1 Sequence determination by hybridization
CTAAGACC
>BD217860.1 Sequence determination by hybridization
TCGGGACT
>BD217859.1 Sequence determination by hybridization
TCGCGACT
>BD217858.1 Sequence determination by hybridization
TCGAGACT
>BD217857.1 Sequence determination by hybridization
CTCTACAG
>BD217856.1 Sequence determination by hybridization
CTCGACAG
>BD217855.1 Sequence determination by hybridization
CTCAACAG
>BD217854.1 Sequence determination by hybridization
CTCTTCAG
>BD217853.1 Sequence determination by hybridization
CTCGTCAG
>BD217852.1 Sequence determination by hybridization
CTCATCAG
>BD217851.1 Sequence determination by hybridization
CACTATGA
>BD217850.1 Sequence determination by hybridization
ACTATGAC
>BD217849.1 Sequence determination by hybridization
CTATGACC
>BD217848.1 Sequence determination by hybridization
TATGACCA
>BD217847.1 Sequence determination by hybridization
ATGACCAT
>BD217846.1 Sequence determination by hybridization
GTGACTGG
>BD217845.1 Sequence determination by hybridization
CGTGACTG
>BD217844.1 Sequence determination by hybridization
TCGTGACT
>BD217843.1 Sequence determination by hybridization
GTCGTGAC
>BD217842.1 Sequence determination by hybridization
CGTCGTGA
>BD217841.1 Sequence determination by hybridization
CTTCTCCA
>BD217840.1 Sequence determination by hybridization
TTCTCCAC
>BD217839.1 Sequence determination by hybridization
TCTCCACA
>BD217838.1 Sequence determination by hybridization
CTCCACAG
>BD217837.1 Sequence determination by hybridization
TCCACAGG
>BD217836.1 Sequence determination by hybridization
CCACAGGA
>BD217835.1 Sequence determination by hybridization
CACAGGAG
>BD217834.1 Sequence determination by hybridization
ACAGGAGT
>BD217833.1 Sequence determination by hybridization
CTTCTCCT
>BD217832.1 Sequence determination by hybridization
TTCTCCTC
>BD217831.1 Sequence determination by hybridization
TCTCCTCA
>BD217830.1 Sequence determination by hybridization
CTCCTCAG
>BD217829.1 Sequence determination by hybridization
TCCTCAGG
>BD217828.1 Sequence determination by hybridization
CCTCAGGA
>BD217827.1 Sequence determination by hybridization
CTCAGGAG
>BD217826.1 Sequence determination by hybridization
TCAGGAGT
>BD211392.1 Method of finding restriction enzyme
CCATTGGA
>BD211195.1 AAV5 vector and uses thereof
CGGTTGAG
>BD211194.1 AAV5 vector and uses thereof
CGGTGTGA
>BD205544.1 Method of controlling hematopoiesis by using CpG oligonucleotide
TCAACGTC
>BD205542.1 Method of controlling hematopoiesis by using CpG oligonucleotide
CCAACGTT
>BD205540.1 Method of controlling hematopoiesis by using CpG oligonucleotide
TCTTCGAA
>BD205539.1 Method of controlling hematopoiesis by using CpG oligonucleotide
TCTTCGAT
>BD205538.1 Method of controlling hematopoiesis by using CpG oligonucleotide
TCAGCGCT
>BD205537.1 Method of controlling hematopoiesis by using CpG oligonucleotide
TCAAGCTT
>BD205536.1 Method of controlling hematopoiesis by using CpG oligonucleotide
TCAACGTT
>DD282700.1 Allele Specific Primer Extension
GATGGTTG
>DD282696.1 Allele Specific Primer Extension
GATGGTTG
>DD282630.1 Methods for Preserving Organs and Tissues
TTCGCGAA
>DD280808.1 Novel Gene Controlling Plant Tillering And Leaf Morphology And Use Of The Same
ACCTGCCC
>DD279070.1 LOX-1 GENE EXPRESSION INHIBITOR
TTCTTCTA
>DD279069.1 LOX-1 GENE EXPRESSION INHIBITOR
GATTGAGT
>CS352902.1 Sequence 8 from Patent EP1679381
TTAAAGGA
>CS352900.1 Sequence 6 from Patent EP1679381
GCCTGCTG
>AX355815.1 Sequence 843 from Patent WO0197843
TNAACGTT
>AX355777.1 Sequence 805 from Patent WO0197843
TTAACGTT
>AX355758.1 Sequence 786 from Patent WO0197843
TGCGCTCT
>AX355746.1 Sequence 774 from Patent WO0197843
TGAACGTT
>AX355742.1 Sequence 770 from Patent WO0197843
TCTTCGAA
>AX355657.1 Sequence 685 from Patent WO0197843
TCGACGTC
>AX355602.1 Sequence 630 from Patent WO0197843
TCCGTACG
>AX355599.1 Sequence 627 from Patent WO0197843
TCCGATCG
>AX355496.1 Sequence 524 from Patent WO0197843
TCATCGAT
>AX355495.1 Sequence 523 from Patent WO0197843
TCAGNGCT
>AX355489.1 Sequence 517 from Patent WO0197843
TCAGCGCT
>AX355482.1 Sequence 510 from Patent WO0197843
TCACCGGT
>AX355480.1 Sequence 508 from Patent WO0197843
TCAANGTT
>AX355478.1 Sequence 506 from Patent WO0197843
TCAAGCTT
>AX355477.1 Sequence 505 from Patent WO0197843
TCAAGCTT
>AX355470.1 Sequence 498 from Patent WO0197843
TCAACGTT
>AX355469.1 Sequence 497 from Patent WO0197843
TCAACGTT
>AX355468.1 Sequence 496 from Patent WO0197843
TCAACGTT
>AX355467.1 Sequence 495 from Patent WO0197843
TCAACGTC
>AX355460.1 Sequence 488 from Patent WO0197843
TAGACGTC
>AX355454.1 Sequence 482 from Patent WO0197843
TAAGCGCT
>AX355453.1 Sequence 481 from Patent WO0197843
TAAACGTT
>AX355428.1 Sequence 456 from Patent WO0197843
GTAACGTT
>AX355373.1 Sequence 401 from Patent WO0197843
GGAACGTT
>AX355285.1 Sequence 313 from Patent WO0197843
GCAACGTT
>AX355244.1 Sequence 272 from Patent WO0197843
GACGTCAT
>AX355234.1 Sequence 262 from Patent WO0197843
GAAACGTT
>AX355233.1 Sequence 261 from Patent WO0197843
TCAACGTT
>AX355231.1 Sequence 259 from Patent WO0197843
AACGTTGA
>AX355206.1 Sequence 234 from Patent WO0197843
CTGACGTG
>AX355186.1 Sequence 214 from Patent WO0197843
CTAGCGCT
>AX355183.1 Sequence 211 from Patent WO0197843
CTAACGTT
>AX355157.1 Sequence 185 from Patent WO0197843
CGAACGTT
>AX355156.1 Sequence 184 from Patent WO0197843
CCTTCGAT
>AX355138.1 Sequence 166 from Patent WO0197843
CCCCCCCC
>AX355132.1 Sequence 160 from Patent WO0197843
CCATGCAT
>AX355131.1 Sequence 159 from Patent WO0197843
CCATCGAT
>AX355123.1 Sequence 151 from Patent WO0197843
CCAACGTT
>AX355106.1 Sequence 134 from Patent WO0197843
CAAACGTT
>AX355098.1 Sequence 126 from Patent WO0197843
TCAACGTT
>AX355075.1 Sequence 103 from Patent WO0197843
ATGCATGT
>AX355070.1 Sequence 98 from Patent WO0197843
ATCGATGT
>AX355049.1 Sequence 77 from Patent WO0197843
ATAACGTT
>AX355039.1 Sequence 67 from Patent WO0197843
AGGATATC
>AX355036.1 Sequence 64 from Patent WO0197843
AGCGCTGA
>AX355026.1 Sequence 54 from Patent WO0197843
AGAACGTT
>AX355003.1 Sequence 31 from Patent WO0197843
ACAACGTT
>AX354993.1 Sequence 21 from Patent WO0197843
AACGTTGA
>AX354991.1 Sequence 19 from Patent WO0197843
AACGTTCT
>AX354980.1 Sequence 8 from Patent WO0197843
AAAACGTT
>A33782.1 Nucleotide sequence 9 from patent number WO9216655
GGCCGTCG
>A33778.1 Nucleotide sequence 5 from patent number WO9216655
GTCGTTTT
>CS283985.1 Sequence 12 from Patent EP1645631
CGGGATCC
>CS283987.1 Sequence 14 from Patent EP1645631
CGGGATCC
>CS284723.1 Sequence 12 from Patent EP1574210
TCAACGTT
>CS284729.1 Sequence 18 from Patent EP1574210
TCTTCGAA
>CS284725.1 Sequence 14 from Patent EP1574210
TCGACGTC
>CS284727.1 Sequence 16 from Patent EP1574210
TCAACGCT
>CS284726.1 Sequence 15 from Patent EP1574210
TCAGCGCT
>CS284728.1 Sequence 17 from Patent EP1574210
TCATCGAT
>CS284724.1 Sequence 13 from Patent EP1574210
GCAACGTT
>CS276777.1 Sequence 6 from Patent WO2005110489
GTGAATGC
>CS276776.1 Sequence 5 from Patent WO2005110489
TTGGACGC
>CS275825.1 Sequence 12 from Patent EP1632778
TGACGTCA
>CS266285.1 Sequence 16 from Patent WO2005121178
GCGGCCGC
>CS256560.1 Sequence 2 from Patent EP1624058
TTTTTTTV
>CS256166.1 Sequence 26 from Patent WO2005121778
TTGCTATA
>CS253398.1 Sequence 6 from Patent EP1616961
GGATCCAA
>CS253365.1 Sequence 45 from Patent EP1616575
CGCGTCTC
>CS253364.1 Sequence 44 from Patent EP1616575
AATTGAGA
>CS253793.1 Sequence 65 from Patent WO2005124343
TTGCTATA
>CS251516.1 Sequence 83 from Patent WO2005124342
TTGCTATA
>CS244867.1 Sequence 7 from Patent WO2005118617
ATTGCATC
>CS238731.1 Sequence 187 from Patent WO2005116070
AGCGCACC
>CS238729.1 Sequence 185 from Patent WO2005116070
TGGTACAG
>CS238674.1 Sequence 130 from Patent WO2005116070
TGGTACAG
>CS236196.1 Sequence 8 from Patent WO2005113779
ACCAGCCC
>CS229950.1 Sequence 6 from Patent WO2005113818
GCACCGTG
>CS227186.1 Sequence 288 from Patent WO2005103713
TTGCTATA
>CS226780.1 Sequence 35 from Patent WO2005103692
TTGCTATA
>CS209837.1 Sequence 1000 from Patent EP1600510
CAGNNCGC
>CS209820.1 Sequence 983 from Patent EP1600510
CGGNNCCA
>CS209813.1 Sequence 976 from Patent EP1600510
GCGNNGAC
>CS209776.1 Sequence 939 from Patent EP1600510
CCGNNGAC
>CS209774.1 Sequence 937 from Patent EP1600510
GGCNNCGA
>CS209734.1 Sequence 897 from Patent EP1600510
GAGNNCGC
>CS209709.1 Sequence 872 from Patent EP1600510
AGGNNCCG
>CS209708.1 Sequence 871 from Patent EP1600510
CGGNNCAG
>CS209679.1 Sequence 842 from Patent EP1600510
CGANNACG
>CS209673.1 Sequence 836 from Patent EP1600510
CAGNNGGC
>CS209666.1 Sequence 829 from Patent EP1600510
CCGNNGTC
>CS209665.1 Sequence 828 from Patent EP1600510
GCGNNGCA
>CS209662.1 Sequence 825 from Patent EP1600510
GCANNGCC
>CS209659.1 Sequence 822 from Patent EP1600510
CGGNNGCA
>CS209658.1 Sequence 821 from Patent EP1600510
CCCNNGCC
>CS209647.1 Sequence 810 from Patent EP1600510
CGTNNGCA
>CS209637.1 Sequence 800 from Patent EP1600510
CGCNNACA
>CS209625.1 Sequence 788 from Patent EP1600510
CCANNGGG
>CS209622.1 Sequence 785 from Patent EP1600510
CGCNNGGA
>CS209607.1 Sequence 770 from Patent EP1600510
CCCNNGAA
>CS209602.1 Sequence 765 from Patent EP1600510
AGCNNCGC
>CS209552.1 Sequence 715 from Patent EP1600510
CAGNNGGG
>CS209548.1 Sequence 711 from Patent EP1600510
CCCNNCCC
>CS209541.1 Sequence 704 from Patent EP1600510
GCCNNCGA
>CS209533.1 Sequence 696 from Patent EP1600510
GACNNCCC
>CS209487.1 Sequence 650 from Patent EP1600510
ACGNNCCC
>CS209475.1 Sequence 638 from Patent EP1600510
CCCNNTCC
>CS209472.1 Sequence 635 from Patent EP1600510
CGCNNCCG
>CS209465.1 Sequence 628 from Patent EP1600510
CCGNNGGC
>CS209456.1 Sequence 619 from Patent EP1600510
CGGNNCCC
>CS209374.1 Sequence 537 from Patent EP1600510
GACNNCGC
>CS209369.1 Sequence 532 from Patent EP1600510
CCGNNGCC
>CS209305.1 Sequence 468 from Patent EP1600510
CCCNNGCG
>CS209287.1 Sequence 450 from Patent EP1600510
CCCNNCGC
>CS209223.1 Sequence 386 from Patent EP1600510
GCGNNCCC
>CS209216.1 Sequence 379 from Patent EP1600510
AGGNNGGG
>CS209210.1 Sequence 373 from Patent EP1600510
GCGNNGCC
>CS209187.1 Sequence 350 from Patent EP1600510
CCCNNCGG
>CS206093.1 Sequence 13 from Patent WO2005108949
TTGCTATA
>CS208115.1 Sequence 63 from Patent WO2005080581
CCCCGTCC
>CS186960.1 Sequence 15 from Patent WO2005097200
GCTAGCGC
>CS182487.1 Sequence 5 from Patent EP1588761
GCGTCGGC
>CS182486.1 Sequence 4 from Patent EP1588761
GCCGACGC
>CS182244.1 Sequence 14 from Patent EP1589118
GGCCTGCC
>CS182239.1 Sequence 9 from Patent EP1589118
GGCCTGCC
>CS177428.1 Sequence 29 from Patent WO2005093097
TGGAAGGA
>CS173515.1 Sequence 1 from Patent WO2005060345
NGCTCTGA
>CS166402.1 Sequence 3 from Patent WO2005066369
AGACATAT
>CS140230.1 Sequence 20 from Patent WO2005071077
GCAGTGNN
>CS140229.1 Sequence 19 from Patent WO2005071077
GCAATGNN
>CS140216.1 Sequence 6 from Patent WO2005071077
GCAATGNN
>CS140215.1 Sequence 5 from Patent WO2005071077
GCAGTGNN
>CS128811.1 Sequence 20 from Patent EP1557464
GCAGTGNN
>CS128810.1 Sequence 19 from Patent EP1557464
GCAATGNN
>CS128797.1 Sequence 6 from Patent EP1557464
GCAATGNN
>CS128796.1 Sequence 5 from Patent EP1557464
GCAGTGNN
>CQ977027.1 Sequence 75 from Patent WO2005000875
TGACGTCA
>CS329884.1 Sequence 34 from Patent EP1674574
TCAACGTC
>CS329882.1 Sequence 32 from Patent EP1674574
CCAACGTT
>CS329880.1 Sequence 30 from Patent EP1674574
TCTTCGAA
>CS329879.1 Sequence 29 from Patent EP1674574
TCTTCGAT
>CS329878.1 Sequence 28 from Patent EP1674574
TCAGCGCT
>CS329877.1 Sequence 27 from Patent EP1674574
TCAAGCTT
>CS329876.1 Sequence 26 from Patent EP1674574
TCAACGTT
>CS319157.1 Sequence 73 from Patent WO2006010891
CCATGGGC
>CS319107.1 Sequence 23 from Patent WO2006010891
GCGGCCGC
>DD272410.1 Modified ADAMTS4 molecules
CATCGATG
>DD272396.1 Modified ADAMTS4 molecules
GCGGCCGC
>DD272395.1 Modified ADAMTS4 molecules
GACTGACT
>DD272389.1 Modified ADAMTS4 molecules
AAATGGGC
>DD272156.1 SPLICEOSOME-MEDIATED RNA TRANS-SPLICING FOR CORRECTION OF SKIN DISORDERS
AGGTRAGT
>A62053.1 Sequence 39 from Patent WO9711189
ATTTCAAA
>A61518.1 Sequence 87 from Patent WO9710332
GGAAAGAA
>A61517.1 Sequence 86 from Patent WO9710332
GTTGCTTA
>A61516.1 Sequence 85 from Patent WO9710332
AAATAAAG
>A61515.1 Sequence 84 from Patent WO9710332
GTGGCGAG
>A61514.1 Sequence 83 from Patent WO9710332
ACTATTCA
>A61513.1 Sequence 82 from Patent WO9710332
ATCGGCCT
>A61512.1 Sequence 81 from Patent WO9710332
TGTCTGTA
>A61511.1 Sequence 80 from Patent WO9710332
GGGAGTTG
>A61510.1 Sequence 79 from Patent WO9710332
GCTCCCCA
>A61509.1 Sequence 78 from Patent WO9710332
AGGCCTCT
>A61508.1 Sequence 77 from Patent WO9710332
CATTGCTG
>A61507.1 Sequence 76 from Patent WO9710332
CTGTCACT
>A61498.1 Sequence 67 from Patent WO9710332
TATCCTGG
>A61497.1 Sequence 66 from Patent WO9710332
GACCGGGG
>A61496.1 Sequence 65 from Patent WO9710332
ATTTGGGA
>A61495.1 Sequence 64 from Patent WO9710332
ATGTATTT
>A61494.1 Sequence 63 from Patent WO9710332
ACAGATGA
>A61493.1 Sequence 62 from Patent WO9710332
ATTTATTT
>A61492.1 Sequence 61 from Patent WO9710332
TATTATTT
>A61491.1 Sequence 60 from Patent WO9710332
TATTTATT
>A61490.1 Sequence 59 from Patent WO9710332
TTATTTAT
>A61489.1 Sequence 58 from Patent WO9710332
ACTTGTGA
>A61488.1 Sequence 57 from Patent WO9710332
ATGTTTGC
>A61487.1 Sequence 56 from Patent WO9710332
CTCTATTT
>A61478.1 Sequence 47 from Patent WO9710332
AGCACTGA
>A61477.1 Sequence 46 from Patent WO9710332
ACACCATG
>A61476.1 Sequence 45 from Patent WO9710332
TGGAAAGG
>A61475.1 Sequence 44 from Patent WO9710332
CTCTCCCC
>A61474.1 Sequence 43 from Patent WO9710332
TCCACCCT
>A61473.1 Sequence 42 from Patent WO9710332
CCCACGGC
>A61472.1 Sequence 41 from Patent WO9710332
CATACTGA
>A61471.1 Sequence 40 from Patent WO9710332
TCCTCTCA
>A61470.1 Sequence 39 from Patent WO9710332
GGTTCTCT
>A61469.1 Sequence 38 from Patent WO9710332
GCCAGGCA
>A61468.1 Sequence 37 from Patent WO9710332
GACAAGCT
>A61467.1 Sequence 36 from Patent WO9710332
CACACCCT
>A61464.1 Sequence 33 from Patent WO9710332
TCCCAAAT
>A61463.1 Sequence 32 from Patent WO9710332
AAATACAT
>A61462.1 Sequence 31 from Patent WO9710332
TCATCTGT
>A61456.1 Sequence 25 from Patent WO9710332
GGGGAGAG
>A61455.1 Sequence 24 from Patent WO9710332
CCTTTCCA
>A61235.1 Sequence 72 from Patent EP0763602
AGATTTGG
>A58620.1 Sequence 26 from Patent EP0754700
CGTAACGT
>A58619.1 Sequence 25 from Patent EP0754700
ACGTTACG
>A58618.1 Sequence 24 from Patent EP0754700
CGTAACGT
>A58557.1 Sequence 2 from Patent EP0747484
TCCCGCCC
>A47242.1 Sequence 2 from Patent WO9530759
GCGGCCGC
>A44295.1 Sequence 3 from Patent WO9511970
GGCCGTCG
>A44294.1 Sequence 2 from Patent WO9511970
GGCCAGTG
>A44293.1 Sequence 1 from Patent WO9511970
AAAACGAC
>A43008.1 Sequence 6 from Patent EP0655499
TCAAAGCT
>A29554.1 Linker no.1
GCGGCCGC
>A29546.1 Kpnl linker
GGGTACCC
>A29545.1 Sall linker
CGTCGACG
>A28778.1 Hpal linker
CGTTAACG
>A28777.1 Ndel linker
CCATATGG
>A28776.1 BamHI linker no.1
CGGATCCG
>A26074.1 Hpal linkers
GGTTAACC
>A17486.1 oligonucleotide seq ID No:5
TCTTTTAT
>A13361.1 Synthetic oligonucleotide BamHI-linker from patent EP0327522
CGGATCCG
>A11950.1 Synthetic octomer from patent EP0070675
GATCCCGG
>A11949.1 Synthetic octomer from patent EP0070675
GATCCCGG
>A11346.1 Nucleotide sequence 7 from patent number EP0276330
GGGTTCCG
>DD050781.1 Screening and activity-measurement method for protein which regulates transcription reaction
TCATTGTT
>DD115291.1 Evolving New Molecular Function
ACCCGTCA
>DD115290.1 Evolving New Molecular Function
TGACGGGT
>DD146136.1 Surface Transfection and Expression Procedure
CCAGGAAG
>DD146128.1 Surface Transfection and Expression Procedure
TGACGTCA
>DD057507.1 Drugs
TAACGGTT
>DD030153.1 METHOD OF PERFORMING SUBTRACTIVE HYBRIDIZATION
GAATTCCG
>BD434123.1 Method for Detecting and Classifying Nucleic Acid Hybridization
TTCAGCTA
>BD434122.1 Method for Detecting and Classifying Nucleic Acid Hybridization
TCAGCTAG
>BD434121.1 Method for Detecting and Classifying Nucleic Acid Hybridization
CAGCTAGG
>BD434120.1 Method for Detecting and Classifying Nucleic Acid Hybridization
AGCTAGGC
>BD434119.1 Method for Detecting and Classifying Nucleic Acid Hybridization
GCTAGGCT
>BD277508.1 New single nucleotide polymorphism of IL-4 gene for allergic risk factor and the use thereof
AAATGTTT
>BD277463.1 Single nucleotide polymorphism-markers for allergic risk factor and the use thereof
GCCTGTCC
>BD277462.1 Single nucleotide polymorphism-markers for allergic risk factor and the use thereof
ATGGGACC
>BD277450.1 Single nucleotide polymorphism-markers for allergic risk factor and the use thereof
GGCTATCG
>BD277443.1 Single nucleotide polymorphism-markers for allergic risk factor and the use thereof
ACTCCTGG
>BD277440.1 Single nucleotide polymorphism-markers for allergic risk factor and the use thereof
AGTGGACA
>BD277438.1 Single nucleotide polymorphism-markers for allergic risk factor and the use thereof
CCAAGTGC
>BD277431.1 Single nucleotide polymorphism-markers for allergic risk factor and the use thereof
AGTTCAAC
>BD277427.1 Single nucleotide polymorphism-markers for allergic risk factor and the use thereof
AACATTGT
>BD277426.1 Single nucleotide polymorphism-markers for allergic risk factor and the use thereof
TCCCCAGT
>DD087181.1 IMMUNOSTIMULATORY RNA/DNA HYBRID MOLECULES
GCAGCGCT
>DD087177.1 IMMUNOSTIMULATORY RNA/DNA HYBRID MOLECULES
TCAACGTT
>DD087162.1 IMMUNOSTIMULATORY RNA/DNA HYBRID MOLECULES
TCAGCGCT
>DD087158.1 IMMUNOSTIMULATORY RNA/DNA HYBRID MOLECULES
TCAACGTT
>DD086942.1 IMMUNOSTIMULATORY RNA/DNA HYBRID MOLECULES
TCAGCGCT
>DD086938.1 IMMUNOSTIMULATORY RNA/DNA HYBRID MOLECULES
TCAACGTT
>DD086921.1 IMMUNOSTIMULATORY RNA/DNA HYBRID MOLECULES
TCAGCGCT
>DD086917.1 IMMUNOSTIMULATORY RNA/DNA HYBRID MOLECULES
TCAACGTT
>DD086895.1 IMMUNOSTIMULATORY RNA/DNA HYBRID MOLECULES
TCAGCGCT
>DD086894.1 IMMUNOSTIMULATORY RNA/DNA HYBRID MOLECULES
TCAGCGCT
>BD493322.1 Method for identifying substances useful for treating inflammation using the ROR receptor response element of the IkBa gene
TAGGTCAG
>DD086870.1 IMMUNOSTIMULATORY RNA/DNA HYBRID MOLECULES
TCAGCGCT
>DD086866.1 IMMUNOSTIMULATORY RNA/DNA HYBRID MOLECULES
TCAACGTT
>DD086849.1 IMMUNOSTIMULATORY RNA/DNA HYBRID MOLECULES
TCAGCGCT
>DD086845.1 IMMUNOSTIMULATORY RNA/DNA HYBRID MOLECULES
TCAACGTT
>DD086783.1 IMMUNOSTIMULATORY RNA/DNA HYBRID MOLECULES
TCAGCGCT
>DD086779.1 IMMUNOSTIMULATORY RNA/DNA HYBRID MOLECULES
TCAACGTT
>BD360158.1 Immobilized Deoxyribozyme
GACATGCC
>BD432850.1 Liver-Specific Gene Expression Cassettes, and Methods of Use
TGTAACAG
>DD100311.1 Pharmaceutical composition containing a decoy and method for use
TGACGTCA
>BD276669.1 ANALYSING POLYNUCLEOTIDE SEQUENCES
GAGGACAC
>BD276651.1 ANALYSING POLYNUCLEOTIDE SEQUENCES
GAGGACTC
>BD276633.1 ANALYSING POLYNUCLEOTIDE SEQUENCES
GAGGATTC
>BD442528.1 Combinatorial probes and uses therefor
CTCATTGA
>BD442527.1 Combinatorial probes and uses therefor
GCTCATTG
>BD442526.1 Combinatorial probes and uses therefor
AGCTCATT
>BD432708.1 HPV-SPECIFIC SHORT-MERS
CCTACCAT
>BD432698.1 HPV-SPECIFIC SHORT-MERS
GAATCGTC
>BD432694.1 HPV-SPECIFIC SHORT-MERS
GTACCTGA
>BD432676.1 HPV-SPECIFIC SHORT-MERS
TCCGCCAT
>BD432675.1 HPV-SPECIFIC SHORT-MERS
TCCGCCAT
>BD432383.1 VEGF-MODULATED GENES AND METHODS EMPLOYING THEM
GTCACATG
>BD344451.1 Soluble Interleukin-20 Receptor
CGCGTCTC
>BD344450.1 Soluble Interleukin-20 Receptor
AATTGAGA
>DD069984.1 Oligonucleotide Conjugates
AGGGTTAG
>DD099115.1 A novel protein and DNA encoding it
TCATTGTT
>DD099097.1 A novel protein and DNA encoding it
ATGCAAAT
>DD099092.1 A novel protein and DNA encoding it
GGACCTGC
>DD099091.1 A novel protein and DNA encoding it
TTGGGAGG
>BD322716.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
GGCTGGGC
>BD301618.1 Process for production of protein by Aspergillus oryzae
CAAAGCAG
>BD410069.1 GENETIC VACCINE THAT MIMICS NATURAL VIRAL INFECTION AND INDUCES LONG-LASTING IMMUNITY TO PATHOGENS
AAGAAGAA
>BD410067.1 GENETIC VACCINE THAT MIMICS NATURAL VIRAL INFECTION AND INDUCES LONG-LASTING IMMUNITY TO PATHOGENS
TTCTTCTT
>DD143029.1 Molecular Interaction Sites Of RNase P RNA And Methods Of Modulating The Same
GCGCACCG
>DD038645.1 REAGENTS FOR OLIGONUCLEOTIDE CLEAVAGE AND DEPROTECTION
TTTTTTTT
>BD322208.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
CCCCGGGG
>BD322204.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
CGGGGGGC
>BD322199.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
GBBGCBGC
>BD322196.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
GGGCCCCC
>DD111912.1 Methods of detecting multiple DNA binding protein and DNA interactions in a sample, and devices, systems and kits for practicing the same
ATGATTAT
>DD111911.1 Methods of detecting multiple DNA binding protein and DNA interactions in a sample, and devices, systems and kits for practicing the same
ATTTGCAT
>DD111894.1 Methods of detecting multiple DNA binding protein and DNA interactions in a sample, and devices, systems and kits for practicing the same
CAAGAAGT
>DD111893.1 Methods of detecting multiple DNA binding protein and DNA interactions in a sample, and devices, systems and kits for practicing the same
CAGGAAGT
>BD322179.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
CGGGCGGG
>BD322137.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
GGCCGTGT
>BD322130.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
GGTGGGGC
>BD322125.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
CGGGGCBG
>BD322124.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
GGGTTGGC
>BD322116.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
GGCTGGGG
>BD322095.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
GGTGGGGC
>BD322089.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
GGBGTBTG
>BD322083.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
GGGGCBGG
>BD322077.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
GCCCTGCC
>BD322071.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
GGGTTTCT
>BD322070.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
GCCCCGGG
>BD322061.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
GBGGTGCC
>BD322053.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
CTCCTTTT
>BD322050.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
GTTGTCCC
>BD322002.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
TGGBCTCC
>BD321996.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
GTCCTCCT
>BD321992.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
CCCCTGGG
>BD321988.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
GBGCBTGC
>BD292375.1 DNA binding protein as insulator having specific enhancer blocking activity for controlling gene expression, and its sequence
GGGCGGGG
>BD420187.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
TNAACGTT
>DD053459.1 COMBINATORIAL SCREENING OF MIXED POPULATIONS OF ORGANISMS
GGAATTCC
>BD420149.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
TTAACGTT
>BD420130.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
TGCGCTCT
>BD420118.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
TGAACGTT
>BD420114.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
TCTTCGAA
>BD420029.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
TCGACGTC
>BD353777.1 Method For Cloning And Expression of BsmBI Restriction Endonuclese And BsmBI Methylase In E. coli And Purification Of BsmBI Endonuclease
GCGGCCGC
>BD430697.1 CYTOKINE RECEPTOR ZCYTOR17
CGCGTCTC
>BD430696.1 CYTOKINE RECEPTOR ZCYTOR17
AATTGAGA
>BD419974.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
TCCGTACG
>BD419971.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
TCCGATCG
>BD419868.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
TCATCGAT
>BD419867.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
TCAGNGCT
>BD419861.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
TCAGCGCT
>BD419854.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
TCACCGGT
>BD419852.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
TCAANGTT
>BD419850.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
TCAAGCTT
>BD419849.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
TCAAGCTT
>BD419842.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
TCAACGTT
>BD419841.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
TCAACGTT
>BD419840.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
TCAACGTT
>BD419839.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
TCAACGTC
>BD419832.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
TAGACGTC
>BD419826.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
TAAGCGCT
>BD419825.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
TAAACGTT
>DD052713.1 Method for Treating Inflammation
CGCGTCTC
>DD052712.1 Method for Treating Inflammation
AATTGAGA
>BD321490.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
CCCGGCGC
>DD155459.1 Method for Cloning And Expression Of TspRI Restriction Endonuclease And TspRI Methylase In E. coli
GCGGCCGC
>DD141483.1 Corona-virus-like particles comprising functionally deleted genomes
TCTCAACT
>DD141482.1 Corona-virus-like particles comprising functionally deleted genomes
CTTAACAA
>DD037399.1 Self-replication determinant of embryonic stem cell
GACAAAGG
>DD037397.1 Self-replication determinant of embryonic stem cell
CCTTTGTA
>DD141301.1 Methods for Targeted Expression of Therapeutic Nucleic Acid
NCWTTGWT
>DD141300.1 Methods for Targeted Expression of Therapeutic Nucleic Acid
AWCAAWGN
>BD419800.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
GTAACGTT
>BD419745.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
GGAACGTT
>BD419657.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
GCAACGTT
>DD037237.1 Complexes between telomere proteins and G-quartet DNAs
TAGGGTTA
>BD419616.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
GACGTCAT
>BD419606.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
GAAACGTT
>BD419605.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
TCAACGTT
>BD419603.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
AACGTTGA
>BD419578.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
CTGACGTG
>BD419558.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
CTAGCGCT
>BD419555.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
CTAACGTT
>BD419529.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
CGAACGTT
>BD419528.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
CCTTCGAT
>BD419510.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
CCCCCCCC
>BD419504.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
CCATGCAT
>BD419503.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
CCATCGAT
>BD419495.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
CCAACGTT
>BD419478.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
CAAACGTT
>BD419470.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
TCAACGTT
>BD419447.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
ATGCATGT
>BD419442.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
ATCGATGT
>BD419421.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
ATAACGTT
>BD419411.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
AGGATATC
>BD419408.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
AGCGCTGA
>BD419398.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
AGAACGTT
>BD419375.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
ACAACGTT
>BD419365.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
AACGTTGA
>BD419363.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
AACGTTCT
>BD419352.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
AAAACGTT
>BD419274.1 Ribozymes for Prevention of Restenosis
CTGANGAR
>BD419272.1 Ribozymes for Prevention of Restenosis
ACTGGCTG
>BD419271.1 Ribozymes for Prevention of Restenosis
TGAGTAGA
>BD419268.1 Ribozymes for Prevention of Restenosis
ACGCCCAC
>BD419267.1 Ribozymes for Prevention of Restenosis
CGTCCGCC
>BD419266.1 Ribozymes for Prevention of Restenosis
ACTGCATT
>BD419265.1 Ribozymes for Prevention of Restenosis
TCTGCACA
>BD419264.1 Ribozymes for Prevention of Restenosis
ATGGGGCT
>BD419263.1 Ribozymes for Prevention of Restenosis
CTCGGCAT
>BD419260.1 Ribozymes for Prevention of Restenosis
ACGCCCCT
>BD419259.1 Ribozymes for Prevention of Restenosis
TCATCAGC
>BD419256.1 Ribozymes for Prevention of Restenosis
AGCAGGGG
>BD419255.1 Ribozymes for Prevention of Restenosis
GGATCAGG
>DD096982.1 COMPOSITIONS AND METHODS FOR HIGH-LEVEL, LARGE-SCALE PRODUCTION OF RECOMBINANT PROTEINS
GACTAGTC
>BD291590.1 Method for conferring herbicide, pest, or disease resistance in plant hosts
GCGGCCGC
>BD352994.1 TRANSCRIPTION FACTOR AND TRANSCRIPTION FACTOR GENE
ACCTGCCC
>DD139986.1 Gap Junction Permeability Assay
TGACGTCA
>BD300500.1 Template-dependent ligation with the use of PNA-DNA chimeric probe
TAGTTCTA
>DD081967.1 A method for isolation of target component, a method for detection of target component, and a method of screening for target component
TGACATCA
>BD449389.1 DUAL-PURPOSE PRIMERS AND PROBES FOR PROVIDING ENHANCED HYBRIDIZATION ASSAYS BY DISRUPTION OF SECONDARY STRUCTURE FORMATION
CCACCAGC
>BD374784.1 Compositions and Methods for Non-Parenteral Delivery of Oligonucleotides
TTGGGGTT
>DD057028.1 Statistical Analysis Of Regulatory Factor Binding Sites Of Differentially Expressed Genes
TTTGGCGG
>DD050763.1 Screening and activity-measurement method for protein which regulates transcription reaction
ATGCAAAT
>DD050758.1 Screening and activity-measurement method for protein which regulates transcription reaction
GGACCTGC
>DD050757.1 Screening and activity-measurement method for protein which regulates transcription reaction
TTGGGAGG
>DD156932.1 AMPLIFIED ONCOGENES AND THEIR INVOLVEMENT IN CANCER
GAAGCTTG
>DD056532.1 GENOMIC PROFILING OF REGULATORY FACTOR BINDING SITES
CTTGGCGG
>DD056531.1 GENOMIC PROFILING OF REGULATORY FACTOR BINDING SITES
AGGGAGGG
>DD056524.1 GENOMIC PROFILING OF REGULATORY FACTOR BINDING SITES
CTTGGCGG
>DD056523.1 GENOMIC PROFILING OF REGULATORY FACTOR BINDING SITES
CTTGGCGG
>DD056522.1 GENOMIC PROFILING OF REGULATORY FACTOR BINDING SITES
CTTGGCGG
>DD056521.1 GENOMIC PROFILING OF REGULATORY FACTOR BINDING SITES
AGGGAGGG
>DD056520.1 GENOMIC PROFILING OF REGULATORY FACTOR BINDING SITES
TGACGTAG
>DD056509.1 GENOMIC PROFILING OF REGULATORY FACTOR BINDING SITES
GCGACAAA
>DD056476.1 GENOMIC PROFILING OF REGULATORY FACTOR BINDING SITES
TTTGGCGG
>BD428790.1 Reactive monomers for the oligonucleotide and polynucleotide synthesis, modified oligonucleotides and polynucleotides, and a method for producing the same
CCCNNTTT
>BD407009.1 Improved mutation analysis of the NF1 Gene
TGGTATGG
>BD407008.1 Improved mutation analysis of the NF1 Gene
CTGTAAGT
>BD407002.1 Improved mutation analysis of the NF1 Gene
ACGTAATT
>BD407001.1 Improved mutation analysis of the NF1 Gene
CAGTAGGT
>BD407000.1 Improved mutation analysis of the NF1 Gene
AGGTTTCT
>BD406999.1 Improved mutation analysis of the NF1 Gene
AGTTAAGC
>BD406998.1 Improved mutation analysis of the NF1 Gene
TGTAGAAG
>DD148642.1 Method for regulating recombinant gene expression, protein useful in the method and inducer for gene expression
TTCATCGC
>DD138538.1 A nucleic acid construct and a method for producing the same
GGAATTCG
>BD374344.1 Use of a Nucleotide Sequence for Enhancing Protein Synthesis and Expression of Proteins
ACCTCGAG
>BD374342.1 Use of a Nucleotide Sequence for Enhancing Protein Synthesis and Expression of Proteins
TTCCATGG
>BD374341.1 Use of a Nucleotide Sequence for Enhancing Protein Synthesis and Expression of Proteins
CACCATGG
>BD326220.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
GGCTGGGC
>DD014225.1 ASYNCHRONOUS PRIMED PCR
TGTTGCCA
>DD148643.1 Method for regulating recombinant gene expression, protein useful in the method and inducer for gene expression
TTGATCGC
>DD094812.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CAGNNCGC
>DD094795.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CGGNNCCA
>DD094788.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
GCGNNGAC
>DD094751.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCGNNGAC
>DD094749.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
GGCNNCGA
>DD094709.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
GAGNNCGC
>DD094684.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
AGGNNCCG
>DD094683.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CGGNNCAG
>DD094654.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CGANNACG
>DD094648.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CAGNNGGC
>DD094641.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCGNNGTC
>DD094640.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
GCGNNGCA
>DD094637.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
GCANNGCC
>DD094634.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CGGNNGCA
>DD094633.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCCNNGCC
>DD094622.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CGTNNGCA
>DD094612.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CGCNNACA
>DD094600.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCANNGGG
>DD094597.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CGCNNGGA
>DD094582.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCCNNGAA
>DD094577.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
AGCNNCGC
>BD309136.1 METHODS FOR DETECTION OF A TARGET NUCLEIC ACID SEQUENCE
TAGTGATC
>DD094527.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CAGNNGGG
>DD094523.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCCNNCCC
>DD094516.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
GCCNNCGA
>DD094508.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
GACNNCCC
>DD094462.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
ACGNNCCC
>DD094450.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCCNNTCC
>DD094447.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CGCNNCCG
>DD094440.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCGNNGGC
>DD094431.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CGGNNCCC
>BD395785.1 NUCLEOTIDE SEQUENCES FOR GENE REGULATION AND METHODS OF USE THEREOF
GGAGGAAA
>DD154096.1 Compositions and methods for generating chimeric heteromultimers
TAAGGAGG
>DD094349.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
GACNNCGC
>DD094344.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCGNNGCC
>DD094280.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCCNNGCG
>DD094262.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCCNNCGC
>DD094198.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
GCGNNCCC
>DD094191.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
AGGNNGGG
>DD094185.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
GCGNNGCC
>DD136542.1 Proteins and DNAs encoding them
TCATTGTT
>DD136524.1 Proteins and DNAs encoding them
ATGCAAAT
>DD136519.1 Proteins and DNAs encoding them
GGACCTGC
>DD136518.1 Proteins and DNAs encoding them
TTGGGAGG
>DD033740.1 A novel protein and DNA encoding it
TCATTGTT
>DD033722.1 A novel protein and DNA encoding it
ATGCAAAT
>DD033717.1 A novel protein and DNA encoding it
GGACCTGC
>DD033716.1 A novel protein and DNA encoding it
TTGGGAGG
>BD413820.1 ARRAY FOR ANALYSING POLYNUCLEOTIDE
GAGGACAC
>BD413802.1 ARRAY FOR ANALYSING POLYNUCLEOTIDE
GAGGACTC
>BD413784.1 ARRAY FOR ANALYSING POLYNUCLEOTIDE
GAGGATTC
>DD111860.1 Methods of detecting multiple DNA binding protein and DNA interactions in a sample, and devices, systems and kits for practicing the same
GAACATAG
>DD111859.1 Methods of detecting multiple DNA binding protein and DNA interactions in a sample, and devices, systems and kits for practicing the same
TGACATCA
>DD111846.1 Methods of detecting multiple DNA binding protein and DNA interactions in a sample, and devices, systems and kits for practicing the same
TATCGGTT
>DD111845.1 Methods of detecting multiple DNA binding protein and DNA interactions in a sample, and devices, systems and kits for practicing the same
TAACGGTT
>BD325712.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
CCCCGGGG
>BD325708.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
CGGGGGGC
>BD325703.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
GBBGCBGC
>BD325700.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
GGGCCCCC
>BD325683.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
CGGGCGGG
>BD325641.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
GGCCGTGT
>BD325634.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
GGTGGGGC
>BD325629.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
CGGGGCBG
>BD325628.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
GGGTTGGC
>BD325620.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
GGCTGGGG
>BD325557.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
CTCCTTTT
>BD325554.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
GTTGTCCC
>BD325506.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
TGGBCTCC
>BD325500.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
GTCCTCCT
>BD325496.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
CCCCTGGG
>BD325492.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
GBGCBTGC
>DD116704.1 Method of Breed Discrimination in Cattle
ACCAGCCC
>DD116159.1 A METHOD FOR DETECTING SNPs
CGCCCGCC
>DD116158.1 A METHOD FOR DETECTING SNPs
CCCGCCCG
>DD116157.1 A METHOD FOR DETECTING SNPs
GGCGGGCA
>DD116156.1 A METHOD FOR DETECTING SNPs
CGGGCGGA
>DD116155.1 A METHOD FOR DETECTING SNPs
GGCGGGCG
>DD116154.1 A METHOD FOR DETECTING SNPs
CGGGCGGG
>DD116153.1 A METHOD FOR DETECTING SNPs
GCGGGCGG
>DD116152.1 A METHOD FOR DETECTING SNPs
GGGCGGGC
>BD324994.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
CCCGGCGC
>BD359110.1 Method of Electrochemically Detecting Nucleic Acid Oligomer Hybridization Events
GAACCGAG
>BD359109.1 Method of Electrochemically Detecting Nucleic Acid Oligomer Hybridization Events
GGAACCGA
>BD359108.1 Method of Electrochemically Detecting Nucleic Acid Oligomer Hybridization Events
GGGAACCG
>BD359107.1 Method of Electrochemically Detecting Nucleic Acid Oligomer Hybridization Events
AGGGAACC
>BD359106.1 Method of Electrochemically Detecting Nucleic Acid Oligomer Hybridization Events
CAGGGAAC
>BD359105.1 Method of Electrochemically Detecting Nucleic Acid Oligomer Hybridization Events
TCAGGGAA
>BD272113.1 Fusogenic lipids and vesicles
TTGGGGTT
>BD272011.1 Multiparticulate formulation
TTGGGGTT
>BD270820.1 Stereoisomer of CpG oligonucleotide and method relating thereto
TCTTCGAT
>BD270755.1 Stereoisomer of CpG oligonucleotide and method relating thereto
TCAACGTC
>BD270754.1 Stereoisomer of CpG oligonucleotide and method relating thereto
AACGTTCT
>BD270547.1 Cytokine receptor mouse ZCYTOR10
CGCGTCTC
>BD270546.1 Cytokine receptor mouse ZCYTOR10
AATTGAGA
>BD270230.1 Method and composition for synthesizing labeled oligonucleotide and analog on solid support
TCCTCCTT
>BD270229.1 Method and composition for synthesizing labeled oligonucleotide and analog on solid support
TCCTCCTT
>BD395638.1 NUCLEOTIDE SEQUENCES FOR GENE REGULATION AND METHODS OF USE THEREOF
CCCGGAAG
>DD094162.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCCNNCGG
>DD135105.1 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
CCAACGTT
>DD135084.1 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
AACGTTCT
>DD106918.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
TAGGCATT
>DD106916.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
TTACGGAT
>DD106913.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
CTAGGATT
>DD106876.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
CTAGGATT
>DD106875.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
AATCCTAG
>DD106874.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
TACGCATT
>DD106873.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
AATGCGTA
>DD106872.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
TAGACTGG
>DD106871.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
CCAGTCTA
>DD106870.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
TATGCCAG
>DD106869.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
CTGGCATA
>DD106868.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
TAGCAGTT
>DD106867.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
AACTGCTA
>DD106866.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
TAGTGACT
>DD106865.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
AGTCACTA
>DD106864.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
TAACGGTT
>DD106863.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
AACCGTTA
>DD106862.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
TGGCAATT
>DD106861.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
AATTGCCA
>DD106860.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
TAGTCAGT
>DD106859.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
ACTGACTA
>DD106858.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
TAAGCGTT
>DD106857.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
AACGCTTA
>DD106856.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
TAGGTCAT
>DD106855.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
ATGACCTA
>DD106854.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
TAAGGCTT
>DD106853.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
AAGCCTTA
>DD106852.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
TGGAACTT
>DD117227.1 Recombinant antibody
CTCTAGAG
>DD135179.1 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
TCTTCGAA
>DD135137.1 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
TCATCGAT
>DD135135.1 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
TCAGCGCT
>DD135134.1 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
TCAAGCTT
>DD135133.1 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
TCAACGTT
>DD135132.1 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
TCAACGTC
>DD106851.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
AAGTTCCA
>DD106850.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
TAGCTAGT
>DD106849.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
ACTAGCTA
>DD106848.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
TAGAGCTT
>DD106847.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
AAGCTCTA
>DD106846.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
TCGAGATT
>DD106845.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
AATCTCGA
>DD106844.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
TGAGTACT
>DD106843.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
AGTACTCA
>DD106842.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
TGAACGTT
>DD106841.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
AACGTTCA
>DD106840.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
TGCGAATT
>DD106839.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
AATTCGCA
>DD106838.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
TACGGATT
>DD106837.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
AATCCGTA
>DD106836.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
TGGACATT
>DD106835.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
AATGTCCA
>DD106834.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
TAGGACTT
>DD106833.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
AAGTCCTA
>DD106832.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
TAGCGATT
>DD106831.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
AATCGCTA
>DD106830.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
TAGGCATT
>DD106829.1 SORTING AND IMMOBILIZATION SYSTEM FOR NUCLEIC ACIDS USING SYNTHETIC BINDING SYSTEMS
AATGCCTA
>DD002225.1 Polynucleotide
GACTAGTC
>DD047427.1 Novel Proteins and DNAs Coding Them
TCATTGTT
>DD047409.1 Novel Proteins and DNAs Coding Them
ATGCAAAT
>DD047404.1 Novel Proteins and DNAs Coding Them
GGACCTGC
>DD047403.1 Novel Proteins and DNAs Coding Them
TTGGGAGG
>BD308173.1 CpG Receptor (CpG) And Methods Relating Thereto
TCTTCGAA
>BD308172.1 CpG Receptor (CpG) And Methods Relating Thereto
TCATCGAT
>BD308171.1 CpG Receptor (CpG) And Methods Relating Thereto
TCAACGCT
>BD308170.1 CpG Receptor (CpG) And Methods Relating Thereto
TCAGCGCT
>BD308169.1 CpG Receptor (CpG) And Methods Relating Thereto
TCGACGTC
>BD308168.1 CpG Receptor (CpG) And Methods Relating Thereto
GCAACGTT
>BD308167.1 CpG Receptor (CpG) And Methods Relating Thereto
TCAACGTT
>DD106448.1 IL-4 RECEPTOR SEQUENCE VARIATION ASSOCIATED WITH TYPE 1 DIABETES
GCCGCCGT
>DD106447.1 IL-4 RECEPTOR SEQUENCE VARIATION ASSOCIATED WITH TYPE 1 DIABETES
GCAGTTAT
>DD106446.1 IL-4 RECEPTOR SEQUENCE VARIATION ASSOCIATED WITH TYPE 1 DIABETES
ACCTCCGT
>DD106445.1 IL-4 RECEPTOR SEQUENCE VARIATION ASSOCIATED WITH TYPE 1 DIABETES
ACAGTTGT
>DD106444.1 IL-4 RECEPTOR SEQUENCE VARIATION ASSOCIATED WITH TYPE 1 DIABETES
ACAGTTAT
>BD298098.1 Recombinase-Based Methods for Producing Expression Vectors and Compositions for Use in Practicing the Same
GCGGCCGC
>BD298008.1 PRODUCER CELL FOR THE PRODUCTION OF RETROVIRAL VECTORS
CAGGTAAG
>DD047130.1 DETECTION OF SUSCEPTIBILITY TO AUTOIMMUNE DISEASES
GCCGCCGT
>DD047129.1 DETECTION OF SUSCEPTIBILITY TO AUTOIMMUNE DISEASES
GCAGTTAT
>DD047128.1 DETECTION OF SUSCEPTIBILITY TO AUTOIMMUNE DISEASES
ACCTCCGT
>DD047127.1 DETECTION OF SUSCEPTIBILITY TO AUTOIMMUNE DISEASES
ACAGTTGT
>DD047126.1 DETECTION OF SUSCEPTIBILITY TO AUTOIMMUNE DISEASES
ACATTTAT
>BD297766.1 Methods Related to Immunostimulatory Nucleic Acid-Induced Interferon
TCTTCGAT
>BD297765.1 Methods Related to Immunostimulatory Nucleic Acid-Induced Interferon
TCTTCGAA
>BD317382.1 DNA Expression Systems Based on Alphaviruses
GCCATGGC
>BD297729.1 Methods Related to Immunostimulatory Nucleic Acid-Induced Interferon
TCATCGAT
>BD297727.1 Methods Related to Immunostimulatory Nucleic Acid-Induced Interferon
TCAGCGCT
>BD297726.1 Methods Related to Immunostimulatory Nucleic Acid-Induced Interferon
TCAACGTT
>BD297725.1 Methods Related to Immunostimulatory Nucleic Acid-Induced Interferon
TCAACGTC
>BD297711.1 Methods Related to Immunostimulatory Nucleic Acid-Induced Interferon
CCAACGTT
>BD297692.1 Methods Related to Immunostimulatory Nucleic Acid-Induced Interferon
AACGTTCT
>DD060901.1 THE USE OF GENES ENCODING MEMBRANE TRANSPORTER PUMPS TO STIMULATE THE PRODUCTION OF SECONDARY METABOLITES IN BIOLOGICAL CELLS
CKCCARTA
>DD060898.1 THE USE OF GENES ENCODING MEMBRANE TRANSPORTER PUMPS TO STIMULATE THE PRODUCTION OF SECONDARY METABOLITES IN BIOLOGICAL CELLS
TCNARNCC
>BD279820.1 Recombinant hosts suitable for simultaneous saccharification and fermentation
GGCGCGCC
>DD132244.1 Natural ligand of G protein coupled receptor CHEMR23 and uses thereof
TGACGTCA
>BD325599.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
GGTGGGGC
>BD325593.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
GGBGTBTG
>BD325587.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
GGGGCBGG
>BD325581.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
GCCCTGCC
>BD325575.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
GGGTTTCT
>BD325574.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
GCCCCGGG
>BD325565.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
GBGGTGCC
>DD253082.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CAGNNCGC
>DD253065.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGGNNCCA
>DD253058.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GCGNNGAC
>DD253021.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCGNNGAC
>DD253019.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GGCNNCGA
>DD252979.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GAGNNCGC
>DD240569.1 SPLICEOSOME MEDIATED RNA TRANS-SPLICING FOR CORRECTION OF FACTOR VIII GENETIC DEFECTS USING SPLICEOSOME MEDIATED RNA TRANS SPLICING
AGGTRAGT
>DD252954.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
AGGNNCCG
>DD252953.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGGNNCAG
>DD252924.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGANNACG
>DD252918.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CAGNNGGC
>DD252911.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCGNNGTC
>DD252910.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GCGNNGCA
>DD252907.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GCANNGCC
>DD252904.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGGNNGCA
>DD252903.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNNGCC
>DD252892.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGTNNGCA
>DD252882.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGCNNACA
>DD252870.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCANNGGG
>DD252867.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGCNNGGA
>DD252852.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNNGAA
>DD252847.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
AGCNNCGC
>DD252797.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CAGNNGGG
>DD252793.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNNCCC
>DD252786.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GCCNNCGA
>DD252778.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GACNNCCC
>DD252732.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
ACGNNCCC
>DD252720.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNNTCC
>DD252717.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGCNNCCG
>DD252710.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCGNNGGC
>DD252701.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGGNNCCC
>DD252619.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GACNNCGC
>DD252614.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCGNNGCC
>DD252550.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNNGCG
>DD252532.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNNCGC
>DD252468.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GCGNNCCC
>DD252461.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
AGGNNGGG
>DD252455.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GCGNNGCC
>DD252432.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNNCGG
>DD235045.1 Method for producing cyclic single-stranded DNA and method for determining polynucleotide sequence to be used in production of cyclic single-stranded DNA
CCACACCG
>DD235044.1 Method for producing cyclic single-stranded DNA and method for determining polynucleotide sequence to be used in production of cyclic single-stranded DNA
CCGGCGCC
>DD246864.1 SPLICEOSOME MEDIATED RNA TRANS-SPLICING IN STEM CELLS
AGGTRAGT
>DD258575.1 The IL-1 Gene Cluster and Associated Inflammatory Polymorphisms and Haplotypes
GCCCTCTG
>DD258574.1 The IL-1 Gene Cluster and Associated Inflammatory Polymorphisms and Haplotypes
GCCTCCTG
>DD258573.1 The IL-1 Gene Cluster and Associated Inflammatory Polymorphisms and Haplotypes
GCTCCCTG
>DD258572.1 The IL-1 Gene Cluster and Associated Inflammatory Polymorphisms and Haplotypes
GTCCCCTG
>DD258571.1 The IL-1 Gene Cluster and Associated Inflammatory Polymorphisms and Haplotypes
ACCCCCTG
>DD258570.1 The IL-1 Gene Cluster and Associated Inflammatory Polymorphisms and Haplotypes
GCCCCCTG
>DD257715.1 ALTERNATIVELY SPLICED NUCLEIC ACID MOLECULES
GTGTAAGT
>DD257714.1 ALTERNATIVELY SPLICED NUCLEIC ACID MOLECULES
GTGTACGT
>DD257707.1 ALTERNATIVELY SPLICED NUCLEIC ACID MOLECULES
AGGTAAGT
>DD257489.1 ANTIBODIES DIRECTED TO PDGFD AND USES THEREOF
ATTACTAC
>DD257460.1 ANTIBODIES DIRECTED TO PDGFD AND USES THEREOF
ATTACTAC
>DD257446.1 ANTIBODIES DIRECTED TO PDGFD AND USES THEREOF
TTACTACT
>DD257441.1 ANTIBODIES DIRECTED TO PDGFD AND USES THEREOF
TCACTTTC
>DD257419.1 ANTIBODIES DIRECTED TO PDGFD AND USES THEREOF
ATTACTAC
>BD270753.1 Stereoisomer of CpG oligonucleotide and method relating thereto
CCAACGTT
>BD270751.1 Stereoisomer of CpG oligonucleotide and method relating thereto
TCTTCGAA
>BD270750.1 Stereoisomer of CpG oligonucleotide and method relating thereto
TCATCGAT
>BD270749.1 Stereoisomer of CpG oligonucleotide and method relating thereto
TCAGCGCT
>BD270748.1 Stereoisomer of CpG oligonucleotide and method relating thereto
TCAACGTT
>E49085.1 Gene analysis method
CGTANNNN
>E00745.1 Synthetic DNA of promoter (-35 region)
CTTGACAT
>E00689.1 DNA oligomer L2
CACAGGAC
>E00688.1 DNA oligomer L1
CACAGGAC
>E02037.1 DNA sequence before initiation codon containing initiation codon
CCAAGATG
>E02036.1 DNA sequence before initiation codon containing initiation codon
CAAACATG
>E02035.1 DNA sequence before initiation codon containing initiation codon
CCATAATG
>E02034.1 DNA sequence before initiation codon containing initiation codon
CAAAGATG
>E09480.1 Phosphorothioate-bound oligodeoxynucleotide which inhibits HIV-1 growth
TTGGGAGG
>E09479.1 Phosphorothioate-bound oligodeoxynucleotide which inhibits HIV-1 growth
TGGGAGGT
>E09478.1 Phosphorothioate-bound oligodeoxynucleotide which inhibits HIV-1 growth
GTGGGAGG
>E09477.1 Phosphorothioate-bound oligodeoxynucleotide which inhibits HIV-1 growth
CTGGGAGG
>E09164.1 Synthetic oligonucleotides for anti-HIV agent
TTGGGAGG
>E09163.1 Synthetic oligonucleotides for anti-HIV agent
TGGGAGGT
>E09162.1 Synthetic oligonucleotides for anti-HIV agent
GTGGGAGG
>E09161.1 Synthetic oligonucleotides for anti-HIV agent
CTGGGAGG
>E11550.1 Oligonucleotide primer to detect trace DNA or RNA by PCR or Southern blotting
WWWWSSST
>E11549.1 Oligonucleotide primer to detect trace DNA or RNA by PCR or Southern blotting
SSSSWWWC
>E11085.1 Commercially available BamHI linker for plasmid pGFC
CGGATCCG
>E11044.1 Oligonucleotide as a probe for sequencing by hybridization
CCTTTTCT
>E11043.1 Oligonucleotide as a probe for sequencing by hybridization
CCTGTTCC
>E11042.1 Oligonucleotide as a probe for sequencing by hybridization
TCTTTTCC
>E11041.1 Oligonucleotide as a probe for sequencing by hybridization
CCTTTTCC
>E11035.1 Oligonucleotide as a probe for sequencing by hybridization
CCTTTTCC
>E11029.1 Oligonucleotide as a probe for sequencing by hybridization
CTCTCTCT
>E11028.1 Oligonucleotide as a probe for sequencing by hybridization
CCTTTTCC
>E11027.1 Oligonucleotide as a probe for sequencing by hybridization
TTCCCCTT
>E11026.1 Oligonucleotide as a probe for sequencing by hybridization
CCCCTTTT
>E06622.1 Synthetic DNA primers
TATANANN
>E06620.1 Synthetic DNA primers
AGCTNNNN
>E41637.1 Antibody against human VEGF receptor KDR having novel complementarity determining region
CTCTAGAG
>E38432.1 Novel polypeptide
CTCTAAAG
>E40318.1 Polynucleotide detecting chip and polynucleotide examination apparatus
CTCGTTTT
>E40317.1 Polynucleotide detecting chip and polynucleotide examination apparatus
ACTGGCCG
>E40316.1 Polynucleotide detecting chip and polynucleotide examination apparatus
CTGGCCGT
>E40315.1 Polynucleotide detecting chip and polynucleotide examination apparatus
TGGCCGTC
>E40314.1 Polynucleotide detecting chip and polynucleotide examination apparatus
GGCCGTCG
>E40313.1 Polynucleotide detecting chip and polynucleotide examination apparatus
GCCGTCGT
>E40312.1 Polynucleotide detecting chip and polynucleotide examination apparatus
CCGTCGTT
>E40311.1 Polynucleotide detecting chip and polynucleotide examination apparatus
CGTCGTTT
>E40310.1 Polynucleotide detecting chip and polynucleotide examination apparatus
GTCGTTTT
>E25506.1 Polyribonucleotide producing various ribozymne molecules or antisense RNA molecules
CTRACAGA
>E25505.1 Polyribonucleotide producing various ribozymne molecules or antisense RNA molecules
AGTGTTAV
>E25504.1 Polyribonucleotide producing various ribozymne molecules or antisense RNA molecules
KTAACACT
>E25503.1 Polyribonucleotide producing various ribozymne molecules or antisense RNA molecules
TCTGTYAG
>E22553.1 Rhodosporidium-derived D-amino acid oxidase
TGTATTGC
>E22552.1 Rhodosporidium-derived D-amino acid oxidase
YGTGTTYY
>E36086.1 Novel polypeptide
CTCTAAAG
>E17122.1 Pythium sp. - specific sequence in 18S rRNA gene
TGCTTGTC
>E17092.1 Rhizoctonia sp. - specific sequence in 18S rRNA gene
TTTGGGGA
>E17045.1 Linker
CTCTAGAG
>E17034.1 Linker
CTCTAGAG
>E17002.1 Linker
CTCTAGAG
>E16301.1 GCM (glial cells missing) protein binding sequences
RCCCGCAT
>E16162.1 Primer
ACCTGCCC
>E15674.1 Repeat unit added artificially to chromosome ends
TAGATATC
>E13637.1 Polyribonucleotide which is a substrate of ribozyme
GAGACCTA
>E13216.1 Antisense DNA to human VEGF mRNA
GCTCTATC
>E12761.1 Target sequence of transposon
GGTTTATT
>E08330.1 Reverse transcription primer
TTTTTTTV
>DD230147.1 Alteration of RAB38 Function to Modulate Mammalian Pigmentation
CTGGKTGT
>DD230146.1 Alteration of RAB38 Function to Modulate Mammalian Pigmentation
CTGGGTGT
>DD228534.1 Human Chronic Lymphocytic Leukemia Modeled In Mouse By Targeted TCL1 Expression
TATGGTTA
>DD227505.1 GENETIC VACCINE AGAINST HUMAN IMMUNODEFICIENCY VIRUS
AAGAAGAA
>DD227503.1 GENETIC VACCINE AGAINST HUMAN IMMUNODEFICIENCY VIRUS
TTCTTCTT
>DD227353.1 Method For Cloning And Expression of BseRI Restriction Endonuclease And BseRI Methylase In E. coli
GCGGCCGC
>DD227140.1 Assay of transcription activity in non-human animal model, and assay of cell number and assay of tumor volume
TTNNNNAA
>DD226277.1 Sequence Accelerating Expression of Gene at Mild Low Temperature
GGCGGGGA
>DD226276.1 Sequence Accelerating Expression of Gene at Mild Low Temperature
TCCCCGAA
>DD226275.1 Sequence Accelerating Expression of Gene at Mild Low Temperature
TCCCCTAC
>DD226274.1 Sequence Accelerating Expression of Gene at Mild Low Temperature
TCCCATCC
>DD226273.1 Sequence Accelerating Expression of Gene at Mild Low Temperature
TCCAAGCC
>DD226272.1 Sequence Accelerating Expression of Gene at Mild Low Temperature
TCAACGCC
>DD226271.1 Sequence Accelerating Expression of Gene at Mild Low Temperature
TAACCGCC
>DD226270.1 Sequence Accelerating Expression of Gene at Mild Low Temperature
GACCCGCC
>DD226269.1 Sequence Accelerating Expression of Gene at Mild Low Temperature
TCCCCCCC
>DD226268.1 Sequence Accelerating Expression of Gene at Mild Low Temperature
TCCCCACC
>DD226267.1 Sequence Accelerating Expression of Gene at Mild Low Temperature
TCCCCGCT
>DD226266.1 Sequence Accelerating Expression of Gene at Mild Low Temperature
TCCCCGTC
>DD226265.1 Sequence Accelerating Expression of Gene at Mild Low Temperature
ACCCCGCC
>DD226264.1 Sequence Accelerating Expression of Gene at Mild Low Temperature
GCCCCGCC
>DD226262.1 Sequence Accelerating Expression of Gene at Mild Low Temperature
GGGGGGGA
>DD226257.1 Sequence Accelerating Expression of Gene at Mild Low Temperature
TCCCCGCC
>DD233536.1 Method of Creating a Library of Bacterial Clones with Varying Levels of Gene Expression
AAGGAAAT
>DD233535.1 Method of Creating a Library of Bacterial Clones with Varying Levels of Gene Expression
AAGGAAAG
>DD233534.1 Method of Creating a Library of Bacterial Clones with Varying Levels of Gene Expression
AAGGAAAA
>DD221920.1 MUTATION DETECTION AND IDENTIFICATION
GGAATSCC
>DD221918.1 MUTATION DETECTION AND IDENTIFICATION
GGAATGCC
>DD221900.1 Life Sciences Business Systems and Methods
TGACCTGG
>DD221899.1 Life Sciences Business Systems and Methods
CGATCTGA
>DD211096.1 TRANSGENIC NON-HUMAN MAMMALS EXPRESSING CONSTITUTIVELY ACTIVATED TYROSINE KINASE RECEPTORS
GGATCCGG
>DD210389.1 COMPOSITIONS AND METHODS FOR SURROGATE ANTIBODY MODULATION OF AN IMMUNE RESPONSE AND TRANSPORT
TCAACGTT
>DD190690.1 Probe set and method for identification of allele of HLA
CACCAGAC
>DD205720.1 RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Synthetic Short Interfering Nucleic Acid (siNA)
TCGAAGTA
>DD205714.1 RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Synthetic Short Interfering Nucleic Acid (siNA)
TCGAAGTA
>DD205679.1 RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Synthetic Short Interfering Nucleic Acid (siNA)
TCGAAGTA
>DD205677.1 RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Synthetic Short Interfering Nucleic Acid (siNA)
TCGAAGTA
>DD205467.1 RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Synthetic Short Interfering Nucleic Acid (siNA)
TCGAAGTA
>DD184445.1 Probe sets for detection of HLA-DR allel and methods thereof
NACCCAAC
>DD195310.1 High Resolution Typing System For Pathogenic E Coli
CGGCAATC
>DD195309.1 High Resolution Typing System For Pathogenic E Coli
GATTGCCG
>DD195278.1 High Resolution Typing System For Pathogenic E Coli
ATGCCGCC
>DD195277.1 High Resolution Typing System For Pathogenic E Coli
GGCGGCAT
>DD195246.1 High Resolution Typing System For Pathogenic E Coli
GTTCTGCT
>DD195245.1 High Resolution Typing System For Pathogenic E Coli
AGCAGAAC
>DD195106.1 High Resolution Typing System For Pathogenic E Coli
GTTCTGCT
>DD195105.1 High Resolution Typing System For Pathogenic E Coli
AGCAGAAC
>DD161462.1 Replicons derived from positive strand RNA virus genomes useful for the production of heterologous proteins
CGAGCATG
>DD161365.1 METHOD FOR ENHANCING THE TRANSLATION AND EXPRESSION OF RECOMBINANT PROTEINS
NNTGANNN
>DD161364.1 METHOD FOR ENHANCING THE TRANSLATION AND EXPRESSION OF RECOMBINANT PROTEINS
NNTAANNN
>DD161363.1 METHOD FOR ENHANCING THE TRANSLATION AND EXPRESSION OF RECOMBINANT PROTEINS
NNTAGNNN
>DD161362.1 METHOD FOR ENHANCING THE TRANSLATION AND EXPRESSION OF RECOMBINANT PROTEINS
TAAGGAGG
>DD178391.1 Genetic sequences having methyltransferase activity and uses therefor
GGTCGACC
>DD178390.1 Genetic sequences having methyltransferase activity and uses therefor
GGCGCGCC
>DD178389.1 Genetic sequences having methyltransferase activity and uses therefor
GGGATCCC
>DD172116.1 NF-kappaB Oligonucleotide Decoy Molecules
GACTTTCC
>DD172125.1 NF-kappaB Oligonucleotide Decoy Molecules
GATTTCCC
>DD172120.1 NF-kappaB Oligonucleotide Decoy Molecules
GGATTTCC
>DD175643.1 Analysis and detection of multiple target sequences using circular probes
GCATCAGT
>DD175634.1 Analysis and detection of multiple target sequences using circular probes
ACGTTACG
>CS155565.1 Sequence 4 from Patent EP1568783
CCGATGCA
>CS123994.1 Sequence 37 from Patent EP1553169
AATTATGG
>CS120653.1 Sequence 1 from Patent WO2005056795
YACGTGCN
>CS120538.1 Sequence 24 from Patent WO2005056020
GATTTCCC
>CS120536.1 Sequence 22 from Patent WO2005056020
TTGAAGGC
>CS120533.1 Sequence 19 from Patent WO2005056020
GGATTTCC
>CS120529.1 Sequence 15 from Patent WO2005056020
GACTTTCC
>CS113185.1 Sequence 1 from Patent WO2005053744
TACGTGCT
>CS111442.1 Sequence 29 from Patent WO2005052194
CAAGCTTC
>CS106961.1 Sequence 135 from Patent WO2005032582
AGTTGGTA
>CS106801.1 Sequence 19 from Patent WO2005042781
TTAATTAA
>CS106800.1 Sequence 18 from Patent WO2005042781
GCGGCCGC
>CS106799.1 Sequence 17 from Patent WO2005042781
GCGATCGC
>CS101525.1 Sequence 41 from Patent WO2005045072
TAGATCCT
>CS101512.1 Sequence 28 from Patent WO2005045072
TAGATCCT
>CS101374.1 Sequence 23 from Patent WO2005045021
CCAGGATC
>CS101299.1 Sequence 15 from Patent EP1536024
GTCGTACA
>CS098213.1 Sequence 195 from Patent WO2000075279
GGAGGAAA
>CS098066.1 Sequence 48 from Patent WO2000075279
CCCGGAAG
>CS079573.1 Sequence 3 from Patent WO2005038024
TTTTCATA
>CS079382.1 Sequence 17 from Patent WO2005020972
GTGAATGC
>CS079381.1 Sequence 16 from Patent WO2005020972
TTGGACGC
>CS079180.1 Sequence 2 from Patent EP1526141
CCACCATG
>CS079013.1 Sequence 1 from Patent WO2005035556
TCTAAACT
>CS078012.1 Sequence 37 from Patent EP1526175
AATTATGG
>CS077281.1 Sequence 71 from Patent WO2005035547
TGTCGCGG
>CS077280.1 Sequence 70 from Patent WO2005035547
TGTGGCGC
>CS077279.1 Sequence 69 from Patent WO2005035547
TTTCGGGC
>CS077278.1 Sequence 68 from Patent WO2005035547
GGTCGCGC
>CS077277.1 Sequence 67 from Patent WO2005035547
CGTCGCGC
>CS077276.1 Sequence 66 from Patent WO2005035547
CTTCCCGG
>CS077275.1 Sequence 65 from Patent WO2005035547
TGTCGCGC
>CS077274.1 Sequence 64 from Patent WO2005035547
GTTGCCGG
>CS077273.1 Sequence 63 from Patent WO2005035547
CTTGCCGG
>CS077272.1 Sequence 62 from Patent WO2005035547
TTTCCCGG
>CS077271.1 Sequence 61 from Patent WO2005035547
GTTCGCGG
>CS077270.1 Sequence 60 from Patent WO2005035547
GTTGGCGG
>CS077269.1 Sequence 59 from Patent WO2005035547
CTTGGCGG
>CS077267.1 Sequence 57 from Patent WO2005035547
GGTGCGCG
>CS077266.1 Sequence 56 from Patent WO2005035547
GTAGCGCG
>CS077265.1 Sequence 55 from Patent WO2005035547
GTTGCGCG
>CS077264.1 Sequence 54 from Patent WO2005035547
TGAGCGCG
>CS077263.1 Sequence 53 from Patent WO2005035547
TGTGCGCG
>CS077262.1 Sequence 52 from Patent WO2005035547
TTAGCGCG
>CS077261.1 Sequence 51 from Patent WO2005035547
TTTGCGCG
>CS077260.1 Sequence 50 from Patent WO2005035547
CTTCGCGG
>CS077259.1 Sequence 49 from Patent WO2005035547
GTTCCCGG
>CS077258.1 Sequence 48 from Patent WO2005035547
TTTGCCGG
>CS077257.1 Sequence 47 from Patent WO2005035547
CTTCCCGG
>CS077256.1 Sequence 46 from Patent WO2005035547
CGTCCGCC
>CS077255.1 Sequence 45 from Patent WO2005035547
CTTCCGCC
>CS077254.1 Sequence 44 from Patent WO2005035547
GGTCCGCC
>CS077253.1 Sequence 43 from Patent WO2005035547
GTTCCGCC
>CS077252.1 Sequence 42 from Patent WO2005035547
TGTCCGCC
>CS077251.1 Sequence 41 from Patent WO2005035547
TTTCCGCC
>CS077250.1 Sequence 40 from Patent WO2005035547
CGACCGCC
>CS077249.1 Sequence 39 from Patent WO2005035547
CTACCGCC
>CS077248.1 Sequence 38 from Patent WO2005035547
GGACCGCC
>CS077247.1 Sequence 37 from Patent WO2005035547
GTACCGCC
>CS077246.1 Sequence 36 from Patent WO2005035547
TGACCGCC
>CS077245.1 Sequence 35 from Patent WO2005035547
TTACCGCC
>CS077244.1 Sequence 34 from Patent WO2005035547
TTTGGCGG
>CS077243.1 Sequence 33 from Patent WO2005035547
GTTGCCGC
>CS077242.1 Sequence 32 from Patent WO2005035547
CTTGCCGC
>CS077241.1 Sequence 31 from Patent WO2005035547
CTTGGCGC
>CS077240.1 Sequence 30 from Patent WO2005035547
GTTGGCGC
>CS077239.1 Sequence 29 from Patent WO2005035547
TTTCGCGG
>CS077237.1 Sequence 27 from Patent WO2005035547
CGTGCGCC
>CS077236.1 Sequence 26 from Patent WO2005035547
CTTGCGCC
>CS077235.1 Sequence 25 from Patent WO2005035547
GGTGCGCC
>CS077234.1 Sequence 24 from Patent WO2005035547
GTTGCGCC
>CS077233.1 Sequence 23 from Patent WO2005035547
TGTGCGCC
>CS077232.1 Sequence 22 from Patent WO2005035547
TTTGCGCC
>CS077231.1 Sequence 21 from Patent WO2005035547
GTTCGCGC
>CS077230.1 Sequence 20 from Patent WO2005035547
CGAGCGCC
>CS077229.1 Sequence 19 from Patent WO2005035547
CTAGCGCC
>CS077228.1 Sequence 18 from Patent WO2005035547
GGAGCGCC
>CS077227.1 Sequence 17 from Patent WO2005035547
GTAGCGCC
>CS077226.1 Sequence 16 from Patent WO2005035547
TGAGCGCC
>CS077225.1 Sequence 15 from Patent WO2005035547
TTAGCGCC
>CS077224.1 Sequence 14 from Patent WO2005035547
CTTCGCGC
>CS077223.1 Sequence 13 from Patent WO2005035547
GTTCCCGC
>CS077222.1 Sequence 12 from Patent WO2005035547
CTTCCCGC
>CS077221.1 Sequence 11 from Patent WO2005035547
TTTGCCGC
>CS077220.1 Sequence 10 from Patent WO2005035547
TTTCCCGC
>CS077219.1 Sequence 9 from Patent WO2005035547
TTTCGCGC
>CS077218.1 Sequence 8 from Patent WO2005035547
TTTGGCGC
>CS077217.1 Sequence 7 from Patent WO2005035547
TTTSGCGS
>CS073995.1 Sequence 9 from Patent WO2005033310
AAACACGT
>CS073992.1 Sequence 6 from Patent WO2005033310
AAGGAGAA
>CS070543.1 Sequence 7 from Patent WO2002034295
AATGTTAT
>CS070542.1 Sequence 6 from Patent WO2002034295
ATAACATT
>CS069949.1 Sequence 3 from Patent WO2005030800
CATATTGA
>CS069947.1 Sequence 1 from Patent WO2005030800
TCAATATG
>CS065844.1 Sequence 48 from Patent WO2005030259
TCGTACGA
>CS065839.1 Sequence 43 from Patent WO2005030259
TCGCGCGA
>CS065820.1 Sequence 24 from Patent WO2005030259
TGACGTTT
>CS065819.1 Sequence 23 from Patent WO2005030259
TAACGTTT
>CS065818.1 Sequence 22 from Patent WO2005030259
CGACGTCG
>CS059608.1 Sequence 15 from Patent WO2005025592
GCTAGCGC
>CS057739.1 Sequence 6 from Patent EP1518933
GGATCCAA
>CS055774.1 Sequence 339 from Patent WO2005024058
TTGCTATA
>CS055041.1 Sequence 24 from Patent WO2005021800
GGCACCCA
>CS049232.1 Sequence 336 from Patent WO2005019453
TCGAAGTA
>CS049226.1 Sequence 330 from Patent WO2005019453
TCGAAGTA
>CS049191.1 Sequence 295 from Patent WO2005019453
TCGAAGTA
>CS049189.1 Sequence 293 from Patent WO2005019453
TCGAAGTA
>CS048979.1 Sequence 83 from Patent WO2005019453
TCGAAGTA
>CS037902.1 Sequence 37 from Patent WO2005017133
AATTATGG
>CS027627.1 Sequence 4 from Patent WO2005014814
GTGAATGC
>CS027626.1 Sequence 3 from Patent WO2005014814
TTGGACGC
>CQ989096.1 Sequence 30 from Patent WO2005003388
GTGTTGCG
>CQ989092.1 Sequence 26 from Patent WO2005003388
GTGTTGCG
>CQ985729.1 Sequence 36 from Patent WO2005001133
ATTTAAAT
>CQ985728.1 Sequence 35 from Patent WO2005001133
CRCCGGYG
>CQ985726.1 Sequence 33 from Patent WO2005001133
CCTGCAGG
>CQ985724.1 Sequence 31 from Patent WO2005001133
GTTTAAAC
>CQ985721.1 Sequence 28 from Patent WO2005001133
TTAATTAA
>CQ985720.1 Sequence 27 from Patent WO2005001133
GCGGCCGC
>CQ985717.1 Sequence 24 from Patent WO2005001133
GGCCGGCC
>CQ985705.1 Sequence 12 from Patent WO2005001133
GCGATCGC
>CQ985704.1 Sequence 11 from Patent WO2005001133
GGCGCGCC
>CQ983541.1 Sequence 36 from Patent WO2005003384
GACGGGCG
>CQ976178.1 Sequence 1 from Patent WO2004111072
GATCCGTA
>CQ970088.1 Sequence 49 from Patent WO2004106375
GCGGCCGC
>CQ947535.1 Sequence 30 from Patent WO2004080378
GTTTAAAC
>CQ945902.1 Sequence 1 from Patent WO2004099411
TTTTTTTT
>CQ924709.1 Sequence 22 from Patent WO2004097417
TGACATCA
>CQ924642.1 Sequence 26 from Patent WO2004097043
CGATTCTG
>CQ924641.1 Sequence 25 from Patent WO2004097043
TGCTTGGC
>CQ924640.1 Sequence 24 from Patent WO2004097043
CGATTGGC
>CQ924639.1 Sequence 23 from Patent WO2004097043
TGTTTGGC
>CQ924621.1 Sequence 5 from Patent WO2004097043
GACTTAGC
>CQ924619.1 Sequence 3 from Patent WO2004097043
GTCTTAGC
>CQ924618.1 Sequence 2 from Patent WO2004097043
CGGTTTGT
>CQ893172.1 Sequence 587 from Patent WO2004087952
AGGCCTTA
>CQ892393.1 Sequence 2 from Patent WO2004087965
TTTGGCGG
>CQ892050.1 Sequence 93 from Patent WO2004087203
TCTTCGAT
>CQ891985.1 Sequence 28 from Patent WO2004087203
TCAACGTC
>CQ891984.1 Sequence 27 from Patent WO2004087203
AACGTTCT
>CQ891983.1 Sequence 26 from Patent WO2004087203
CCAACGTT
>CQ891981.1 Sequence 24 from Patent WO2004087203
TCTTCGAA
>CQ891980.1 Sequence 23 from Patent WO2004087203
TCATCGAT
>CQ891979.1 Sequence 22 from Patent WO2004087203
TCAGCGCT
>CQ891978.1 Sequence 21 from Patent WO2004087203
TCAACGTT
>CQ891950.1 Sequence 58 from Patent WO2004087966
CTTGGCGG
>CQ891949.1 Sequence 57 from Patent WO2004087966
AGGGAGGG
>CQ891942.1 Sequence 50 from Patent WO2004087966
CTTGGCGG
>CQ891941.1 Sequence 49 from Patent WO2004087966
CTTGGCGG
>CQ891940.1 Sequence 48 from Patent WO2004087966
CTTGGCGG
>CQ891939.1 Sequence 47 from Patent WO2004087966
AGGGAGGG
>CQ891938.1 Sequence 46 from Patent WO2004087966
TGACGTAG
>CQ891927.1 Sequence 35 from Patent WO2004087966
GCGACAAA
>CQ891894.1 Sequence 2 from Patent WO2004087966
TTTGGCGG
>CQ891672.1 Sequence 37 from Patent EP1469009
TTGGGGTT
>CQ854812.1 Sequence 22 from Patent WO2004067772
GCTGGTGG
>CQ841207.1 Sequence 22 from Patent EP1441036
GCTGGTGG
>CQ829844.1 Sequence 18 from Patent WO2004046362
ACCTGCCC
>CQ829055.1 Sequence 773 from Patent WO2004053120
ATTGGGGA
>CQ829054.1 Sequence 772 from Patent WO2004053120
GCAGGGGA
>CQ829047.1 Sequence 765 from Patent WO2004053120
TCGGGGGA
>CQ829036.1 Sequence 754 from Patent WO2004053120
GGCGGGGA
>CQ829019.1 Sequence 737 from Patent WO2004053120
TGACGTCG
>CQ829013.1 Sequence 731 from Patent WO2004053120
TTTGGGGA
>CQ828969.1 Sequence 687 from Patent WO2004053120
GCACGTGC
>CQ828949.1 Sequence 667 from Patent WO2004053120
ATTAATTG
>CQ828927.1 Sequence 645 from Patent WO2004053120
GAAGGGGA
>CQ828921.1 Sequence 639 from Patent WO2004053120
CTGGGGGA
>CQ828882.1 Sequence 600 from Patent WO2004053120
TGTGGGGA
>CQ828867.1 Sequence 585 from Patent WO2004053120
CGGGGGGA
>CQ828865.1 Sequence 583 from Patent WO2004053120
GGAGGGGA
>CQ828849.1 Sequence 567 from Patent WO2004053120
CCAGGGGA
>CQ828805.1 Sequence 523 from Patent WO2004053120
AGAGGGGA
>CQ828804.1 Sequence 522 from Patent WO2004053120
TGTGGGGA
>CQ828778.1 Sequence 496 from Patent WO2004053120
CTTAATTC
>CQ828776.1 Sequence 494 from Patent WO2004053120
TCAGGGGA
>CQ828765.1 Sequence 483 from Patent WO2004053120
CTGGGGGA
>CQ828694.1 Sequence 412 from Patent WO2004053120
TCACGTGC
>CQ828680.1 Sequence 398 from Patent WO2004053120
CTCGGGGA
>CQ828674.1 Sequence 392 from Patent WO2004053120
CCAGGGGA
>CQ828653.1 Sequence 371 from Patent WO2004053120
CTGGGGGA
>CQ828641.1 Sequence 359 from Patent WO2004053120
AGAGGGGA
>CQ828637.1 Sequence 355 from Patent WO2004053120
AAGGGGGA
>CQ828626.1 Sequence 344 from Patent WO2004053120
TGACGTGA
>CQ828625.1 Sequence 343 from Patent WO2004053120
TGACGTGA
>CQ828610.1 Sequence 328 from Patent WO2004053120
GTTGGGGA
>CQ828608.1 Sequence 326 from Patent WO2004053120
GTTGGGGA
>CQ828593.1 Sequence 311 from Patent WO2004053120
CTTAATTC
>CQ828592.1 Sequence 310 from Patent WO2004053120
ATAGGGGA
>CQ828575.1 Sequence 293 from Patent WO2004053120
GCTGGGGA
>CQ828573.1 Sequence 291 from Patent WO2004053120
GCTGGGGA
>CQ828548.1 Sequence 266 from Patent WO2004053120
GATGGGGA
>CQ828541.1 Sequence 259 from Patent WO2004053120
GATGGGGA
>CQ828505.1 Sequence 223 from Patent WO2004053120
CATAATTC
>CQ828491.1 Sequence 209 from Patent WO2004053120
AAGGGGGA
>CQ828463.1 Sequence 181 from Patent WO2004053120
TGACGTGC
>CQ828456.1 Sequence 174 from Patent WO2004053120
GCACGTGA
>CQ828444.1 Sequence 162 from Patent WO2004053120
CTGGGGGA
>CQ828435.1 Sequence 153 from Patent WO2004053120
TGTGGGGA
>CQ828426.1 Sequence 144 from Patent WO2004053120
GTAGGGGA
>CQ828388.1 Sequence 106 from Patent WO2004053120
AATGGGGA
>CQ828386.1 Sequence 104 from Patent WO2004053120
CTTAATGG
>CQ828382.1 Sequence 100 from Patent WO2004053120
AGTGGGGA
>CQ828380.1 Sequence 98 from Patent WO2004053120
CCTAATTG
>CQ828373.1 Sequence 91 from Patent WO2004053120
GTAGGGGA
>CQ828372.1 Sequence 90 from Patent WO2004053120
TGAGGGGA
>CQ828321.1 Sequence 39 from Patent WO2004053120
CATAATTA
>CQ828315.1 Sequence 33 from Patent WO2004053120
AATGGGGA
>CQ828306.1 Sequence 24 from Patent WO2004053120
AGTGGGGA
>CQ821473.1 Sequence 9 from Patent EP1428892
CCACCAGC
>CQ818362.1 Sequence 4 from Patent WO2004044581
GGCGTGTG
>CQ806365.1 Sequence 2776 from Patent WO2004035798
TTTCCCGC
>CQ806364.1 Sequence 2775 from Patent WO2004035798
WTTSSCSS
>CQ802992.1 Sequence 20 from Patent WO2004035781
GCAGTGNN
>CQ802991.1 Sequence 19 from Patent WO2004035781
GCAATGNN
>CQ802978.1 Sequence 6 from Patent WO2004035781
GCAATGNN
>CQ802977.1 Sequence 5 from Patent WO2004035781
GCAGTGNN
>CQ798757.1 Sequence 20 from Patent EP1411122
GCAGTGNN
>CQ798756.1 Sequence 19 from Patent EP1411122
GCAATGNN
>CQ798743.1 Sequence 6 from Patent EP1411122
GCAATGNN
>CQ798742.1 Sequence 5 from Patent EP1411122
GCAGTGNN
>CQ796052.1 Sequence 24 from Patent EP1405921
GCCGCCGT
>CQ796051.1 Sequence 23 from Patent EP1405921
GCAGTTAT
>CQ796050.1 Sequence 22 from Patent EP1405921
ACCTCCGT
>CQ796049.1 Sequence 21 from Patent EP1405921
ACAGTTGT
>CQ796048.1 Sequence 20 from Patent EP1405921
ACATTTAT
>CQ774840.1 Sequence 3 from Patent WO2004012688
TGACGTTC
>CQ771719.1 Sequence 11 from Patent WO2004009824
NATTTTTN
>CQ771715.1 Sequence 7 from Patent WO2004009824
NTATTTTN
>CQ771713.1 Sequence 5 from Patent WO2004009824
NTATATAN
>CQ758730.1 Sequence 1034 from Patent WO2003106684
CAGNNCGC
>CQ758713.1 Sequence 1017 from Patent WO2003106684
CGGNNCCA
>CQ758706.1 Sequence 1010 from Patent WO2003106684
GCGNNGAC
>CQ758669.1 Sequence 973 from Patent WO2003106684
CCGNNGAC
>CQ758667.1 Sequence 971 from Patent WO2003106684
GGCNNCGA
>CQ758627.1 Sequence 931 from Patent WO2003106684
GAGNNCGC
>CQ758602.1 Sequence 906 from Patent WO2003106684
AGGNNCCG
>CQ758601.1 Sequence 905 from Patent WO2003106684
CGGNNCAG
>CQ758572.1 Sequence 876 from Patent WO2003106684
CGANNACG
>CQ758566.1 Sequence 870 from Patent WO2003106684
CAGNNGGC
>CQ758559.1 Sequence 863 from Patent WO2003106684
CCGNNGTC
>CQ758558.1 Sequence 862 from Patent WO2003106684
GCGNNGCA
>CQ758555.1 Sequence 859 from Patent WO2003106684
GCANNGCC
>CQ758552.1 Sequence 856 from Patent WO2003106684
CGGNNGCA
>CQ758551.1 Sequence 855 from Patent WO2003106684
CCCNNGCC
>CQ758540.1 Sequence 844 from Patent WO2003106684
CGTNNGCA
>CQ758530.1 Sequence 834 from Patent WO2003106684
CGCNNACA
>CQ758518.1 Sequence 822 from Patent WO2003106684
CCANNGGG
>CQ758515.1 Sequence 819 from Patent WO2003106684
CGCNNGGA
>CQ758500.1 Sequence 804 from Patent WO2003106684
CCCNNGAA
>CQ758495.1 Sequence 799 from Patent WO2003106684
AGCNNCGC
>CQ758445.1 Sequence 749 from Patent WO2003106684
CAGNNGGG
>CQ758441.1 Sequence 745 from Patent WO2003106684
CCCNNCCC
>CQ758434.1 Sequence 738 from Patent WO2003106684
GCCNNCGA
>CQ758426.1 Sequence 730 from Patent WO2003106684
GACNNCCC
>CQ758380.1 Sequence 684 from Patent WO2003106684
ACGNNCCC
>CQ758368.1 Sequence 672 from Patent WO2003106684
CCCNNTCC
>CQ758365.1 Sequence 669 from Patent WO2003106684
CGCNNCCG
>CQ758358.1 Sequence 662 from Patent WO2003106684
CCGNNGGC
>CQ758349.1 Sequence 653 from Patent WO2003106684
CGGNNCCC
>CQ758267.1 Sequence 571 from Patent WO2003106684
GACNNCGC
>CQ758262.1 Sequence 566 from Patent WO2003106684
CCGNNGCC
>CQ758198.1 Sequence 502 from Patent WO2003106684
CCCNNGCG
>CQ758180.1 Sequence 484 from Patent WO2003106684
CCCNNCGC
>CQ758116.1 Sequence 420 from Patent WO2003106684
GCGNNCCC
>CQ758109.1 Sequence 413 from Patent WO2003106684
AGGNNGGG
>CQ758103.1 Sequence 407 from Patent WO2003106684
GCGNNGCC
>CQ758080.1 Sequence 384 from Patent WO2003106684
CCCNNCGG
>CQ756492.1 Sequence 993 from Patent WO2003106674
CAGNNCGC
>CQ756475.1 Sequence 976 from Patent WO2003106674
CGGNNCCA
>CQ756468.1 Sequence 969 from Patent WO2003106674
GCGNNGAC
>CQ756431.1 Sequence 932 from Patent WO2003106674
CCGNNGAC
>CQ756429.1 Sequence 930 from Patent WO2003106674
GGCNNCGA
>CQ756389.1 Sequence 890 from Patent WO2003106674
GAGNNCGC
>CQ756364.1 Sequence 865 from Patent WO2003106674
AGGNNCCG
>CQ756363.1 Sequence 864 from Patent WO2003106674
CGGNNCAG
>CQ756334.1 Sequence 835 from Patent WO2003106674
CGANNACG
>CQ756328.1 Sequence 829 from Patent WO2003106674
CAGNNGGC
>CQ756321.1 Sequence 822 from Patent WO2003106674
CCGNNGTC
>CQ756320.1 Sequence 821 from Patent WO2003106674
GCGNNGCA
>CQ756317.1 Sequence 818 from Patent WO2003106674
GCANNGCC
>CQ756314.1 Sequence 815 from Patent WO2003106674
CGGNNGCA
>CQ756313.1 Sequence 814 from Patent WO2003106674
CCCNNGCC
>CQ756302.1 Sequence 803 from Patent WO2003106674
CGTNNGCA
>CQ756292.1 Sequence 793 from Patent WO2003106674
CGCNNACA
>CQ756280.1 Sequence 781 from Patent WO2003106674
CCANNGGG
>CQ756277.1 Sequence 778 from Patent WO2003106674
CGCNNGGA
>CQ756262.1 Sequence 763 from Patent WO2003106674
CCCNNGAA
>CQ756257.1 Sequence 758 from Patent WO2003106674
AGCNNCGC
>CQ756207.1 Sequence 708 from Patent WO2003106674
CAGNNGGG
>CQ756203.1 Sequence 704 from Patent WO2003106674
CCCNNCCC
>CQ756196.1 Sequence 697 from Patent WO2003106674
GCCNNCGA
>CQ756188.1 Sequence 689 from Patent WO2003106674
GACNNCCC
>CQ756142.1 Sequence 643 from Patent WO2003106674
ACGNNCCC
>CQ756130.1 Sequence 631 from Patent WO2003106674
CCCNNTCC
>CQ756127.1 Sequence 628 from Patent WO2003106674
CGCNNCCG
>CQ756120.1 Sequence 621 from Patent WO2003106674
CCGNNGGC
>CQ756111.1 Sequence 612 from Patent WO2003106674
CGGNNCCC
>CQ756029.1 Sequence 530 from Patent WO2003106674
GACNNCGC
>CQ756024.1 Sequence 525 from Patent WO2003106674
CCGNNGCC
>CQ755960.1 Sequence 461 from Patent WO2003106674
CCCNNGCG
>CQ755942.1 Sequence 443 from Patent WO2003106674
CCCNNCGC
>CQ755878.1 Sequence 379 from Patent WO2003106674
GCGNNCCC
>CQ755871.1 Sequence 372 from Patent WO2003106674
AGGNNGGG
>CQ755865.1 Sequence 366 from Patent WO2003106674
GCGNNGCC
>CQ755842.1 Sequence 343 from Patent WO2003106674
CCCNNCGG
>AX963318.1 Sequence 12 from Patent WO03104462
TGGCCGAC
>BD010775.1 Specific gene activation by chimeric Gal4 transcription factors in stable transgenic plants
CATGCATA
>BD010774.1 Specific gene activation by chimeric Gal4 transcription factors in stable transgenic plants
CATGCAAG
>BD010773.1 Specific gene activation by chimeric Gal4 transcription factors in stable transgenic plants
CATGCATG
>AJ538802.1 Nicotiana tabacum cDNA-AFLP-fragment BT1-M32-057
AGGCCTTA
>AX934363.1 Sequence 3 from Patent EP1357184
TTACCTCA
>AX934362.1 Sequence 2 from Patent EP1357184
STGASTMA
>AX933968.1 Sequence 77 from Patent WO03087409
CCTGCAGG
>AX933965.1 Sequence 74 from Patent WO03087409
TTAATTAA
>AX933935.1 Sequence 44 from Patent WO03087409
CRCCGGYG
>AX933932.1 Sequence 41 from Patent WO03087409
GGCGCGCC
>AX933926.1 Sequence 35 from Patent WO03087409
CACCGGTG
>AX926314.1 Sequence 5 from Patent WO02068667
TGACGTCA
>AX923460.1 Sequence 37 from Patent WO03080816
ATTTGCAT
>AX923456.1 Sequence 33 from Patent WO03080816
ATGCTAAT
>AX923454.1 Sequence 31 from Patent WO03080816
ATGCAAAT
>AX840587.1 Sequence 131 from Patent WO03077643
GCCACYTC
>AX840586.1 Sequence 130 from Patent WO03077643
CATGCATG
>AX840270.1 Sequence 29 from Patent WO03078660
AGGTRAGT
>AX840242.1 Sequence 1 from Patent WO03078660
AGGTRAGT
>AX825544.1 Sequence 4 from Patent WO03073105
GGGGGCCC
>AX821789.1 Sequence 22 from Patent WO03068992
GGTTAACC
>AX821786.1 Sequence 19 from Patent WO03068992
TAGGCCGT
>AX815436.1 Sequence 11 from Patent EP1336658
GCGGGAAA
>AX815435.1 Sequence 10 from Patent EP1336658
TTTNNCGC
>AX812718.1 Sequence 4 from Patent WO03062433
AAACCCTA
>AX812716.1 Sequence 2 from Patent WO03062433
TTTCCCGC
>AX812715.1 Sequence 1 from Patent WO03062433
GCGGGAAA
>AX805889.1 Sequence 35 from Patent WO03060163
GGGAGAGG
>AX805888.1 Sequence 34 from Patent WO03060163
GGGTTGGA
>AX805887.1 Sequence 33 from Patent WO03060163
GGTTGGTT
>AX805886.1 Sequence 32 from Patent WO03060163
GGTATATT
>AX805885.1 Sequence 31 from Patent WO03060163
ATTATATA
>AX805884.1 Sequence 30 from Patent WO03060163
CCTGTCTG
>AX805883.1 Sequence 29 from Patent WO03060163
GCTCCTAC
>AX805882.1 Sequence 28 from Patent WO03060163
CACCCATC
>AX805881.1 Sequence 27 from Patent WO03060163
CTCCCTCC
>AX799762.1 Sequence 10 from Patent WO03030656
NNTTTTNN
>AX799758.1 Sequence 6 from Patent WO03030656
NNTTTTNN
>AX797034.1 Sequence 49 from Patent WO03052140
GCATCAGT
>AX797025.1 Sequence 40 from Patent WO03052140
ACGTTACG
>AX796772.1 Sequence 49 from Patent WO03052142
GCATCAGT
>AX796763.1 Sequence 40 from Patent WO03052142
ACGTTACG
>AX795480.1 Sequence 49 from Patent WO03052141
GCATCAGT
>AX795471.1 Sequence 40 from Patent WO03052141
ACGTTACG
>BD193395.1 Therapeutic and diagnostic tools for impaired glucose tolerance conditions
CAAAAYAA
>BD192539.1 Compositions and methods for the delivery of oligonucleotides via the alimentary canal
TTGGGGTT
>BD191595.1 Enzymatic DNA molecules
TCACTATN
>BD191357.1 DNA-based transposon system for the introduction of nucleic acid into DNA of a cell
ACATACAC
>BD190434.1 Microemulsions with Adsorbed Macromoelecules and Microparticles
TCTTCGAA
>BD190433.1 Microemulsions with Adsorbed Macromoelecules and Microparticles
TCATCGAT
>BD190432.1 Microemulsions with Adsorbed Macromoelecules and Microparticles
TCAACGCT
>BD190431.1 Microemulsions with Adsorbed Macromoelecules and Microparticles
TCAGCGCT
>BD190430.1 Microemulsions with Adsorbed Macromoelecules and Microparticles
TCGACGTC
>BD190429.1 Microemulsions with Adsorbed Macromoelecules and Microparticles
GCAACGTT
>BD190428.1 Microemulsions with Adsorbed Macromoelecules and Microparticles
TCAACGTT
>BD187832.1 A method for designing a peptide nucleic acid
GAGCCGTG
>BD187831.1 A method for designing a peptide nucleic acid
CACGGCTC
>BD187830.1 A method for designing a peptide nucleic acid
GCCGTGAG
>BD187829.1 A method for designing a peptide nucleic acid
CTCACGGC
>AX794201.1 Sequence 32 from Patent WO02092827
TCTCAACT
>AX794200.1 Sequence 31 from Patent WO02092827
CTTAACAA
>AX787347.1 Sequence 62 from Patent WO03044193
NNAGAGAC
>AX787346.1 Sequence 61 from Patent WO03044193
NNGGAAGA
>AX787309.1 Sequence 24 from Patent WO03044193
NGGTCTCN
>AX787306.1 Sequence 21 from Patent WO03044193
NCGTCTCN
>AX787304.1 Sequence 19 from Patent WO03044193
NNNNNGTC
>AX787291.1 Sequence 6 from Patent WO03044193
GCAATGNN
>AX787290.1 Sequence 5 from Patent WO03044193
GCAGTGNN
>AX786602.1 Sequence 93 from Patent WO03030934
TCTTCGAT
>AX786537.1 Sequence 28 from Patent WO03030934
TCAACGTC
>AX786536.1 Sequence 27 from Patent WO03030934
AACGTTCT
>AX786535.1 Sequence 26 from Patent WO03030934
CCAACGTT
>AX786533.1 Sequence 24 from Patent WO03030934
TCTTCGAA
>AX786532.1 Sequence 23 from Patent WO03030934
TCATCGAT
>AX786531.1 Sequence 22 from Patent WO03030934
TCAGCGCT
>AX786530.1 Sequence 21 from Patent WO03030934
TCAACGTT
>AX775646.1 Sequence 49 from Patent EP1319718
GCATCAGT
>AX775637.1 Sequence 40 from Patent EP1319718
ACGTTACG
>AX770099.1 Sequence 9 from Patent WO03016537
TACTAACA
>AX766264.1 Sequence 12 from Patent WO03027324
TGGTAATA
>AX766261.1 Sequence 9 from Patent WO03027324
GGGGAACC
>AX766260.1 Sequence 8 from Patent WO03027324
TGGGGATT
>AX765530.1 Sequence 1000 from Patent WO03004704
CAGNNCGC
>AX765513.1 Sequence 983 from Patent WO03004704
CGGNNCCA
>AX765506.1 Sequence 976 from Patent WO03004704
GCGNNGAC
>AX765469.1 Sequence 939 from Patent WO03004704
CCGNNGAC
>AX765467.1 Sequence 937 from Patent WO03004704
GGCNNCGA
>AX765427.1 Sequence 897 from Patent WO03004704
GAGNNCGC
>AX765402.1 Sequence 872 from Patent WO03004704
AGGNNCCG
>AX765401.1 Sequence 871 from Patent WO03004704
CGGNNCAG
>AX765372.1 Sequence 842 from Patent WO03004704
CGANNACG
>AX765366.1 Sequence 836 from Patent WO03004704
CAGNNGGC
>AX765359.1 Sequence 829 from Patent WO03004704
CCGNNGTC
>AX765358.1 Sequence 828 from Patent WO03004704
GCGNNGCA
>AX765355.1 Sequence 825 from Patent WO03004704
GCANNGCC
>AX765352.1 Sequence 822 from Patent WO03004704
CGGNNGCA
>AX765351.1 Sequence 821 from Patent WO03004704
CCCNNGCC
>AX765340.1 Sequence 810 from Patent WO03004704
CGTNNGCA
>AX765330.1 Sequence 800 from Patent WO03004704
CGCNNACA
>AX765318.1 Sequence 788 from Patent WO03004704
CCANNGGG
>AX765315.1 Sequence 785 from Patent WO03004704
CGCNNGGA
>AX765300.1 Sequence 770 from Patent WO03004704
CCCNNGAA
>AX765295.1 Sequence 765 from Patent WO03004704
AGCNNCGC
>AX765245.1 Sequence 715 from Patent WO03004704
CAGNNGGG
>AX765241.1 Sequence 711 from Patent WO03004704
CCCNNCCC
>AX765234.1 Sequence 704 from Patent WO03004704
GCCNNCGA
>AX765226.1 Sequence 696 from Patent WO03004704
GACNNCCC
>AX765180.1 Sequence 650 from Patent WO03004704
ACGNNCCC
>AX765168.1 Sequence 638 from Patent WO03004704
CCCNNTCC
>AX765165.1 Sequence 635 from Patent WO03004704
CGCNNCCG
>AX765158.1 Sequence 628 from Patent WO03004704
CCGNNGGC
>AX765149.1 Sequence 619 from Patent WO03004704
CGGNNCCC
>AX765067.1 Sequence 537 from Patent WO03004704
GACNNCGC
>AX765062.1 Sequence 532 from Patent WO03004704
CCGNNGCC
>AX764998.1 Sequence 468 from Patent WO03004704
CCCNNGCG
>AX764980.1 Sequence 450 from Patent WO03004704
CCCNNCGC
>AX764916.1 Sequence 386 from Patent WO03004704
GCGNNCCC
>AX764909.1 Sequence 379 from Patent WO03004704
AGGNNGGG
>AX764903.1 Sequence 373 from Patent WO03004704
GCGNNGCC
>AX764880.1 Sequence 350 from Patent WO03004704
CCCNNCGG
>BD183528.1 Recombinant avipox virus
ATTTTTAT
>BD183525.1 Recombinant avipox virus
ATGGCGTC
>BD183524.1 Recombinant avipox virus
CCTGCAGG
>BD181780.1 The apparatus and method for genetic testing
GCAGATCG
>AX741054.1 Sequence 2 from Patent WO03026688
TCAACGTT
>AX722024.1 Sequence 9 from Patent EP1298212
GCGGCCGC
>AX720832.1 Sequence 12 from Patent WO03006996
TGACGTCA
>AX720169.1 Sequence 5 from Patent EP1296143
TAAGGAGG
>AX719140.1 Sequence 12 from Patent EP1295950
TGGTAATA
>AX719137.1 Sequence 9 from Patent EP1295950
GGGGAACC
>AX719136.1 Sequence 8 from Patent EP1295950
TGGGGATT
>AX698535.1 Sequence 24 from Patent WO03010335
GCCGCCGT
>AX698534.1 Sequence 23 from Patent WO03010335
GCAGTTAT
>AX698533.1 Sequence 22 from Patent WO03010335
ACCTCCGT
>AX698532.1 Sequence 21 from Patent WO03010335
ACAGTTGT
>AX698531.1 Sequence 20 from Patent WO03010335
ACAGTTAT
>AX687169.1 Sequence 90 from Patent WO03008638
TAGGCATT
>AX687167.1 Sequence 88 from Patent WO03008638
TTACGGAT
>AX687164.1 Sequence 85 from Patent WO03008638
CTAGGATT
>AX687127.1 Sequence 48 from Patent WO03008638
CTAGGATT
>AX687126.1 Sequence 47 from Patent WO03008638
AATCCTAG
>AX687125.1 Sequence 46 from Patent WO03008638
TACGCATT
>AX687124.1 Sequence 45 from Patent WO03008638
AATGCGTA
>AX687123.1 Sequence 44 from Patent WO03008638
TAGACTGG
>AX687122.1 Sequence 43 from Patent WO03008638
CCAGTCTA
>AX687121.1 Sequence 42 from Patent WO03008638
TATGCCAG
>AX687120.1 Sequence 41 from Patent WO03008638
CTGGCATA
>AX687119.1 Sequence 40 from Patent WO03008638
TAGCAGTT
>AX687118.1 Sequence 39 from Patent WO03008638
AACTGCTA
>AX687117.1 Sequence 38 from Patent WO03008638
TAGTGACT
>AX687116.1 Sequence 37 from Patent WO03008638
AGTCACTA
>AX687115.1 Sequence 36 from Patent WO03008638
TAACGGTT
>AX687114.1 Sequence 35 from Patent WO03008638
AACCGTTA
>AX687113.1 Sequence 34 from Patent WO03008638
TGGCAATT
>AX687112.1 Sequence 33 from Patent WO03008638
AATTGCCA
>AX687111.1 Sequence 32 from Patent WO03008638
TAGTCAGT
>AX687110.1 Sequence 31 from Patent WO03008638
ACTGACTA
>AX687109.1 Sequence 30 from Patent WO03008638
TAAGCGTT
>AX687108.1 Sequence 29 from Patent WO03008638
AACGCTTA
>AX687107.1 Sequence 28 from Patent WO03008638
TAGGTCAT
>AX687106.1 Sequence 27 from Patent WO03008638
ATGACCTA
>AX687105.1 Sequence 26 from Patent WO03008638
TAAGGCTT
>AX687104.1 Sequence 25 from Patent WO03008638
AAGCCTTA
>AX687103.1 Sequence 24 from Patent WO03008638
TGGAACTT
>AX687102.1 Sequence 23 from Patent WO03008638
AAGTTCCA
>AX687101.1 Sequence 22 from Patent WO03008638
TAGCTAGT
>AX687100.1 Sequence 21 from Patent WO03008638
ACTAGCTA
>AX687099.1 Sequence 20 from Patent WO03008638
TAGAGCTT
>AX687098.1 Sequence 19 from Patent WO03008638
AAGCTCTA
>AX687097.1 Sequence 18 from Patent WO03008638
TCGAGATT
>AX687096.1 Sequence 17 from Patent WO03008638
AATCTCGA
>AX687095.1 Sequence 16 from Patent WO03008638
TGAGTACT
>AX687094.1 Sequence 15 from Patent WO03008638
AGTACTCA
>AX687093.1 Sequence 14 from Patent WO03008638
TGAACGTT
>AX687092.1 Sequence 13 from Patent WO03008638
AACGTTCA
>AX687091.1 Sequence 12 from Patent WO03008638
TGCGAATT
>AX687090.1 Sequence 11 from Patent WO03008638
AATTCGCA
>AX687089.1 Sequence 10 from Patent WO03008638
TACGGATT
>AX687088.1 Sequence 9 from Patent WO03008638
AATCCGTA
>AX687087.1 Sequence 8 from Patent WO03008638
TGGACATT
>AX687086.1 Sequence 7 from Patent WO03008638
AATGTCCA
>AX687085.1 Sequence 6 from Patent WO03008638
TAGGACTT
>AX687084.1 Sequence 5 from Patent WO03008638
AAGTCCTA
>AX687083.1 Sequence 4 from Patent WO03008638
TAGCGATT
>AX687082.1 Sequence 3 from Patent WO03008638
AATCGCTA
>AX687081.1 Sequence 2 from Patent WO03008638
TAGGCATT
>AX687080.1 Sequence 1 from Patent WO03008638
AATGCCTA
>AX617011.1 Sequence 18 from Patent WO02095023
CGAGCATG
>BD166144.1 Recombinant vaccinia virus
ATGGCGTC
>BD166143.1 Recombinant vaccinia virus
CCTGCAGG
>AX590208.1 Sequence 15 from Patent WO02083888
CKCCARTA
>AX590205.1 Sequence 12 from Patent WO02083888
TCNARNCC
>BD166147.1 Recombinant vaccinia virus
ATTTTTAT
>BD144670.1 Peptide nucleic acid having elevated binding affinity, sequence specificity and solubility
GCGTTTGC
>BD144664.1 Peptide nucleic acid having elevated binding affinity, sequence specificity and solubility
GCNNNCGC
>AX583614.1 Sequence 2 from Patent WO02072877
ACCTGCCC
>AX573622.1 Sequence 32 from Patent WO02079467
GCTGTTTC
>AX556266.1 Sequence 11 from Patent WO0242447
CCAGGAAG
>AX556258.1 Sequence 3 from Patent WO0242447
TGACGTCA
>AX547853.1 Sequence 992 from Patent WO02053141
TCAACGTT
>AX547684.1 Sequence 823 from Patent WO02053141
CTGACGTG
>AX547674.1 Sequence 813 from Patent WO02053141
CCCCCCCC
>AX547671.1 Sequence 810 from Patent WO02053141
TGCGCTCT
>AX547652.1 Sequence 791 from Patent WO02053141
TCAACGTC
>AX547651.1 Sequence 790 from Patent WO02053141
TCTTCGAA
>AX547570.1 Sequence 709 from Patent WO02053141
TNAACGTT
>AX547568.1 Sequence 707 from Patent WO02053141
TCAGNGCT
>AX547560.1 Sequence 699 from Patent WO02053141
CCTTCGAT
>AX547559.1 Sequence 698 from Patent WO02053141
TCAANGTT
>AX547542.1 Sequence 681 from Patent WO02053141
TCCGTACG
>AX547541.1 Sequence 680 from Patent WO02053141
TCCGATCG
>AX547540.1 Sequence 679 from Patent WO02053141
AACGTTCT
>AX547539.1 Sequence 678 from Patent WO02053141
ATAACGTT
>AX547538.1 Sequence 677 from Patent WO02053141
AAAACGTT
